Clinerion Ltd Contact Details:
Main address: Margarethenstrasse 47 4053 Basel, Switzerland ,
Tel:+41 61 865 60 60 , E-mail: info(at)clinerion.com Website:

Clinerion Patient Network Explorer

Clinerion Patient Network Explorer

Optimized study design, precise site selection and faster patient search and identification for clinical research - in real time.

Clinerion Cookie Policy

Welcome to the Clinerion website. This website uses cookies. These cookies are used on your browser to understand how you are using our website. Using this website means you agree to our use of cookies. If you prefer not to have these cookies on your device, we advise you to disable them in your web browser settings. You accept the use of cookies by accepting this notice. You can read more details via our Privacy Policy page.

Privacy Policy page >


News

Keep up-to-date with Clinerion!



Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

Publication date: April 05, 2023

Publication in eClinicalMedicine, Volume 58, April 2023

Authors: E.A. Voss, et al - incl. Clinerion's Barış Erdoğan
https://doi.org/10.1016/j.eclinm.2023.101932

Since coronavirus disease 2019 (COVID-19) was first reported until July 2022, over 554 million cases and 6.3 million deaths have been reported worldwide. COVID-19 vaccines have demonstrated to reduce COVID-19 hospitalisations and deaths, both in randomised controlled trials and in real-world observational studies. As of 30th May 2022, more than 5 billion people (approximately 67% of the global population) have received at least one dose of a COVID-19 vaccine. At least 39 vaccines have been authorised or approved for use by at least one country, of which 11 have been granted emergency use by the World Health Organization (WHO). Although vaccine safety has been rigorously monitored in clinical trials, rare adverse events can go undetected during vaccine development due to limited number of trial participants, a relatively short follow-up duration, and insufficient generalisability to the broader population ...

Link to the paper in eClinicalMedicine >

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
Publication in eClinicalMedicine, Volume 58, April 2023
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24

Authors: E.A. Voss, et al - incl. Clinerion's Barış Erdoğan
https://doi.org/10.1016/j.eclinm.2023.101932

Since coronavirus disease 2019 (COVID-19) was first reported until July 2022, over 554 million cases and 6.3 million deaths have been reported worldwide. COVID-19 vaccines have demonstrated to reduce COVID-19 hospitalisations and deaths, both in randomised controlled trials and in real-world observational studies. As of 30th May 2022, more than 5 billion people (approximately 67% of the global population) have received at least one dose of a COVID-19 vaccine. At least 39 vaccines have been authorised or approved for use by at least one country, of which 11 have been granted emergency use by the World Health Organization (WHO). Although vaccine safety has been rigorously monitored in clinical trials, rare adverse events can go undetected during vaccine development due to limited number of trial participants, a relatively short follow-up duration, and insufficient generalisability to the broader population ...

Link to the paper in eClinicalMedicine >



TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership

Publication date: April 04, 2023

As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary.

TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership

TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership
As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary.
TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership


Clinerion is part of Citeline, a Norstella company!

Publication date: January 30, 2023

We are pleased to officially announce that Clinerion has become part of Citeline, a Norstella company. Norstella is now poised to be one of the world’s largest pharma intelligence solutions providers on the market.

Link to the announcement from Clinerion CEO Barış Erdoğan >
Link to the announcement of the merger of Citeline and Norstella >

With the integration into Citeline, Clinerion has the opportunity to access tools and services complementary to our own, expanding the portfolio of offers, as well as access to experts and expertise along the entire clinical intelligence, planning, development and trials process streams. This will allow us to continue to develop cutting-edge technologies and expand our real-world data network. 

Our joining Citeline and the Norstella group is excellent news for you, our partners and customers, who will benefit from our combined expertise, a wider portfolio of products, faster innovation, and enhanced capabilities, providing even greater value to your business over time. In the meantime, Clinerion will continue to provide the outstanding customer service you have come to expect, and your interaction with our business will continue as usual.

Link to the announcement from Clinerion CEO Barış Erdoğan >
Link to the announcement of the merger of Citeline and Norstella >

Clinerion is part of Citeline, a Norstella company!

Clinerion is part of Citeline, a Norstella company!
We are pleased to officially announce that Clinerion has become part of Citeline, a Norstella company. Norstella is now poised to be one of the world’s largest pharma intelligence solutions providers on the market.
Clinerion is part of Citeline, a Norstella company!

Link to the announcement from Clinerion CEO Barış Erdoğan >
Link to the announcement of the merger of Citeline and Norstella >

With the integration into Citeline, Clinerion has the opportunity to access tools and services complementary to our own, expanding the portfolio of offers, as well as access to experts and expertise along the entire clinical intelligence, planning, development and trials process streams. This will allow us to continue to develop cutting-edge technologies and expand our real-world data network. 

Our joining Citeline and the Norstella group is excellent news for you, our partners and customers, who will benefit from our combined expertise, a wider portfolio of products, faster innovation, and enhanced capabilities, providing even greater value to your business over time. In the meantime, Clinerion will continue to provide the outstanding customer service you have come to expect, and your interaction with our business will continue as usual.

Link to the announcement from Clinerion CEO Barış Erdoğan >
Link to the announcement of the merger of Citeline and Norstella >



Press release: Mount Lebanon Hospital University Medical Center joins the Clinerion Patient Network Explorer platform, accelerating the introduction of innovative therapies to Lebanon.

Publication date: November 23, 2022

Mount Lebanon Hospital University Medical Center - MLHUMC is partnering with Clinerion and has joined the global network of partner hospitals on Clinerion’s Patient Network Explorer. Patients at MLHUMC will gain accelerated access to innovative therapies via participation in international clinical trials. MLHUMC will gain access to metrics to support patient care, and the country of Lebanon itself will benefit from early data to support registration of new therapies.

Mount Lebanon Hospital University Medical Center - MLHUMC is a hospital in the city of Hazmieh, Lebanon, with a 400-bed capacity and specializing in cardiology, oncology, rare diseases, diabetes, dermatology, surgery, imaging, critical care and endocrinology, with 12 pediatric life support (PLS) stations. As a clinical trial site, MLHUMC performs 59 trials per year.

PDF File: Click here to read the full release >

Press release: Mount Lebanon Hospital University Medical Center joins the Clinerion Patient Network Explorer platform, accelerating the introduction of innovative therapies to Lebanon.

Press release: Mount Lebanon Hospital University Medical Center joins the Clinerion Patient Network Explorer platform, accelerating the introduction of innovative therapies to Lebanon.
Mount Lebanon Hospital University Medical Center - MLHUMC is partnering with Clinerion and has joined the global network of partner hospitals on Clinerion’s Patient Network Explorer. Patients at MLHUMC will gain accelerated access to innovative therapies via participation in international clinical trials. MLHUMC will gain access to metrics to support patient care, and the country of Lebanon itself will benefit from early data to support registration of new therapies.
Press release: Mount Lebanon Hospital University Medical Center joins the Clinerion Patient Network E

Mount Lebanon Hospital University Medical Center - MLHUMC is a hospital in the city of Hazmieh, Lebanon, with a 400-bed capacity and specializing in cardiology, oncology, rare diseases, diabetes, dermatology, surgery, imaging, critical care and endocrinology, with 12 pediatric life support (PLS) stations. As a clinical trial site, MLHUMC performs 59 trials per year.



Press release: Clinerion launches its Federated Machine Learning Platform, a machine learning (ML) infrastructure to train machine learning algorithms on a global, distributed real-world data (RWD) network.

Publication date: November 09, 2022

Clinerion launches its Federated Machine Learning Platform, a global, federated machine learning (ML) platform on its Patient Network Explorer infrastructure, incorporating its global network of partner hospitals. This new platform will enable sophisticated analytics and pattern recognition use cases on real-world data (RWD) across the Patient Network Explorer network, ultimately offering better diagnosis of patients.

Using the Clinerion Federated Machine Learning Platform, users can train models on local data to identify pattern in local patient cohorts, and further optimize models by using data from multiple sites. For RWD, it can be used to develop detailed models based upon all possible heterogenous disease presentations and novel predictive biomarkers, enabling the prediction of high risk in patients before they reach critical state, as well as the generation of disease phenotype sets for the identification of undiagnosed diseases, e.g., to find rare disease patients.

See more about our Federated Machine Learning Platform >

PDF File: Click here to read the full release >

Press release: Clinerion launches its Federated Machine Learning Platform, a machine learning (ML) infrastructure to train machine learning algorithms on a global, distributed real-world data (RWD) network.

Press release: Clinerion launches its Federated Machine Learning Platform, a machine learning (ML) infrastructure to train machine learning algorithms on a global, distributed real-world data (RWD) network.
Clinerion launches its Federated Machine Learning Platform, a global, federated machine learning (ML) platform on its Patient Network Explorer infrastructure, incorporating its global network of partner hospitals. This new platform will enable sophisticated analytics and pattern recognition use cases on real-world data (RWD) across the Patient Network Explorer network, ultimately offering better diagnosis of patients.
Press release: Clinerion launches its Federated Machine Learning Platform, a machine learning (ML) in

Using the Clinerion Federated Machine Learning Platform, users can train models on local data to identify pattern in local patient cohorts, and further optimize models by using data from multiple sites. For RWD, it can be used to develop detailed models based upon all possible heterogenous disease presentations and novel predictive biomarkers, enabling the prediction of high risk in patients before they reach critical state, as well as the generation of disease phenotype sets for the identification of undiagnosed diseases, e.g., to find rare disease patients.

See more about our Federated Machine Learning Platform >



Clinerion article: Why Do We Need Patient Diversity in Clinical Trials? (Journal for Clinical Studies)

Publication date: October 04, 2022

Diversity in clinical trials is the topic of the moment and the Journal for Clinical Studies invited Clinerion to write an article on why it's so important ... and why it's so difficult.

Ensuring Drug Safety, First and Foremost, Even Ahead of Drug Efficacy:
In the commercialisation of new medications, the paramount legal responsibilities of the pharmaceutical company are, firstly, to prove that the pharmacology is safe and well understood, and, secondly, to prove  effectiveness against the targeted disease ...

Link to the article in Journal for Clinical Studies, Volume 14, Issue 5 >

PDF File: Download here

Clinerion article: Why Do We Need Patient Diversity in Clinical Trials? (Journal for Clinical Studies)

Clinerion article: Why Do We Need Patient Diversity in Clinical Trials? (Journal for Clinical Studies)
Diversity in clinical trials is the topic of the moment and the Journal for Clinical Studies invited Clinerion to write an article on why it's so important ... and why it's so difficult.
Clinerion article: Why Do We Need Patient Diversity in Clinical Trials? (Journal for Clinical Studies

Ensuring Drug Safety, First and Foremost, Even Ahead of Drug Efficacy:
In the commercialisation of new medications, the paramount legal responsibilities of the pharmaceutical company are, firstly, to prove that the pharmacology is safe and well understood, and, secondly, to prove  effectiveness against the targeted disease ...

Link to the article in Journal for Clinical Studies, Volume 14, Issue 5 >



Press article: 21 Most Innovative Electronic Health Record (EHR) Startups & Companies (Switzerland)

Publication date: September 28, 2022

Data Magazine selected Clinerion as one of their top picks for the best Electronic Health Record (EHR) companies in Switzerland innovating the industry and demonstrating exceptional performance!

Press article: 21 Most Innovative Electronic Health Record (EHR) Startups & Companies (Switzerland)

Press article: 21 Most Innovative Electronic Health Record (EHR) Startups & Companies (Switzerland)
Data Magazine selected Clinerion as one of their top picks for the best Electronic Health Record (EHR) companies in Switzerland innovating the industry and demonstrating exceptional performance!
Press article: 21 Most Innovative Electronic Health Record (EHR) Startups & Companies (Switzerlan


Press release: SCRS Global Impact Partner Program Grows with Addition of Clinerion

Publication date: June 07, 2022

The Society for Clinical Research Sites (SCRS) announced yesterday that Clinerion has joined the organization as a Global Impact Partner (GIP).

“Clinerion is looking forward to a great collaboration with SCRS as a GIP member, based on our mutual principles of supporting clinical trial sites with access to trials, improving trial efficiency and sharing best practices,” said Luis Magalhaes, Clinerion’s Customer Solutions Director. “Clinerion’s worldwide network of hospitals can benefit greatly from SCRS’ expertise and we expect SCRS will benefit from Clinerion’s global reach as they expand beyond the USA. We have great expectations of our contacts with SCRS sites and the other GIP members.”

More information on our Partners page >

PDF File: Click here to read the full release >

Press release: SCRS Global Impact Partner Program Grows with Addition of Clinerion

Press release: SCRS Global Impact Partner Program Grows with Addition of Clinerion
The Society for Clinical Research Sites (SCRS) announced yesterday that Clinerion has joined the organization as a Global Impact Partner (GIP).
Press release: SCRS Global Impact Partner Program Grows with Addition of Clinerion

“Clinerion is looking forward to a great collaboration with SCRS as a GIP member, based on our mutual principles of supporting clinical trial sites with access to trials, improving trial efficiency and sharing best practices,” said Luis Magalhaes, Clinerion’s Customer Solutions Director. “Clinerion’s worldwide network of hospitals can benefit greatly from SCRS’ expertise and we expect SCRS will benefit from Clinerion’s global reach as they expand beyond the USA. We have great expectations of our contacts with SCRS sites and the other GIP members.”

More information on our Partners page >



Press release: Clinerion’s revolutionary ANID technology for de-identification and identification of patient record data in Patient Network Explorer is now patent protected.

Publication date: May 05, 2022

New Clinerion patent constitutes a new technology for patient search and identification based on the electronic medical records of patients held by hospitals. The ANID technology involves exclusively the use of de-identified data, unlinked from identifiers, ensuring the privacy and security of patient information.

Highlights:

  • ANID is based on fully de-identified patient records, with no use of pseudo-IDs.
  • Newly patented technology uses a combination of techniques to match de-identified records with corresponding hospital medical records.
  • Newly patented system set-up increases data security and privacy protection.
  • The newly patented technology uses de-identified records, but enables the duly authorized clinical trial manager at the hospital to identify eligible clinical trial candidate patients.
  • Technology has been in use in the Patient Network Explorer hospital network since 2017.
     

The newly patented ANID technology, implemented in the hospitals in Clinerion’s global hospital network on Patient Network Explorer since 2017, significantly increases the security of private information when using patient medical records to evaluate study feasibility, or identifying patients for enrollment in clinical trials.

PDF File: Click here to read the full release >

Press release: Clinerion’s revolutionary ANID technology for de-identification and identification of patient record data in Patient Network Explorer is now patent protected.

Press release: Clinerion’s revolutionary ANID technology for de-identification and identification of patient record data in Patient Network Explorer is now patent protected.
New Clinerion patent constitutes a new technology for patient search and identification based on the electronic medical records of patients held by hospitals. The ANID technology involves exclusively the use of de-identified data, unlinked from identifiers, ensuring the privacy and security of patient information.
Press release: Clinerion’s revolutionary ANID technology for de-identification and identification of

Highlights:

  • ANID is based on fully de-identified patient records, with no use of pseudo-IDs.
  • Newly patented technology uses a combination of techniques to match de-identified records with corresponding hospital medical records.
  • Newly patented system set-up increases data security and privacy protection.
  • The newly patented technology uses de-identified records, but enables the duly authorized clinical trial manager at the hospital to identify eligible clinical trial candidate patients.
  • Technology has been in use in the Patient Network Explorer hospital network since 2017.
     

The newly patented ANID technology, implemented in the hospitals in Clinerion’s global hospital network on Patient Network Explorer since 2017, significantly increases the security of private information when using patient medical records to evaluate study feasibility, or identifying patients for enrollment in clinical trials.



Press release: Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bringing the Brazilian total to 22 hospitals and over 8 million patients.

Publication date: April 19, 2022

Clinerion has extended its patient coverage in Brazil to three new hospitals with the help of partner iHealth Group. This raises the footprint of Clinerion’s Patient Network Explorer to 22 healthcare organisations and over 8 million patients in Brazil.

The three newest Brazilian hospitals to join the global community of partner hospitals on Clinerion’s Patient Network Explorer platform are:

  • Santa Casa de Misericórdia, Belo Horizonte, Minas Gerais
  • Hospital Tacchini, Bento Gonçalves, Rio Grande do Sul
  • UOPECCAN – União Oeste Paranaense de Estudos e Combate ao Câncer, also known as the Hospital do Câncer, Cascavel, Paraná
     

“We have always said that patients are at the center of everything that we do, and we are pleased to have established a strong coverage in Brazil to support patients in the country,” says Barış Erdoğan, CEO of Clinerion. “As we expand, we become able to offer more and more real-world data useful for the development of next generation treatments and procedures.”

PDF File: Click here to read the full release >

Press release: Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bringing the Brazilian total to 22 hospitals and over 8 million patients.

Press release: Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bringing the Brazilian total to 22 hospitals and over 8 million patients.
Clinerion has extended its patient coverage in Brazil to three new hospitals with the help of partner iHealth Group. This raises the footprint of Clinerion’s Patient Network Explorer to 22 healthcare organisations and over 8 million patients in Brazil.
Press release: Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bri

The three newest Brazilian hospitals to join the global community of partner hospitals on Clinerion’s Patient Network Explorer platform are:

  • Santa Casa de Misericórdia, Belo Horizonte, Minas Gerais
  • Hospital Tacchini, Bento Gonçalves, Rio Grande do Sul
  • UOPECCAN – União Oeste Paranaense de Estudos e Combate ao Câncer, also known as the Hospital do Câncer, Cascavel, Paraná
     

“We have always said that patients are at the center of everything that we do, and we are pleased to have established a strong coverage in Brazil to support patients in the country,” says Barış Erdoğan, CEO of Clinerion. “As we expand, we become able to offer more and more real-world data useful for the development of next generation treatments and procedures.”



Clinerion article: Leveraging Electronic Health Data (in Turkish)

Publication date: March 02, 2022

How can real-word data be used in preventive health and clinical decision support systems, in parallel with the increasing impact of artificial intelligence (AI) and innovative biomedical approaches?

We are happy to share Sinan Findik's new article (only in Turkish for now) in which he defines the main areas where we can benefit from electronic health records (EHRs), draw attention to the potential use of EHRs in preventive health, and present examples where we can benefit more from EHRs in clinical decision support systems in parallel with the increasing impact of artificial intelligence (AI) and innovative biomedical approaches. Our article also includes a real-world evidence (RWE) example of patients who have come to the hospital for a general examination with Clinerion's Patient Network Explorer to make it more understandable what information we can use and how.

PDF File: Download here

Clinerion article: Leveraging Electronic Health Data (in Turkish)

Clinerion article: Leveraging Electronic Health Data (in Turkish)
How can real-word data be used in preventive health and clinical decision support systems, in parallel with the increasing impact of artificial intelligence (AI) and innovative biomedical approaches?
Clinerion article: Leveraging Electronic Health Data (in Turkish)

We are happy to share Sinan Findik's new article (only in Turkish for now) in which he defines the main areas where we can benefit from electronic health records (EHRs), draw attention to the potential use of EHRs in preventive health, and present examples where we can benefit more from EHRs in clinical decision support systems in parallel with the increasing impact of artificial intelligence (AI) and innovative biomedical approaches. Our article also includes a real-world evidence (RWE) example of patients who have come to the hospital for a general examination with Clinerion's Patient Network Explorer to make it more understandable what information we can use and how.



Clinerion article: Utilizing EHR to protect our physicians from COVID (in Turkish)

Publication date: March 01, 2022

How can real-word data be used to protect healthcare professionals from COVID-19, now and in the post-COVID-19 period?

In this article (for now, only in Turkish) Clinerion's Sinan Findik summarizes our new preventive health service model, created using EHRs.

Sinan's article is on page 27.

Link to the original article (in Turkish) >

PDF File: Download here

Clinerion article: Utilizing EHR to protect our physicians from COVID (in Turkish)

Clinerion article: Utilizing EHR to protect our physicians from COVID (in Turkish)
How can real-word data be used to protect healthcare professionals from COVID-19, now and in the post-COVID-19 period?
Clinerion article: Utilizing EHR to protect our physicians from COVID (in Turkish)

In this article (for now, only in Turkish) Clinerion's Sinan Findik summarizes our new preventive health service model, created using EHRs.

Sinan's article is on page 27.

Link to the original article (in Turkish) >



Report: "Industry Clinical Trials In Poland. Possibilities to increase number and scope of trials in Poland"

Publication date: February 22, 2022

Did you know that Clinerion has significant coverage in Poland? We recently contributed to the report "Industry Clinical Trials in Poland."

"Industry Clinical Trials in Poland. Possibilities to increase number and scope of trials in Poland." is a report sponsored by the Polish Association of Innovative Pharmaceutical Companies (INFARMA) and the Polish Association for Employers of Contract Research Organizations (POLCRO). Clinerion was invited to contribute a chapter on "Harnessing the Power of Electronic Health Records to Increase Speed and Precision of Clinical Trials."

Download the report here (page is in Polish, but an English language report is available) >

Report: "Industry Clinical Trials In Poland. Possibilities to increase number and scope of trials in Poland"

Report: "Industry Clinical Trials In Poland. Possibilities to increase number and scope of trials in Poland"
Did you know that Clinerion has significant coverage in Poland? We recently contributed to the report "Industry Clinical Trials in Poland."
Report: "Industry Clinical Trials In Poland. Possibilities to increase number and scope of trial

"Industry Clinical Trials in Poland. Possibilities to increase number and scope of trials in Poland." is a report sponsored by the Polish Association of Innovative Pharmaceutical Companies (INFARMA) and the Polish Association for Employers of Contract Research Organizations (POLCRO). Clinerion was invited to contribute a chapter on "Harnessing the Power of Electronic Health Records to Increase Speed and Precision of Clinical Trials."

Download the report here (page is in Polish, but an English language report is available) >



Clinerion article: AI/ML to Generate Medical Insights ... While Maintaining Patient Data Security and Privacy (Journal for Clinical Studies)

Publication date: February 14, 2022

The Journal for Clinical Studies invited Clinerion to write an article on the topic of how AI/ML and patient EHR data can clarify the patient journey, while still preserving patient data privacy and security.

Machine Learning (ML) and Artificial Intelligence (AI) have come to the forefront of data analytics with the promise of generating new medical insights. However, for healthcare data, patient data security is paramount due to the GDPR and similar regulations. Traditional methods of data consolidation for Machine Learning / AI modelling into a single warehouse or a data lake are often not possible even with anonymized data due to data protection rules. The new, emerging alternative is a federated in situ data analytics construct in which healthcare data are anonymized within the care facility and accessed via a secure cloud application. This paper demonstrates how this ensures data security within the original data domain, while allowing analytics for modelling and AI to be applied in a federated fashion.

PDF File: Download here

Clinerion article: AI/ML to Generate Medical Insights ... While Maintaining Patient Data Security and Privacy (Journal for Clinical Studies)

Clinerion article: AI/ML to Generate Medical Insights ... While Maintaining Patient Data Security and Privacy (Journal for Clinical Studies)
The Journal for Clinical Studies invited Clinerion to write an article on the topic of how AI/ML and patient EHR data can clarify the patient journey, while still preserving patient data privacy and security.
Clinerion article: AI/ML to Generate Medical Insights ... While Maintaining Patient Data Security and

Machine Learning (ML) and Artificial Intelligence (AI) have come to the forefront of data analytics with the promise of generating new medical insights. However, for healthcare data, patient data security is paramount due to the GDPR and similar regulations. Traditional methods of data consolidation for Machine Learning / AI modelling into a single warehouse or a data lake are often not possible even with anonymized data due to data protection rules. The new, emerging alternative is a federated in situ data analytics construct in which healthcare data are anonymized within the care facility and accessed via a secure cloud application. This paper demonstrates how this ensures data security within the original data domain, while allowing analytics for modelling and AI to be applied in a federated fashion.



Clinical Research & Healthcare Digitalization in the Middle East & Turkey (Clinical Research at MENA)

Publication date: February 03, 2022

Everything you need to know about clinical research & healthcare digitalization in the Middle East & Turkey: read our chapter, by Barış Erdoğan and Le Vin Chin, in the new book on the challenges & solutions of Clinical Research at MENA, by Fatih Özdener!

"The meaning of Clinical Trials for humans has recently changed significantly, “evolved”, so to speak. In today’s environment, where ethical validity is much more strictly controlled, this meaning is far beyond “human drug testing” and much closer to the “therapeutic goal”. The number of clinical trials in western countries that have perceived this change has increased rapidly and continues to increase. Although the number of clinical studies in the MENA region is increasing day by day, it is still far from its potential. Among the reasons for this are legal, technological, ethical, epidemiological, educational and economic factors. This book presents both the difficulties encountered in conducting clinical trials in MENA and
suggestions for solving these difficulties."

Fatih Özdener has broad pharmaceutical industry experience at different local and regional medical functions including clinical operations, clinical quality and medical management in Turkey, Middle East and Africa. He has more than twenty publications in the fields of molecular and clinical pharmacology. Currently, he is a faculty member and a member of management board at Bahcesehir University School of Medicine and the program coordinator of Pharmaceutical Medicine master’s degree program at the same university.

More details and ordering >

Clinical Research & Healthcare Digitalization in the Middle East & Turkey (Clinical Research at MENA)

Clinical Research & Healthcare Digitalization in the Middle East & Turkey (Clinical Research at MENA)
Everything you need to know about clinical research & healthcare digitalization in the Middle East & Turkey: read our chapter, by Barış Erdoğan and Le Vin Chin, in the new book on the challenges & solutions of Clinical Research at MENA, by Fatih Özdener!
Clinical Research & Healthcare Digitalization in the Middle East & Turkey (Clinical Research

"The meaning of Clinical Trials for humans has recently changed significantly, “evolved”, so to speak. In today’s environment, where ethical validity is much more strictly controlled, this meaning is far beyond “human drug testing” and much closer to the “therapeutic goal”. The number of clinical trials in western countries that have perceived this change has increased rapidly and continues to increase. Although the number of clinical studies in the MENA region is increasing day by day, it is still far from its potential. Among the reasons for this are legal, technological, ethical, epidemiological, educational and economic factors. This book presents both the difficulties encountered in conducting clinical trials in MENA and
suggestions for solving these difficulties."

Fatih Özdener has broad pharmaceutical industry experience at different local and regional medical functions including clinical operations, clinical quality and medical management in Turkey, Middle East and Africa. He has more than twenty publications in the fields of molecular and clinical pharmacology. Currently, he is a faculty member and a member of management board at Bahcesehir University School of Medicine and the program coordinator of Pharmaceutical Medicine master’s degree program at the same university.

More details and ordering >



Press article: Futures made of virtual immunity (The Evidence Base)

Publication date: December 17, 2021

Clinerion's Douglas Drake was interviewed by The Evidence Base following our webinar on identification of rare disease patients by using artificial intelligence (AI), machine learning (ML) and electronic health records (EHR) to benefit understanding on rare diseases.

"The next few years will see the development of natural language processing capabilities to capture the physician’s diagnostic interpretation, digitally, from their patient notes, as well as AI or ML capabilities to research and model the patient journey and understand the critical steps and timepoints in diagnosis and treatment as well as patient stratification. It is an exciting time to be in digital healthcare and be patient care and outcomes-focused."

Read the interview at The Evidence Base >

Press article: Futures made of virtual immunity (The Evidence Base)

Press article: Futures made of virtual immunity (The Evidence Base)
Clinerion's Douglas Drake was interviewed by The Evidence Base following our webinar on identification of rare disease patients by using artificial intelligence (AI), machine learning (ML) and electronic health records (EHR) to benefit understanding on rare diseases.
Press article: Futures made of virtual immunity (The Evidence Base)

"The next few years will see the development of natural language processing capabilities to capture the physician’s diagnostic interpretation, digitally, from their patient notes, as well as AI or ML capabilities to research and model the patient journey and understand the critical steps and timepoints in diagnosis and treatment as well as patient stratification. It is an exciting time to be in digital healthcare and be patient care and outcomes-focused."

Read the interview at The Evidence Base >



Clinerion article: Health Outcomes in Clinical Trials (Journal for Clinical Studies)

Publication date: December 10, 2021

Clinerion's Douglas Drake was interviewed in the Journal for Clinical Studies on how Clinerion's RWD solutions support improved health outcomes in clinical trials.

"Real World Data is entirely about perspective. What health data is needed to answer your question? RWD now encompasses the entire pharmaceutical process from discovery and development into clinical research and commercialization. The specifc question requires a specifc answer and thereby a specifc data capability to answer. EHR data, such as Clinerion´s, help in pre-clinical and clinical understanding of patient journey and outcomes and improving outcomes."

Link to the article in Journal for Clinical Studies, Volume 13, Issue 6 >

PDF File: Download here

Clinerion article: Health Outcomes in Clinical Trials (Journal for Clinical Studies)

Clinerion article: Health Outcomes in Clinical Trials (Journal for Clinical Studies)
Clinerion's Douglas Drake was interviewed in the Journal for Clinical Studies on how Clinerion's RWD solutions support improved health outcomes in clinical trials.
Clinerion article: Health Outcomes in Clinical Trials (Journal for Clinical Studies)

"Real World Data is entirely about perspective. What health data is needed to answer your question? RWD now encompasses the entire pharmaceutical process from discovery and development into clinical research and commercialization. The specifc question requires a specifc answer and thereby a specifc data capability to answer. EHR data, such as Clinerion´s, help in pre-clinical and clinical understanding of patient journey and outcomes and improving outcomes."

Link to the article in Journal for Clinical Studies, Volume 13, Issue 6 >



Clinerion article: A Vision for Real-World Data Technology (International Clinical Trials)

Publication date: December 01, 2021

Douglas Drake presents Clinerion's vision for the future of RWD in the latest edition of International Clinical Trials.

"To enable faster access to innovative medical interventions for patients and physicians, part of the strategic approach must be unlocking the full scope of usable, useful information from patient electronic health records (EHR) to generate productive real-world data."

This article is taken from International Clinical Trials November 2021, pages 76-80. © Samedan Ltd.

Link to the article in International Clinical Trials November 2021 >

PDF File: Read the full article >

Clinerion article: A Vision for Real-World Data Technology (International Clinical Trials)

Clinerion article: A Vision for Real-World Data Technology (International Clinical Trials)
Douglas Drake presents Clinerion's vision for the future of RWD in the latest edition of International Clinical Trials.
Clinerion article: A Vision for Real-World Data Technology (International Clinical Trials)

"To enable faster access to innovative medical interventions for patients and physicians, part of the strategic approach must be unlocking the full scope of usable, useful information from patient electronic health records (EHR) to generate productive real-world data."

This article is taken from International Clinical Trials November 2021, pages 76-80. © Samedan Ltd.

Link to the article in International Clinical Trials November 2021 >



Press release: Clinerion Patient Network Explorer technology used by the Swiss Personalized Health Network (SPHN) to enable feasibility queries on clinical data across all five of Switzerland’s university hospitals simultaneously.

Publication date: November 18, 2021

Clinerion Patient Network Explorer technology powers the Federated Query System (FQS) of the Swiss Personalized Health Network (SPHN), which operates across all five of Switzerland’s university hospitals. Via the FQS, authorized researchers can run feasibility queries for multisite data-driven research projects on clinical data in all five hospitals simultaneously.

Clinerion was selected by the Swiss Personalized Health Network (SPHN) to be the backbone of its Federated Query System (FQS) due to the unique nature of its patented federated cloud infrastructure, which allows patient data to remain inside the IT infrastructure and under the control of each hospital, while still allowing queries of anonymized and obfuscated patient data from other hospitals in the network.

More on Clinerion's collaboration with the SPHN > 

PDF File: Click here to read the full release >

Press release: Clinerion Patient Network Explorer technology used by the Swiss Personalized Health Network (SPHN) to enable feasibility queries on clinical data across all five of Switzerland’s university hospitals simultaneously.

Press release: Clinerion Patient Network Explorer technology used by the Swiss Personalized Health Network (SPHN) to enable feasibility queries on clinical data across all five of Switzerland’s university hospitals simultaneously.
Clinerion Patient Network Explorer technology powers the Federated Query System (FQS) of the Swiss Personalized Health Network (SPHN), which operates across all five of Switzerland’s university hospitals. Via the FQS, authorized researchers can run feasibility queries for multisite data-driven research projects on clinical data in all five hospitals simultaneously.
Press release: Clinerion Patient Network Explorer technology used by the Swiss Personalized Health Ne

Clinerion was selected by the Swiss Personalized Health Network (SPHN) to be the backbone of its Federated Query System (FQS) due to the unique nature of its patented federated cloud infrastructure, which allows patient data to remain inside the IT infrastructure and under the control of each hospital, while still allowing queries of anonymized and obfuscated patient data from other hospitals in the network.

More on Clinerion's collaboration with the SPHN > 



Press release: Hospital Pablo Tobón Uribe joins Patient Network Explorer, expanding Clinerion’s patient coverage to Colombia.

Publication date: October 28, 2021

Hospital Pablo Tobón Uribe, Medellin, is the first hospital in Colombia to join the global network on Clinerion’s Patient Network Explorer and bring its patients access to international sponsored clinical trials and thereby to innovative medical interventions.

Hospital Pablo Tobón Uribe is a general hospital with 483 beds, offering all the key medical specializations to the catchment area around Medellin, Colombia. The hospital runs 72 clinical trials per year. The hospital is notable for its academic and clinical research expertise, as it is also a University Hospital that is invested in the education of medical students and in innovating in scientific areas and infrastructure.

PDF File: Click here to read the full release >

Press release: Hospital Pablo Tobón Uribe joins Patient Network Explorer, expanding Clinerion’s patient coverage to Colombia.

Press release: Hospital Pablo Tobón Uribe joins Patient Network Explorer, expanding Clinerion’s patient coverage to Colombia.
Hospital Pablo Tobón Uribe, Medellin, is the first hospital in Colombia to join the global network on Clinerion’s Patient Network Explorer and bring its patients access to international sponsored clinical trials and thereby to innovative medical interventions.
Press release: Hospital Pablo Tobón Uribe joins Patient Network Explorer, expanding Clinerion’s patie

Hospital Pablo Tobón Uribe is a general hospital with 483 beds, offering all the key medical specializations to the catchment area around Medellin, Colombia. The hospital runs 72 clinical trials per year. The hospital is notable for its academic and clinical research expertise, as it is also a University Hospital that is invested in the education of medical students and in innovating in scientific areas and infrastructure.



Press release: Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer.

Publication date: August 30, 2021

Grupo NotreDame Intermédica (GNDI) is the largest healthcare operator in Brazil, with 6.4 million members. Founded in 1968, it is a pioneer in preventive medicine. GNDI has a wide offer, comprising 29 hospitals, 88 clinical centers, 23 autonomous emergency rooms, 15 preventive medicine centers and 2 health centers exclusively dedicated to the over-fifties.

“Grupo NotreDame Intermédica is our 21st hospital group partner in Brazil, bringing our Brazil coverage north of 10 million patients,” says Barış Erdoğan, CEO of Clinerion. “We can truly say that we have the largest coverage on Brazil for EHR-based search. Once again, we thank iHealth Group for their continued support for the Clinerion Community of hospitals in Brazil.”

PDF File: Click here to read the full release >

Press release: Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer.

Press release: Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer.
Grupo NotreDame Intermédica (GNDI) is the largest healthcare operator in Brazil, with 6.4 million members. Founded in 1968, it is a pioneer in preventive medicine. GNDI has a wide offer, comprising 29 hospitals, 88 clinical centers, 23 autonomous emergency rooms, 15 preventive medicine centers and 2 health centers exclusively dedicated to the over-fifties.
Press release: Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patien

“Grupo NotreDame Intermédica is our 21st hospital group partner in Brazil, bringing our Brazil coverage north of 10 million patients,” says Barış Erdoğan, CEO of Clinerion. “We can truly say that we have the largest coverage on Brazil for EHR-based search. Once again, we thank iHealth Group for their continued support for the Clinerion Community of hospitals in Brazil.”



Press release: Clinerion patent for technology underpinning Patient Network Explorer is published.

Publication date: August 23, 2021

Clinerion wins patent for technology underpinning Patient Network Explorer, covering federated EHR database infrastructure & method for search of patient cohorts across the platform.

The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as well as any method for search of patient cohort care metrics across such a platform. This allows real-time search at each individual hospital across the entire network at once, returning aggregate metrics from the entire network. This technology forms the basis of Clinerion’s Patient Network Explorer.

Overview of Clinerion patents >

PDF File: Click here to read the full release >

Press release: Clinerion patent for technology underpinning Patient Network Explorer is published.

Press release: Clinerion patent for technology underpinning Patient Network Explorer is published.
Clinerion wins patent for technology underpinning Patient Network Explorer, covering federated EHR database infrastructure & method for search of patient cohorts across the platform.
Press release: Clinerion patent for technology underpinning Patient Network Explorer is published.

The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as well as any method for search of patient cohort care metrics across such a platform. This allows real-time search at each individual hospital across the entire network at once, returning aggregate metrics from the entire network. This technology forms the basis of Clinerion’s Patient Network Explorer.

Overview of Clinerion patents >



DIA 2021 poll results!

Publication date: July 07, 2021

The DIA community visiting our virtual booth voiced their opinions on the challenges and trends in real-world data analytics - we're pleased to present you the results.

At the recent DIA 2021 Global Annual Meeting, we asked booth visitors to to let us know their thoughts on the following topics - and they they didn't disappoint!

  • What is most important to your data analytics?

  • What trends in real-world data do you see having the biggest impact in clinical research and/or healthcare in general in the next 5 years?
     

Find out the results >

Event details >

DIA 2021 poll results!

DIA 2021 poll results!
The DIA community visiting our virtual booth voiced their opinions on the challenges and trends in real-world data analytics - we're pleased to present you the results.
DIA 2021 poll results!

At the recent DIA 2021 Global Annual Meeting, we asked booth visitors to to let us know their thoughts on the following topics - and they they didn't disappoint!

  • What is most important to your data analytics?

  • What trends in real-world data do you see having the biggest impact in clinical research and/or healthcare in general in the next 5 years?
     

Find out the results >

Event details >



Press release: Clinerion adds aggregate patient metrics for the real-world data on Patient Network Explorer with the RWD RADAR service.

Publication date: June 21, 2021

Clinerion’s RWD RADAR offers daily-updated, aggregate metrics on patient cohorts and the patient journey, including usage of terminologies, covering diagnoses, medications, laboratory tests, and procedures, across the Patient Network Explorer hospital network.

Supporting epidemiological research, RWD RADAR generates patient cohort aggregate metrics, as well as offers metrics on the patient journey, from diagnosis to treatment modalities, and geographically, all based on real-world data available on Clinerion’s Patient Network Explorer platform. Patient cohort aggregate metrics show insights on disease-treatment relationships and disease-disease relationships, and are visualized as Top N lists, ranking the related concepts within a field code with the highest patient hits.

The statistics are based on real-time data and available with timestamps, allowing the generation of an incidence timeline. Data may be visualized aggregated, or geographically mapped, as well as showing gender and age distributions.

RWD RADAR can be used for epidemiology studies to look at disease occurrence, treatment metrics, differences by hospital, region and country, as well as to identify differential treatment groups or cohorts by location, procedure or medication (segmentation by different treatment options and/or by drug/drug class). As Clinerion’s patient network expands, this will provide deep insights into hard-to-find patient groups, locations and countries within the network.

Find out more about RWD RADAR >

Contact us to get a demo >

PDF File: Click here to read the full release >

Press release: Clinerion adds aggregate patient metrics for the real-world data on Patient Network Explorer with the RWD RADAR service.

Press release: Clinerion adds aggregate patient metrics for the real-world data on Patient Network Explorer with the RWD RADAR service.
Clinerion’s RWD RADAR offers daily-updated, aggregate metrics on patient cohorts and the patient journey, including usage of terminologies, covering diagnoses, medications, laboratory tests, and procedures, across the Patient Network Explorer hospital network.
Press release: Clinerion adds aggregate patient metrics for the real-world data on Patient Network Ex

Supporting epidemiological research, RWD RADAR generates patient cohort aggregate metrics, as well as offers metrics on the patient journey, from diagnosis to treatment modalities, and geographically, all based on real-world data available on Clinerion’s Patient Network Explorer platform. Patient cohort aggregate metrics show insights on disease-treatment relationships and disease-disease relationships, and are visualized as Top N lists, ranking the related concepts within a field code with the highest patient hits.

The statistics are based on real-time data and available with timestamps, allowing the generation of an incidence timeline. Data may be visualized aggregated, or geographically mapped, as well as showing gender and age distributions.

RWD RADAR can be used for epidemiology studies to look at disease occurrence, treatment metrics, differences by hospital, region and country, as well as to identify differential treatment groups or cohorts by location, procedure or medication (segmentation by different treatment options and/or by drug/drug class). As Clinerion’s patient network expands, this will provide deep insights into hard-to-find patient groups, locations and countries within the network.

Find out more about RWD RADAR >

Contact us to get a demo >



Clinerion Poster: Can real world data support drug development with better trial design and real-world evidence?

Publication date: June 09, 2021

Our work with our partner Datametrix uncovers how use of statistical analytics methodologies on electronic health records can build synthetic control arms to supplement clinical trial data for better clinical and regulatory decisions.

Clinerion Poster: Can real world data support drug development with better trial design and real-world evidence?

Clinerion Poster: Can real world data support drug development with better trial design and real-world evidence?
Our work with our partner Datametrix uncovers how use of statistical analytics methodologies on electronic health records can build synthetic control arms to supplement clinical trial data for better clinical and regulatory decisions.
Clinerion Poster: Can real world data support drug development with better trial design and real-worl


Clinerion article: An Electronic Data Model for a More Efficient Health System in Latin America by Daniel Gutierrez (Clinical Research Insider)

Publication date: May 21, 2021

Clinical Research Insider invited us to contribute an article on digital health in Latin America. Daniel Gutierrez took up the challenge.

Access to electronic health data has never been so crucial both for Latin American healthcare systems as well as for its economies, as evidenced right now during the time of COVID-19. We outline the issues and challenges encouraging digitalization and the benefits it can bring, in particular, for accelerating recruitment for clinical trials, and tracking epidemiology of diseases within and across regions and populations.

Clinical Research Insider website >

PDF File: Read the full article >

Clinerion article: An Electronic Data Model for a More Efficient Health System in Latin America by Daniel Gutierrez (Clinical Research Insider)

Clinerion article: An Electronic Data Model for a More Efficient Health System in Latin America by Daniel Gutierrez (Clinical Research Insider)
Clinical Research Insider invited us to contribute an article on digital health in Latin America. Daniel Gutierrez took up the challenge.
Clinerion article: An Electronic Data Model for a More Efficient Health System in Latin America by Da

Access to electronic health data has never been so crucial both for Latin American healthcare systems as well as for its economies, as evidenced right now during the time of COVID-19. We outline the issues and challenges encouraging digitalization and the benefits it can bring, in particular, for accelerating recruitment for clinical trials, and tracking epidemiology of diseases within and across regions and populations.

Clinical Research Insider website >



Press release: Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, bringing the total to 17 hospitals and over 7 million patients.

Publication date: April 19, 2021

Clinerion has extended its patient coverage in Brazil to four new hospitals with the help of partner iHealth Group. This raises the footprint of Clinerion’s Patient Network Explorer to 17 healthcare organisations and over 7 million patients.

The four newest Brazilian hospitals to join the global community of partner hospitals on Clinerion’s Patient Network Explorer platform are:

  • Hospital São Lucas – PUCRS, Porto Alegre, Rio Grande do Sul
  • Hospital Martagão Gesteira, Salvador, Bahia
  • Hospital Ana Nery, Salvador, Bahia
  • Centro Regional Integrado de Oncologia (CRIO), Fortaleza, Ceará

They are projected to go online in Patient Network Explorer by the end of May, 2021.

PDF File: Click here to read the full release >

Press release: Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, bringing the total to 17 hospitals and over 7 million patients.

Press release: Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, bringing the total to 17 hospitals and over 7 million patients.
Clinerion has extended its patient coverage in Brazil to four new hospitals with the help of partner iHealth Group. This raises the footprint of Clinerion’s Patient Network Explorer to 17 healthcare organisations and over 7 million patients.
Press release: Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, brin

The four newest Brazilian hospitals to join the global community of partner hospitals on Clinerion’s Patient Network Explorer platform are:

  • Hospital São Lucas – PUCRS, Porto Alegre, Rio Grande do Sul
  • Hospital Martagão Gesteira, Salvador, Bahia
  • Hospital Ana Nery, Salvador, Bahia
  • Centro Regional Integrado de Oncologia (CRIO), Fortaleza, Ceará

They are projected to go online in Patient Network Explorer by the end of May, 2021.



Clinerion Research Ambassador: Nadine Abdelhadi

Publication date: March 30, 2021

We are pleased to welcome Nadine Abdelhadi as our very first Clinerion Research Ambassador!

Nadine Abdelhadi has expertise in the fields of clinical pharmacy, biochemistry, pharmacoeconomics, clinical research, innovation, intellectual property, and commercialization.

“Joining Clinerion, I aim to improve patient care through high-quality clinical research,” she says.

Clinerion Research Ambassadors are brilliant scientists around the world who have significant experience in their area and conduct advanced long-term research projects in clinical research, RWE or related scientific fields. 

Our inspiring, vital message is powerful and simple! We work to help health professionals connect with research opportunities. Through the Clinerion Research Ambassadors, we aim to promote research throughout our Clinerion community; at the partner institutions, and among the individual members, their peers and colleagues.

Clinerion Research Ambassador: Nadine Abdelhadi

Clinerion Research Ambassador: Nadine Abdelhadi
We are pleased to welcome Nadine Abdelhadi as our very first Clinerion Research Ambassador!
Clinerion Research Ambassador: Nadine Abdelhadi

Nadine Abdelhadi has expertise in the fields of clinical pharmacy, biochemistry, pharmacoeconomics, clinical research, innovation, intellectual property, and commercialization.

“Joining Clinerion, I aim to improve patient care through high-quality clinical research,” she says.

Clinerion Research Ambassadors are brilliant scientists around the world who have significant experience in their area and conduct advanced long-term research projects in clinical research, RWE or related scientific fields. 

Our inspiring, vital message is powerful and simple! We work to help health professionals connect with research opportunities. Through the Clinerion Research Ambassadors, we aim to promote research throughout our Clinerion community; at the partner institutions, and among the individual members, their peers and colleagues.



Press release: Clinerion and Medexprim join forces to combine clinical and imaging data for research.

Publication date: March 05, 2021

Clinerion and Medexprim have concluded a three-year partnership dedicated to the merger of electronic health records and imaging data into a private clinical data cloud warehouse dedicated to research.

Clinerion and Medexprim will set up a joint offering which allows access to de-identified, enriched, longitudinal data points derived from complex medical data sets, which combine electronic health records and their corresponding clinical images, to improve research and help patients receive better care. This collaboration will accelerate and expand Clinerion’s and Medexprim’s networks of hospital partners and accelerate the implementation of a clinical data warehouse globally accessible via a proprietary cloud.

PDF File: Click here to read the full release >

Press release: Clinerion and Medexprim join forces to combine clinical and imaging data for research.

Press release: Clinerion and Medexprim join forces to combine clinical and imaging data for research.
Clinerion and Medexprim have concluded a three-year partnership dedicated to the merger of electronic health records and imaging data into a private clinical data cloud warehouse dedicated to research.
Press release: Clinerion and Medexprim join forces to combine clinical and imaging data for research.

Clinerion and Medexprim will set up a joint offering which allows access to de-identified, enriched, longitudinal data points derived from complex medical data sets, which combine electronic health records and their corresponding clinical images, to improve research and help patients receive better care. This collaboration will accelerate and expand Clinerion’s and Medexprim’s networks of hospital partners and accelerate the implementation of a clinical data warehouse globally accessible via a proprietary cloud.



Press article: interview with Baris Erdogan, CEO, Clinerion (Pharma Boardroom)

Publication date: February 16, 2021

Clinerion's CEO Baris Erdogan was interviewed by Pharma Boardroom on how Clinerion is helping bring medical data informatics to the life sciences industry.

"CEO Baris Erdogan explains how the company is creating and applying technology to significantly reduce the drug development timeline. Clinerion uses Big Data analytics technologies to help hospitals, pharmaceutical companies and research organizations identify high-risk patients for different diseases, improve the market access process, respecting privacy laws and regulations along the way."

Read the interview at Pharma Boardroom, the global platform for C-Level healthcare & life sciences executives >

Press article: interview with Baris Erdogan, CEO, Clinerion (Pharma Boardroom)

Press article: interview with Baris Erdogan, CEO, Clinerion (Pharma Boardroom)
Clinerion's CEO Baris Erdogan was interviewed by Pharma Boardroom on how Clinerion is helping bring medical data informatics to the life sciences industry.
Press article: interview with Baris Erdogan, CEO, Clinerion (Pharma Boardroom)

"CEO Baris Erdogan explains how the company is creating and applying technology to significantly reduce the drug development timeline. Clinerion uses Big Data analytics technologies to help hospitals, pharmaceutical companies and research organizations identify high-risk patients for different diseases, improve the market access process, respecting privacy laws and regulations along the way."

Read the interview at Pharma Boardroom, the global platform for C-Level healthcare & life sciences executives >



Press article: Santa Casa incorporates Swiss tool for recruiting patients for clinical studies (Setor Saúde, translation)

Publication date: December 24, 2020

Santa Casa de Misericórdia, Porto Alegre, Brazil, talks about the benefits of becoming a member of Clinerion's global hospital community.

The following article is translated from the Portuguese and was originally published in Setor Saúde.
Go to the original article >
 

Institution incorporates Clinerion's Patient Network platform

The Santa Casa de Porto Alegre currently conducts 110 clinical studies sponsored by the pharmaceutical industry in the areas of cardiology, oncology, nephrology, pneumology, infectious diseases, pulmonary hypertension, pediatrics, endocrinology and intensive care. These are studies that seek new treatments, able to control patients' symptoms, cure and prevent disease, and restore people's health. In order to facilitate the capture of patients eligible to participate of these studies, Santa Casa incorporated the Patient Network platform, which combines sponsors' study protocols with anonymous patient data in the hospitals of Clinerion, a Swiss-based company that accelerates clinical research and medical access to treatments for patients.

At Santa Casa, the tool is integrated with Tasy, a medical record system that gathers information from all patients in the nine hospitals that make up the institution, in order to facilitate the participation of these patients in clinical studies.

“Clinical research is aimed at improving the quality of life of people. Participation in the research reaches a greater number of people who may benefit, either through treatments aimed at their recovery, as well as improving health problems,” says Antônio Kalil , medical director of Santa Casa.

As explained by the Teaching and Research coordinator at Santa Casa, Roberta de Almeida da Silva, before the implantation of tool, which is being conducted by iHealth - a company focused on serving the health informatics sector - the search for patients for participation in clinical studies was manual, through electronic medical records and the ICD: “The results, many times, were compromised due to possible record failures, in addition to taking much longer, when in fact the process should be finished with agility.”
 

International patient privacy rules and data security

According to Santa Casa, the process involves the analysis of Big Data provided by Clinerion, leveraging real-time data from electronic health records that meet international regulations on patient privacy and data security, enabling the Teaching and Research sector of Santa Casa de Porto Alegre the necessary support to constant expansion in their research.

 

Press article: Santa Casa incorporates Swiss tool for recruiting patients for clinical studies (Setor Saúde, translation)

Press article: Santa Casa incorporates Swiss tool for recruiting patients for clinical studies (Setor Saúde, translation)
Santa Casa de Misericórdia, Porto Alegre, Brazil, talks about the benefits of becoming a member of Clinerion's global hospital community.
Press article: Santa Casa incorporates Swiss tool for recruiting patients for clinical studies (Setor

The following article is translated from the Portuguese and was originally published in Setor Saúde.
Go to the original article >
 

Institution incorporates Clinerion's Patient Network platform

The Santa Casa de Porto Alegre currently conducts 110 clinical studies sponsored by the pharmaceutical industry in the areas of cardiology, oncology, nephrology, pneumology, infectious diseases, pulmonary hypertension, pediatrics, endocrinology and intensive care. These are studies that seek new treatments, able to control patients' symptoms, cure and prevent disease, and restore people's health. In order to facilitate the capture of patients eligible to participate of these studies, Santa Casa incorporated the Patient Network platform, which combines sponsors' study protocols with anonymous patient data in the hospitals of Clinerion, a Swiss-based company that accelerates clinical research and medical access to treatments for patients.

At Santa Casa, the tool is integrated with Tasy, a medical record system that gathers information from all patients in the nine hospitals that make up the institution, in order to facilitate the participation of these patients in clinical studies.

“Clinical research is aimed at improving the quality of life of people. Participation in the research reaches a greater number of people who may benefit, either through treatments aimed at their recovery, as well as improving health problems,” says Antônio Kalil , medical director of Santa Casa.

As explained by the Teaching and Research coordinator at Santa Casa, Roberta de Almeida da Silva, before the implantation of tool, which is being conducted by iHealth - a company focused on serving the health informatics sector - the search for patients for participation in clinical studies was manual, through electronic medical records and the ICD: “The results, many times, were compromised due to possible record failures, in addition to taking much longer, when in fact the process should be finished with agility.”
 

International patient privacy rules and data security

According to Santa Casa, the process involves the analysis of Big Data provided by Clinerion, leveraging real-time data from electronic health records that meet international regulations on patient privacy and data security, enabling the Teaching and Research sector of Santa Casa de Porto Alegre the necessary support to constant expansion in their research.

 



Press release: Baris Erdogan succeeds Ian Rentsch as CEO of Clinerion.

Publication date: December 21, 2020

Baris Erdogan, currently Vice President, Site & Patient Networks, at Clinerion, has been promoted by the Board of Directors to the position of Chief Executive Officer as of January 1st, 2021.

After a three-year tenure, Clinerion’s current CEO, Ian Rentsch, has decided to step down for personal reasons and to return to his family in Berlin by the end of January, 2021.

PDF File: Click here to read the full release >

Press release: Baris Erdogan succeeds Ian Rentsch as CEO of Clinerion.

Press release: Baris Erdogan succeeds Ian Rentsch as CEO of Clinerion.
Baris Erdogan, currently Vice President, Site & Patient Networks, at Clinerion, has been promoted by the Board of Directors to the position of Chief Executive Officer as of January 1st, 2021.
Press release: Baris Erdogan succeeds Ian Rentsch as CEO of Clinerion.

After a three-year tenure, Clinerion’s current CEO, Ian Rentsch, has decided to step down for personal reasons and to return to his family in Berlin by the end of January, 2021.



Press article: Applying machine learning to real-world data: an interview with Douglas Drake (The Evidence Base)

Publication date: December 02, 2020

Clinerion's Douglas Drake was interviewed by The Evidence Base on how machine learning (ML) may be applied to real-world data (RWD) in order to help achieve better outreach for diagnostic testing and correct therapeutic treatment.

"Rare diseases are rare by nature; they often present heterogeneously, and patients may be diagnosed late or incorrectly at first. Because of the complexity and differential symptom presentation by individuals with rare diseases, their RWD – from their electronic records – are often the best and only resource to understand these patients’ journeys and how their conditions have and continue to develop/evolve."

Read the interview at The Evidence Base >

Press article: Applying machine learning to real-world data: an interview with Douglas Drake (The Evidence Base)

Press article: Applying machine learning to real-world data: an interview with Douglas Drake (The Evidence Base)
Clinerion's Douglas Drake was interviewed by The Evidence Base on how machine learning (ML) may be applied to real-world data (RWD) in order to help achieve better outreach for diagnostic testing and correct therapeutic treatment.
Press article: Applying machine learning to real-world data: an interview with Douglas Drake (The Evi

"Rare diseases are rare by nature; they often present heterogeneously, and patients may be diagnosed late or incorrectly at first. Because of the complexity and differential symptom presentation by individuals with rare diseases, their RWD – from their electronic records – are often the best and only resource to understand these patients’ journeys and how their conditions have and continue to develop/evolve."

Read the interview at The Evidence Base >



Clinerion article: Finding and Treating Rare Disease Patients in a Global Digital Haybale (Journal for Clinical Studies)

Publication date: September 21, 2020

Clinerion's Douglas Drake discusses the use of digital data in finding rare disease patients in the latest issue of the Journal for Clinical Studies.

"The volume and diversity of digital data is exploding, and, in healthcare, the number of electronic medical records is growing exponentially as technology makes this information increasingly available. Real-world data is increasingly accessible and useful for outcomes research and regulatory purposes. While clinical trial evidence remains the gold standard for evaluation of treatment efficacy, there is increasing interest and potential for converting RWD into real-world evidence that, through analysis and interpretation, can be used to inform healthcare decision-making."

This article was written with the support of our partners, Volv.

PDF File: Download here

Clinerion article: Finding and Treating Rare Disease Patients in a Global Digital Haybale (Journal for Clinical Studies)

Clinerion article: Finding and Treating Rare Disease Patients in a Global Digital Haybale (Journal for Clinical Studies)
Clinerion's Douglas Drake discusses the use of digital data in finding rare disease patients in the latest issue of the Journal for Clinical Studies.
Clinerion article: Finding and Treating Rare Disease Patients in a Global Digital Haybale (Journal fo

"The volume and diversity of digital data is exploding, and, in healthcare, the number of electronic medical records is growing exponentially as technology makes this information increasingly available. Real-world data is increasingly accessible and useful for outcomes research and regulatory purposes. While clinical trial evidence remains the gold standard for evaluation of treatment efficacy, there is increasing interest and potential for converting RWD into real-world evidence that, through analysis and interpretation, can be used to inform healthcare decision-making."

This article was written with the support of our partners, Volv.



Clinerion article: COVID-19 pushes Digital Trial Revolution ... (Clinical Research Insider)

Publication date: September 17, 2020

Léon Van Wouwe discusses how COVID-19 is accelerating the use of digital technologies in clinical research in the latest issue of Clinical Research Insider.

"COVID-19 research is hungry for immediate access to real-world data to gain insights. Digital health technologies that enable continuous, real-time data collection meet this need. Across COVID-19 clinical trials, social-distancing measures force widespread use of virtual connectivity, and remote monitoring and management. So, we are likely to see real acceleration in the uptake of new technologies and process.

"These technologies can significantly reduce the time, effort, and burden on investigators, clinical research centers, and participants. The industry has been discussing these benefits for years, but with the traditional ecosystem at a standstill, COVID-19 powers the adoption of digital and virtual technology."

Link to the article in Clinical Research Insider, No. 2 >

Clinerion article: COVID-19 pushes Digital Trial Revolution ... (Clinical Research Insider)

Clinerion article: COVID-19 pushes Digital Trial Revolution ... (Clinical Research Insider)
Léon Van Wouwe discusses how COVID-19 is accelerating the use of digital technologies in clinical research in the latest issue of Clinical Research Insider.
Clinerion article: COVID-19 pushes Digital Trial Revolution ... (Clinical Research Insider)

"COVID-19 research is hungry for immediate access to real-world data to gain insights. Digital health technologies that enable continuous, real-time data collection meet this need. Across COVID-19 clinical trials, social-distancing measures force widespread use of virtual connectivity, and remote monitoring and management. So, we are likely to see real acceleration in the uptake of new technologies and process.

"These technologies can significantly reduce the time, effort, and burden on investigators, clinical research centers, and participants. The industry has been discussing these benefits for years, but with the traditional ecosystem at a standstill, COVID-19 powers the adoption of digital and virtual technology."

Link to the article in Clinical Research Insider, No. 2 >



Press release: Clinerion and Maxer Consulting partner to boost the identification and the recruitment of patients into clinical trials in Italy, and promote safer and more effective clinical outcomes.

Publication date: September 03, 2020

Clinerion's Patient Network Explorer will leverage Maxer's extended network of relations in the international healthcare sector to access promising business opportunities and expand Clinerion’s patient coverage into Italy, promoting and delivering clinical trials-related solutions.

Clinerion and Maxer will cooperate to engage clinical trial sponsors to fully exploit Patient Network Explorer’s potential and provide added-value services arising from Maxer’s experience in clinical data management, regulatory affairs, medical affairs, clinical trial disclosure and data transparency, and medical writing services.

The partners' joint mission is to liaise with study sites to increase patient participation in trials to its full potential by offering tools to optimize protocol design, supporting the efficient start-up of local trials, and planning and consistently hitting realistic patient recruitment targets to enable the achievement of total timeline targets.

PDF File: Click here to read the full release >

Press release: Clinerion and Maxer Consulting partner to boost the identification and the recruitment of patients into clinical trials in Italy, and promote safer and more effective clinical outcomes.

Press release: Clinerion and Maxer Consulting partner to boost the identification and the recruitment of patients into clinical trials in Italy, and promote safer and more effective clinical outcomes.
Clinerion's Patient Network Explorer will leverage Maxer's extended network of relations in the international healthcare sector to access promising business opportunities and expand Clinerion’s patient coverage into Italy, promoting and delivering clinical trials-related solutions.
Press release: Clinerion and Maxer Consulting partner to boost the identification and the recruitment

Clinerion and Maxer will cooperate to engage clinical trial sponsors to fully exploit Patient Network Explorer’s potential and provide added-value services arising from Maxer’s experience in clinical data management, regulatory affairs, medical affairs, clinical trial disclosure and data transparency, and medical writing services.

The partners' joint mission is to liaise with study sites to increase patient participation in trials to its full potential by offering tools to optimize protocol design, supporting the efficient start-up of local trials, and planning and consistently hitting realistic patient recruitment targets to enable the achievement of total timeline targets.



Press release: Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials

Publication date: August 25, 2020

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Clinerion, a worldwide leader in medical data informatics with a global research network comprised of 30.2 million patients online across 69 healthcare organizations in 15 countries. This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.

More than eighty percent of trials are delayed and approximately thirty percent of sites never enroll patients because of limited access to patients who match the study criteria. The combination of Clinerion’s expertise in leveraging real-time, real-patient, and real-world electronic health record (EHR) data for clinical research combined with Trialbee’s unique multiple step qualification process, which includes online qualification and nurse practitioner interviews to ensure high-quality patient matches prior to obtaining consent and enrollment, will significantly improve and streamline this process. The Trialbee platform provides full transparency of the status of the referred patient flow throughout the entire clinical trial and continuously offers sites and sponsors full insight into the effectiveness of recruitment strategies.

PDF File: Click here to read the full release >

Press release: Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials

Press release: Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials
Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Clinerion, a worldwide leader in medical data informatics with a global research network comprised of 30.2 million patients online across 69 healthcare organizations in 15 countries. This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.
Press release: Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Acce

More than eighty percent of trials are delayed and approximately thirty percent of sites never enroll patients because of limited access to patients who match the study criteria. The combination of Clinerion’s expertise in leveraging real-time, real-patient, and real-world electronic health record (EHR) data for clinical research combined with Trialbee’s unique multiple step qualification process, which includes online qualification and nurse practitioner interviews to ensure high-quality patient matches prior to obtaining consent and enrollment, will significantly improve and streamline this process. The Trialbee platform provides full transparency of the status of the referred patient flow throughout the entire clinical trial and continuously offers sites and sponsors full insight into the effectiveness of recruitment strategies.



Clinerion is on the Swiss Digital Health Map

Publication date: August 25, 2020

Clinerion is proud to join digital health leaders across Switzerland on Health-Trends' Swiss Digital Health Map.

Health Trends' research activities focus on digital health, trends, and new technologies in the context of the Swiss healthcare system.

"This is a great recognition as it acknowledges our capacity as an established organization to innovate in an uncertain and changing environment, in difficult times," says Ian Rentsch, Clinerion CEO. "We will continue to provide the best real-world data analysis and patient recruitment tools to support all pharma stakeholders so they can navigate today’s uncharted waters.”

Download the full-sized map from Health-Trends >

Clinerion is on the Swiss Digital Health Map

Clinerion is on the Swiss Digital Health Map
Clinerion is proud to join digital health leaders across Switzerland on Health-Trends' Swiss Digital Health Map.
Clinerion is on the Swiss Digital Health Map

Health Trends' research activities focus on digital health, trends, and new technologies in the context of the Swiss healthcare system.

"This is a great recognition as it acknowledges our capacity as an established organization to innovate in an uncertain and changing environment, in difficult times," says Ian Rentsch, Clinerion CEO. "We will continue to provide the best real-world data analysis and patient recruitment tools to support all pharma stakeholders so they can navigate today’s uncharted waters.”

Download the full-sized map from Health-Trends >



Press release: Clinerion protects security of Patient Network Explorer user accounts with 2-step authentication.

Publication date: August 19, 2020

The “Clinerion PNEx Authenticator” app gives users of Clinerion’s Patient Network Explorer additional data security with 2-step authentication.

To protect Patient Network Explorer user accounts from breach, Clinerion is activating a second verification step during the sign-in process. In addition to the password, Patient Network Explorer now includes an authorization step that will run via the “Clinerion PNEx Authenticator” smartphone app.

The “Clinerion PNEx Authenticator” smartphone app is available now on the Apple App Store and on the Google Play Store, in English, Chinese, French, German and Italian.

Clinerion PNEx Authenticator in the Google Play Android Store: https://play.google.com/store/apps/details?id=com.clinerion.pnex.accessapp
Clinerion PNEx Authenticator in the Apple App Store: https://apps.apple.com/us/app/clinerion-pnex-authenticator/id1521800088

PDF File: Click here to read the full release >

Press release: Clinerion protects security of Patient Network Explorer user accounts with 2-step authentication.

Press release: Clinerion protects security of Patient Network Explorer user accounts with 2-step authentication.
The “Clinerion PNEx Authenticator” app gives users of Clinerion’s Patient Network Explorer additional data security with 2-step authentication.
Press release: Clinerion protects security of Patient Network Explorer user accounts with 2-step auth

To protect Patient Network Explorer user accounts from breach, Clinerion is activating a second verification step during the sign-in process. In addition to the password, Patient Network Explorer now includes an authorization step that will run via the “Clinerion PNEx Authenticator” smartphone app.

The “Clinerion PNEx Authenticator” smartphone app is available now on the Apple App Store and on the Google Play Store, in English, Chinese, French, German and Italian.

Clinerion PNEx Authenticator in the Google Play Android Store: https://play.google.com/store/apps/details?id=com.clinerion.pnex.accessapp
Clinerion PNEx Authenticator in the Apple App Store: https://apps.apple.com/us/app/clinerion-pnex-authenticator/id1521800088



Press release: Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020

Publication date: August 10, 2020

Clinerion announced today that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, produced by Questex.

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. Clinerion was recognized as a finalist in the category of  Data Analytics/Business Intelligence.

Clinerion was selected as a finalist for its innovative, industry-leading real-world data service solutions for the generation of real-world evidence (RWE) and health economics and outcomes research (HEOR) on its Patient Network Explorer platform, in particular for real-world data for COVID-19.

In the battle against COVID-19, researchers and health authorities require immediate patient data from a global perspective on disease transmittance, cohorts, and success rates for treatment regimes, among many other indicators. Patient Network Explorer supports research and RWE for COVID-19 cases, as well as for conditions that are associated with SARS-CoV-2 infections.

Fierce Innovation Awards website >

PDF File: Click here to read the full release >

Press release: Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020

Press release: Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
Clinerion announced today that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, produced by Questex.
Press release: Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 202

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. Clinerion was recognized as a finalist in the category of  Data Analytics/Business Intelligence.

Clinerion was selected as a finalist for its innovative, industry-leading real-world data service solutions for the generation of real-world evidence (RWE) and health economics and outcomes research (HEOR) on its Patient Network Explorer platform, in particular for real-world data for COVID-19.

In the battle against COVID-19, researchers and health authorities require immediate patient data from a global perspective on disease transmittance, cohorts, and success rates for treatment regimes, among many other indicators. Patient Network Explorer supports research and RWE for COVID-19 cases, as well as for conditions that are associated with SARS-CoV-2 infections.

Fierce Innovation Awards website >



Clinerion received a Medtech Breakthrough Award!

Publication date: July 27, 2020

have been selected as the winner for the category "EHR (e-Health Records) Innovation" for the 2020 edition of MedTech Breakthrough awards.

We are pleased to receive this award in "EHR Innovation"!

All nominees were to address the question – “How does your company or product break through the crowded MedTech market?” and the evaluation criteria for the MedTech Breakthrough Awards program were focused around the concept of innovation. 

Per the judging process, all award nominations were fully analyzed, evaluated and scored by MedTech Breakthrough's expert panel of judges, representing a mix of technical, business, academic and marketing expertise within the industry.

View all 2020 winners via MedTech Breakthrough's website: https://medtechbreakthrough.com/ >

Clinerion received a Medtech Breakthrough Award!

Clinerion received a Medtech Breakthrough Award!
have been selected as the winner for the category "EHR (e-Health Records) Innovation" for the 2020 edition of MedTech Breakthrough awards.
Clinerion received a Medtech Breakthrough Award!

We are pleased to receive this award in "EHR Innovation"!

All nominees were to address the question – “How does your company or product break through the crowded MedTech market?” and the evaluation criteria for the MedTech Breakthrough Awards program were focused around the concept of innovation. 

Per the judging process, all award nominations were fully analyzed, evaluated and scored by MedTech Breakthrough's expert panel of judges, representing a mix of technical, business, academic and marketing expertise within the industry.

View all 2020 winners via MedTech Breakthrough's website: https://medtechbreakthrough.com/ >



Article: The New Healthcare, Digital by Design

Publication date: July 21, 2020

Our colleague Douglas Drake's article was published in the peer-reviewed magazine, Journal for Clinical Studies.

Our healthcare is becoming increasingly interconnected as technologies allow us to be more connected to our devices, to other people and healthcare services and providers. Our healthcare footprint is now part of our digital footprint.
Our digital footprint is now part of a larger ecosystem that promises to enable better patient care through better insights.

The challenge is to enable while also maintaining individual privacy and data security.

Read the full article by clicking the link below.

PDF File: Download here

Article: The New Healthcare, Digital by Design

Article: The New Healthcare, Digital by Design
Our colleague Douglas Drake's article was published in the peer-reviewed magazine, Journal for Clinical Studies.
Article: The New Healthcare, Digital by Design

Our healthcare is becoming increasingly interconnected as technologies allow us to be more connected to our devices, to other people and healthcare services and providers. Our healthcare footprint is now part of our digital footprint.
Our digital footprint is now part of a larger ecosystem that promises to enable better patient care through better insights.

The challenge is to enable while also maintaining individual privacy and data security.

Read the full article by clicking the link below.



Press release: DCC Ascendent joins Clinerion’s Patient Network Explorer platform and improves access to leading-edge healthcare treatment options for patients and physicians in Bulgaria.

Publication date: July 09, 2020

By joining the international hospital network on Clinerion’s Patient Network Explorer, DCC Ascendent’s patients and their physicians are brought to the attention of researchers and trial sponsors who are recruiting for clinical trials, thereby bringing its patients earlier access to leading-edge treatments and medications.

The Diagnostic and Consultative Center “Ascendent” Ltd., Sofia, Bulgaria, performs outpatient clinical trials for bioavailability and bioequivalence studies. DCC Ascendent conducts examinations, non-invasive procedures and clinical trials in obstetrics and gynecology, neurology, endocrinology, psychiatry, psychology, dermatology, pulmonology, and hematology.

The clinic has twelve beds and has been consecrated to conducting clinical trials and investigating new treatments for more than 15 years, performing 15-16 clinical trials per year. They follow GCP guidelines and have been inspected by the FDA and BfArM, as well by other competent authorities.

PDF File: Click here to read the full release >

Press release: DCC Ascendent joins Clinerion’s Patient Network Explorer platform and improves access to leading-edge healthcare treatment options for patients and physicians in Bulgaria.

Press release: DCC Ascendent joins Clinerion’s Patient Network Explorer platform and improves access to leading-edge healthcare treatment options for patients and physicians in Bulgaria.
By joining the international hospital network on Clinerion’s Patient Network Explorer, DCC Ascendent’s patients and their physicians are brought to the attention of researchers and trial sponsors who are recruiting for clinical trials, thereby bringing its patients earlier access to leading-edge treatments and medications.
Press release: DCC Ascendent joins Clinerion’s Patient Network Explorer platform and improves access

The Diagnostic and Consultative Center “Ascendent” Ltd., Sofia, Bulgaria, performs outpatient clinical trials for bioavailability and bioequivalence studies. DCC Ascendent conducts examinations, non-invasive procedures and clinical trials in obstetrics and gynecology, neurology, endocrinology, psychiatry, psychology, dermatology, pulmonology, and hematology.

The clinic has twelve beds and has been consecrated to conducting clinical trials and investigating new treatments for more than 15 years, performing 15-16 clinical trials per year. They follow GCP guidelines and have been inspected by the FDA and BfArM, as well by other competent authorities.



Press release: Ege University improves patient access to leading-edge healthcare treatment options by joining Clinerion’s Patient Network Explorer platform. (Corrected)

Publication date: July 02, 2020

Ege University Medical Faculty Hospital brings its patients earlier access to leading-edge treatments and medications by joining the international hospital network on Clinerion’s Patient Network Explorer platform. On the platform, the university hospital’s patients are brought to the attention of researchers and trial sponsors who are recruiting for clinical trials.

Ege University Hospital serves as the largest hospital in the western part of the country, with 1,896 beds. Beyond Turkey itself, the university hospital provides services throughout the neighboring countries, as well as the Balkans and the Caucasus, with its experienced team and state-of-the-art equipment.

EDIT: the number of beds at Ege University was incorrectly reported in the original release dated 2nd July, and has been updated

PDF File: Click here to read the full release >

Press release: Ege University improves patient access to leading-edge healthcare treatment options by joining Clinerion’s Patient Network Explorer platform. (Corrected)

Press release: Ege University improves patient access to leading-edge healthcare treatment options by joining Clinerion’s Patient Network Explorer platform. (Corrected)
Ege University Medical Faculty Hospital brings its patients earlier access to leading-edge treatments and medications by joining the international hospital network on Clinerion’s Patient Network Explorer platform. On the platform, the university hospital’s patients are brought to the attention of researchers and trial sponsors who are recruiting for clinical trials.
Press release: Ege University improves patient access to leading-edge healthcare treatment options by

Ege University Hospital serves as the largest hospital in the western part of the country, with 1,896 beds. Beyond Turkey itself, the university hospital provides services throughout the neighboring countries, as well as the Balkans and the Caucasus, with its experienced team and state-of-the-art equipment.

EDIT: the number of beds at Ege University was incorrectly reported in the original release dated 2nd July, and has been updated



Clinerion article: Recruitment Challenges in Oncology (Clinical Research Insider)

Publication date: June 27, 2020

Sébastien Wischlen discusses overcoming barriers to recruitment for clinical research in the latest issue of Clinical Research Insider.

"In the field of clinical research, the therapeutic area of oncology in particular is facing a substantial patient recruitment challenge. At present, roughly 15,000 oncology trials are actively recruiting (Longtaal Clinical Trials Landscape Dashboard; www.clinicaltrials.gov), while participation rates have been estimated at a mere 3%-8% of possible candidates, with even smaller numbers in minority and geriatric populations (Institute of Medicine [US] Forum on Drug Discovery, Development, and Translation, 2010). Low enrolment rates threaten more than just the success of individual clinical trials: they may also hinder treatment advances and corresponding benefits to outcomes (Unger et al., 2016).

"Improving cancer care for patients in all aspects is the most important outcome promised by trials, but the fact is that any success stories happen in defiance of competition for patients among oncology researchers and of barriers of protocol feasibility and patient eligibility."

Link to the article in Clinical Research Insider, No. 2 >
Link to the article in our Expert Corner >

Clinerion article: Recruitment Challenges in Oncology (Clinical Research Insider)

Clinerion article: Recruitment Challenges in Oncology (Clinical Research Insider)
Sébastien Wischlen discusses overcoming barriers to recruitment for clinical research in the latest issue of Clinical Research Insider.
Clinerion article: Recruitment Challenges in Oncology (Clinical Research Insider)

"In the field of clinical research, the therapeutic area of oncology in particular is facing a substantial patient recruitment challenge. At present, roughly 15,000 oncology trials are actively recruiting (Longtaal Clinical Trials Landscape Dashboard; www.clinicaltrials.gov), while participation rates have been estimated at a mere 3%-8% of possible candidates, with even smaller numbers in minority and geriatric populations (Institute of Medicine [US] Forum on Drug Discovery, Development, and Translation, 2010). Low enrolment rates threaten more than just the success of individual clinical trials: they may also hinder treatment advances and corresponding benefits to outcomes (Unger et al., 2016).

"Improving cancer care for patients in all aspects is the most important outcome promised by trials, but the fact is that any success stories happen in defiance of competition for patients among oncology researchers and of barriers of protocol feasibility and patient eligibility."

Link to the article in Clinical Research Insider, No. 2 >
Link to the article in our Expert Corner >



Press release: Clinerion’s Patient Network Explorer offers clinical trial performance data for sites in its global site network.

Publication date: June 22, 2020

Clinerion’s Patient Network Explorer adds new, actionable functionality to support clinical trial sponsors during site selection as a result of Clinerion’s collaboration with LongTaal, a clinical trial informatics company. The platform now shows current and historical clinical trial performance data for all partner hospitals and trial sites in Clinerion’s worldwide patient network.

Effective immediately, users of Clinerion’s Patient Network Explorer can review detailed clinical trial statistics on an individual hospital level. Derived and mapped from multiple public sources, this new functionality allows for browsing, filtering, reviewing, and comparing site trial performance statistics, including breakdowns on studies by sponsor, by condition, by trial phase and by recruitment status.

The possibility to further filter by study status, sponsor, phase, or condition offers detailed results and a list of the respective studies which provides more information such as on other locations where the study is being conducted.

More details >

PDF File: Click here to read the full release >

Press release: Clinerion’s Patient Network Explorer offers clinical trial performance data for sites in its global site network.

Press release: Clinerion’s Patient Network Explorer offers clinical trial performance data for sites in its global site network.
Clinerion’s Patient Network Explorer adds new, actionable functionality to support clinical trial sponsors during site selection as a result of Clinerion’s collaboration with LongTaal, a clinical trial informatics company. The platform now shows current and historical clinical trial performance data for all partner hospitals and trial sites in Clinerion’s worldwide patient network.
Press release: Clinerion’s Patient Network Explorer offers clinical trial performance data for sites

Effective immediately, users of Clinerion’s Patient Network Explorer can review detailed clinical trial statistics on an individual hospital level. Derived and mapped from multiple public sources, this new functionality allows for browsing, filtering, reviewing, and comparing site trial performance statistics, including breakdowns on studies by sponsor, by condition, by trial phase and by recruitment status.

The possibility to further filter by study status, sponsor, phase, or condition offers detailed results and a list of the respective studies which provides more information such as on other locations where the study is being conducted.

More details >



Clinerion received a GHP Biotechnology Award!

Publication date: June 15, 2020

We have been selected as "Leading Innovators in Patient Data & Clinical Research Acceleration" for the 2020 edition of GHP Biotechnology awards.

Among the criteria which were used to select the award winners were the company's history, services, products, presence within the industry, articles, and social media presence.

We are very pleased to receive this award which highlights our willingness and successful efforts to support and accelerate clinical research, using real-world patient data and innovative approaches. 

Read the full press release via GHP's website: GHP Biotechnology Awards 2020 Winners Announcement

 

 

Clinerion received a GHP Biotechnology Award!

Clinerion received a GHP Biotechnology Award!
We have been selected as "Leading Innovators in Patient Data & Clinical Research Acceleration" for the 2020 edition of GHP Biotechnology awards.
Clinerion received a GHP Biotechnology Award!

Among the criteria which were used to select the award winners were the company's history, services, products, presence within the industry, articles, and social media presence.

We are very pleased to receive this award which highlights our willingness and successful efforts to support and accelerate clinical research, using real-world patient data and innovative approaches. 

Read the full press release via GHP's website: GHP Biotechnology Awards 2020 Winners Announcement

 

 



Press release: EVEX Hospitals joins Clinerion’s Patient Network Explorer platform and enables patient access to increased options for healthcare treatment in Georgia.

Publication date: June 11, 2020

EVEX Hospitals joins the international hospital network on Clinerion’s Patient Network Explorer platform, bringing their patients to the attention of researchers and trial sponsors who are recruiting for clinical trials. This offers the hospitals’ patients’ earlier access to leading-edge treatments and medications in Georgia.

Joining Patient Network Explorer, EVEX Hospitals’ patients and their treating physicians gain increased treatment options and quicker access to new medical interventions. Patients will be matched to clinical studies according to their electronic health records, ensuring better screening when recruiting for clinical trials. Trial managers gain the ability to include eligible patients for trials more quickly and efficiently than before.

PDF File: Click here to read the full release >

Press release: EVEX Hospitals joins Clinerion’s Patient Network Explorer platform and enables patient access to increased options for healthcare treatment in Georgia.

Press release: EVEX Hospitals joins Clinerion’s Patient Network Explorer platform and enables patient access to increased options for healthcare treatment in Georgia.
EVEX Hospitals joins the international hospital network on Clinerion’s Patient Network Explorer platform, bringing their patients to the attention of researchers and trial sponsors who are recruiting for clinical trials. This offers the hospitals’ patients’ earlier access to leading-edge treatments and medications in Georgia.
Press release: EVEX Hospitals joins Clinerion’s Patient Network Explorer platform and enables patient

Joining Patient Network Explorer, EVEX Hospitals’ patients and their treating physicians gain increased treatment options and quicker access to new medical interventions. Patients will be matched to clinical studies according to their electronic health records, ensuring better screening when recruiting for clinical trials. Trial managers gain the ability to include eligible patients for trials more quickly and efficiently than before.



Press release: Clinerion gains ISO/IEC 15504 (SPICE) certification.

Publication date: June 04, 2020

Clinerion has gained ISO/IEC 15504 (SPICE) certification, the international standard that describes a framework for assessment of software development processes.

“This certification is a great validation of the vital importance Clinerion places on having rigorous and meaningful business processes, in support of our work developing our software and services for the future,” says Barış Erdoğan, Vice President Site & Patient Networks, Clinerion. “Clinerion has been on this journey for a while, recently gaining ISO 27001:2013 certification, confirming that we are following best practice information security principles.

PDF File: Click here to read the full release >

Press release: Clinerion gains ISO/IEC 15504 (SPICE) certification.

Press release: Clinerion gains ISO/IEC 15504 (SPICE) certification.
Clinerion has gained ISO/IEC 15504 (SPICE) certification, the international standard that describes a framework for assessment of software development processes.
Press release: Clinerion gains ISO/IEC 15504 (SPICE) certification.

“This certification is a great validation of the vital importance Clinerion places on having rigorous and meaningful business processes, in support of our work developing our software and services for the future,” says Barış Erdoğan, Vice President Site & Patient Networks, Clinerion. “Clinerion has been on this journey for a while, recently gaining ISO 27001:2013 certification, confirming that we are following best practice information security principles.



Report: Clinerion featured in Global Switzerland Enterprise

Publication date: May 20, 2020

We are very pleased to be featured in Switzerland Global Enterprise (S-GE)'s report on personalized healthcare called "Switzerland: a hub for personalized health".

For the 2020 edition of this fact sheet, our CEO Ian Rentsch was interviewed by S-GE and Clinerion is mentioned as a key example of a thriving life sciences SME.

View fact sheet via S-GE website >

PDF File: Download here

Report: Clinerion featured in Global Switzerland Enterprise

Report: Clinerion featured in Global Switzerland Enterprise
We are very pleased to be featured in Switzerland Global Enterprise (S-GE)'s report on personalized healthcare called "Switzerland: a hub for personalized health".
Report: Clinerion featured in Global Switzerland Enterprise

For the 2020 edition of this fact sheet, our CEO Ian Rentsch was interviewed by S-GE and Clinerion is mentioned as a key example of a thriving life sciences SME.

View fact sheet via S-GE website >



Press release: Clinerion gains ISO 27001:2013 certification.

Publication date: March 16, 2020

Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS).

“We are very pleased to receive this certification, which reflects the fact that Clinerion’s information security management system is part of and integrated with our processes and overall management structure,” says Ian Rentsch, CEO of Clinerion. “For Clinerion, information security is considered in the design of processes, information systems, and controls. Our implementation of our information security management system can be scaled in accordance with the needs of the organization.”

PDF File: Click here to read the full release >

Press release: Clinerion gains ISO 27001:2013 certification.

Press release: Clinerion gains ISO 27001:2013 certification.
Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS).
Press release: Clinerion gains ISO 27001:2013 certification.

“We are very pleased to receive this certification, which reflects the fact that Clinerion’s information security management system is part of and integrated with our processes and overall management structure,” says Ian Rentsch, CEO of Clinerion. “For Clinerion, information security is considered in the design of processes, information systems, and controls. Our implementation of our information security management system can be scaled in accordance with the needs of the organization.”



Press release: Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil.

Publication date: March 09, 2020

Hospital PUC-Campinas Celso Pierro joins the global hospital network on Patient Network Explorer, bringing its patients access to leading-edge medical interventions via international, sponsored clinical trials, and expanding Clinerion’s existing presence in São Paulo State.

"Hospital PUC-Campinas Celso Pierro is a reference hospital in high-complexity care in Campinas, São Paulo, and surrounding regions, with 339 beds. The hospital runs clinical trials in cardiology, dermatology, endocrinology and haematology, among others.

"By joining the Patient Network Explorer platform, patients at Hospital PUC-Campinas Celso Pierro will gain visibility when sponsors are seeking patient cohorts and selecting sites for clinical trials. Patient Network Explorer matches sponsors’ trial protocols to the anonymized EHR data of patients in Clinerion’s hospital network."

PDF File: Click here to read the full release >

Press release: Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil.

Press release: Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil.
Hospital PUC-Campinas Celso Pierro joins the global hospital network on Patient Network Explorer, bringing its patients access to leading-edge medical interventions via international, sponsored clinical trials, and expanding Clinerion’s existing presence in São Paulo State.
Press release: Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion

"Hospital PUC-Campinas Celso Pierro is a reference hospital in high-complexity care in Campinas, São Paulo, and surrounding regions, with 339 beds. The hospital runs clinical trials in cardiology, dermatology, endocrinology and haematology, among others.

"By joining the Patient Network Explorer platform, patients at Hospital PUC-Campinas Celso Pierro will gain visibility when sponsors are seeking patient cohorts and selecting sites for clinical trials. Patient Network Explorer matches sponsors’ trial protocols to the anonymized EHR data of patients in Clinerion’s hospital network."



Press release: Clinerion and iClusion partner to boost the identification and recruitment of more patients into clinical trials.

Publication date: March 03, 2020

Clinerion’s Patient Network Explorer and iClusion’s Trial Eye platforms both connect clinical trial sponsors with networks of partner hospitals, giving trial managers the ability to include eligible patients for trials more quickly and efficiently than before. Treating physicians and patients benefit from increased treatment options and quicker access to new medical interventions.

"Together, the partners’ joint mission is to increase patient participation in studies to its full potential by optimizing protocol design, enabling study sites to efficiently start up their trials locally and plan and meet realistic patient recruitment and therefore total timeline targets.

"This new clinical trial optimization partnership also facilitates a total study site network activation for all trials, beyond the study sites already chosen to participate, by facilitating online referral and activation services.

"Both iClusion and Clinerion maintain cloud platforms which bring together participants from across the clinical study ecosystem, comprising sponsors, hospitals and clinicians, and treating physicians and patients. However, the partners offer complementary support and solutions throughout the product development process."

UPDATE: The European Site Solutions Summit is postponed.  We will forward more details when we get them.

PDF File: Click here to read the full release >

Press release: Clinerion and iClusion partner to boost the identification and recruitment of more patients into clinical trials.

Press release: Clinerion and iClusion partner to boost the identification and recruitment of more patients into clinical trials.
Clinerion’s Patient Network Explorer and iClusion’s Trial Eye platforms both connect clinical trial sponsors with networks of partner hospitals, giving trial managers the ability to include eligible patients for trials more quickly and efficiently than before. Treating physicians and patients benefit from increased treatment options and quicker access to new medical interventions.
Press release: Clinerion and iClusion partner to boost the identification and recruitment of more pat

"Together, the partners’ joint mission is to increase patient participation in studies to its full potential by optimizing protocol design, enabling study sites to efficiently start up their trials locally and plan and meet realistic patient recruitment and therefore total timeline targets.

"This new clinical trial optimization partnership also facilitates a total study site network activation for all trials, beyond the study sites already chosen to participate, by facilitating online referral and activation services.

"Both iClusion and Clinerion maintain cloud platforms which bring together participants from across the clinical study ecosystem, comprising sponsors, hospitals and clinicians, and treating physicians and patients. However, the partners offer complementary support and solutions throughout the product development process."

UPDATE: The European Site Solutions Summit is postponed.  We will forward more details when we get them.



Press release: Clinerion partners with Wefight to optimize patient recruitment in clinical trials by leveraging artificial intelligence to identify eligible patients from Vik community.

Publication date: February 26, 2020

Clinerion’s Patient Network Explorer platform allows clinical trial sponsors to identify cohorts of patients eligible for recruitment from its global network of partner hospitals. Wefight’s Vik app brings appropriate support to patients throughout the patient journey. The collaboration will bring Vik’s patients a view on clinical studies they are eligible for.

"Wefight’s Vik is a virtual companion supporting patients through their healthcare pathway. Vik brings patients appropriate support at the right time and engages patients over the long run. The app provides consented patients with a platform to gather information about their disease. Through partnership with Clinerion, Vik will now also leverage both retrospective data at the hospital level and direct-to-patient prospective data to identify, engage and recruit patients to participate in the most appropriate clinical trials, according to the trials’ protocol criteria."

PDF File: Click here to read the full release >

Press release: Clinerion partners with Wefight to optimize patient recruitment in clinical trials by leveraging artificial intelligence to identify eligible patients from Vik community.

Press release: Clinerion partners with Wefight to optimize patient recruitment in clinical trials by leveraging artificial intelligence to identify eligible patients from Vik community.
Clinerion’s Patient Network Explorer platform allows clinical trial sponsors to identify cohorts of patients eligible for recruitment from its global network of partner hospitals. Wefight’s Vik app brings appropriate support to patients throughout the patient journey. The collaboration will bring Vik’s patients a view on clinical studies they are eligible for.
Press release: Clinerion partners with Wefight to optimize patient recruitment in clinical trials by

"Wefight’s Vik is a virtual companion supporting patients through their healthcare pathway. Vik brings patients appropriate support at the right time and engages patients over the long run. The app provides consented patients with a platform to gather information about their disease. Through partnership with Clinerion, Vik will now also leverage both retrospective data at the hospital level and direct-to-patient prospective data to identify, engage and recruit patients to participate in the most appropriate clinical trials, according to the trials’ protocol criteria."



Press release: Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network.

Publication date: February 03, 2020

The partners will deliver an integrated clinical research offer transforming Real World Data (RWD) from the global site and patient network on Clinerion’s Patient Network Explorer into Real World Evidence (RWE) through the use of Datametrix’s analytical capabilities.

"The synergy that follows from the combination of Clinerion’s RWD and Datametrix’s analytical capabilities supports pharmaceutical companies with optimization of clinical study design to meet strategic development needs while reflecting real patient populations, where the patients are. It helps pharma customers drive successful recruitment by being able to select sites that see a sufficiently large population of potentially eligible patients; and then also helping those sites directly identify the eligible patients. It also enables improvement in the accuracy of RWD comparative clinical studies by applying statistical models to define the RWD study end points. Clinerion can use their access to RWD data to recruit patient to RWD comparative arms."

PDF File: Click here to read the full release >

Press release: Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network.

Press release: Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network.
The partners will deliver an integrated clinical research offer transforming Real World Data (RWD) from the global site and patient network on Clinerion’s Patient Network Explorer into Real World Evidence (RWE) through the use of Datametrix’s analytical capabilities.
Press release: Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Re

"The synergy that follows from the combination of Clinerion’s RWD and Datametrix’s analytical capabilities supports pharmaceutical companies with optimization of clinical study design to meet strategic development needs while reflecting real patient populations, where the patients are. It helps pharma customers drive successful recruitment by being able to select sites that see a sufficiently large population of potentially eligible patients; and then also helping those sites directly identify the eligible patients. It also enables improvement in the accuracy of RWD comparative clinical studies by applying statistical models to define the RWD study end points. Clinerion can use their access to RWD data to recruit patient to RWD comparative arms."



Press release: Karadeniz Hospital joins Clinerion’s Patient Network Explorer.

Publication date: January 06, 2020

Patients at Karadeniz Technical University Farabi Hospital will have access to international clinical trials bringing world-class quality of care and the most innovative treatments. This results from the fact that the hospital’s EHR will be integrated to Clinerion’s Patient Network Explorer.

“We are pleased that this collaboration will bring many benefits to the Karadeniz Technical University Farabi Hospital,” says Dean Prof. Dr. Mustafa Imamoğlu, “Our hospital will be recognized for contributing to worldwide scientific research. Our patients will be treated more quickly. We will contribute to the national economy through clinical research funding, research related travels and inspections."

PDF File: Click here to read the full release >

Press release: Karadeniz Hospital joins Clinerion’s Patient Network Explorer.

Press release: Karadeniz Hospital joins Clinerion’s Patient Network Explorer.
Patients at Karadeniz Technical University Farabi Hospital will have access to international clinical trials bringing world-class quality of care and the most innovative treatments. This results from the fact that the hospital’s EHR will be integrated to Clinerion’s Patient Network Explorer.
Press release: Karadeniz Hospital joins Clinerion’s Patient Network Explorer.

“We are pleased that this collaboration will bring many benefits to the Karadeniz Technical University Farabi Hospital,” says Dean Prof. Dr. Mustafa Imamoğlu, “Our hospital will be recognized for contributing to worldwide scientific research. Our patients will be treated more quickly. We will contribute to the national economy through clinical research funding, research related travels and inspections."



Press release: Clinerion and Pangaea partner to improve cancer patient lives.

Publication date: December 18, 2019

Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Pangaea, a machine learning company, partner to improve faster identification of patient cohorts based on phenotypes from electronic health record (EHR) data.

Pangaea’s partnership with Clinerion allows it to apply its machine learning algorithms to de-identified patient EHR data and unstructured doctors’ notes through Clinerion’s federated network of hospitals across 21 countries in Europe, Middle East, South America and Asia Pacific. Pangaea’s and Clinerion’s customers, scientists and clinicians from the Biopharmaceutical industry, will be able to find patients of specific phenotypes from across these different regions at speed and with higher accuracy.

PDF File: Click here to read the full release >

Press release: Clinerion and Pangaea partner to improve cancer patient lives.

Press release: Clinerion and Pangaea partner to improve cancer patient lives.
Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Pangaea, a machine learning company, partner to improve faster identification of patient cohorts based on phenotypes from electronic health record (EHR) data.
Press release: Clinerion and Pangaea partner to improve cancer patient lives.

Pangaea’s partnership with Clinerion allows it to apply its machine learning algorithms to de-identified patient EHR data and unstructured doctors’ notes through Clinerion’s federated network of hospitals across 21 countries in Europe, Middle East, South America and Asia Pacific. Pangaea’s and Clinerion’s customers, scientists and clinicians from the Biopharmaceutical industry, will be able to find patients of specific phenotypes from across these different regions at speed and with higher accuracy.



Press release: Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe.

Publication date: December 12, 2019

Clinerion has been certified by EHDEN (European Health Data & Evidence Network) to map health data from various formats to the OMOP common data model. As an OMOP ambassador, Clinerion will support the speeding up of the process to map health data from various formats and institutions to the OMOP common data model in Europe.

Clinerion was selected as one of eleven SMEs (Small and medium-sized enterprises) from a pool of twenty-eight eligible applications to the first EHDEN pilot call this year, to be trained and certified, with the objective to speed up the process to map health data from various formats and institutions to the OMOP common data model.

For more information, please visit the EHDEN website.

The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

More on EHDEN >

Clinerion Partners page >

PDF File: Click here to read the full release >

Press release: Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe.

Press release: Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe.
Clinerion has been certified by EHDEN (European Health Data & Evidence Network) to map health data from various formats to the OMOP common data model. As an OMOP ambassador, Clinerion will support the speeding up of the process to map health data from various formats and institutions to the OMOP common data model in Europe.
Press release: Clinerion becomes EHDEN certified, supporting the building of a federated health data

Clinerion was selected as one of eleven SMEs (Small and medium-sized enterprises) from a pool of twenty-eight eligible applications to the first EHDEN pilot call this year, to be trained and certified, with the objective to speed up the process to map health data from various formats and institutions to the OMOP common data model.

For more information, please visit the EHDEN website.

The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

More on EHDEN >

Clinerion Partners page >



Press release: Clinerion and EvidNet partner to drive healthcare forward by extending their global reach and technologies for real-world data-driven solutions.

Publication date: December 06, 2019

Clinerion and EvidNet, both offering patient data harmonization and integration services to healthcare organizations, both operating access to EHRs from healthcare networks, partner to extend their respective real-world data-offerings to accelerate patient access to medicines and improve health outcomes.

“This partnership with EvidNet allows us to strengthen and expand our presence in Asia as well as collaborate with OHDSI, through our Partner, on the implementation of the OMOP CDM in the rest of Asia,” Says Ian Rentsch, CEO of Clinerion. “The core benefit of the partnership will be to provide accelerated access to treatments and visibility on clinical trials for patients in the Asian markets.

PDF File: Click here to read the full release >

Press release: Clinerion and EvidNet partner to drive healthcare forward by extending their global reach and technologies for real-world data-driven solutions.

Press release: Clinerion and EvidNet partner to drive healthcare forward by extending their global reach and technologies for real-world data-driven solutions.
Clinerion and EvidNet, both offering patient data harmonization and integration services to healthcare organizations, both operating access to EHRs from healthcare networks, partner to extend their respective real-world data-offerings to accelerate patient access to medicines and improve health outcomes.
Press release: Clinerion and EvidNet partner to drive healthcare forward by extending their global re

“This partnership with EvidNet allows us to strengthen and expand our presence in Asia as well as collaborate with OHDSI, through our Partner, on the implementation of the OMOP CDM in the rest of Asia,” Says Ian Rentsch, CEO of Clinerion. “The core benefit of the partnership will be to provide accelerated access to treatments and visibility on clinical trials for patients in the Asian markets.



Press release: Clinerion and Massive Bio partner to improve cancer patient lives.

Publication date: December 03, 2019

Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Massive Bio, provider of end-to-end patient enrollment services for oncology, partner to improve trial site selection and thereby offer better access for cancer patients to leading-edge clinical trials.

Clinerion offers Massive Bio access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment. Clinerion’s Patient Network Explorer queries anonymized patient data from its international network of partner hospitals to deliver real-world health data insights useful for Massive Bio’s site outreach programs.

View MassiveBio's website >

PDF File: Click here to read the full release >

Press release: Clinerion and Massive Bio partner to improve cancer patient lives.

Press release: Clinerion and Massive Bio partner to improve cancer patient lives.
Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Massive Bio, provider of end-to-end patient enrollment services for oncology, partner to improve trial site selection and thereby offer better access for cancer patients to leading-edge clinical trials.
Press release: Clinerion and Massive Bio partner to improve cancer patient lives.

Clinerion offers Massive Bio access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment. Clinerion’s Patient Network Explorer queries anonymized patient data from its international network of partner hospitals to deliver real-world health data insights useful for Massive Bio’s site outreach programs.

View MassiveBio's website >

Press release: Clinerion partners with Eugen to expand Patient Network Explorer coverage to patients and hospitals in Uruguay.

Press release: Clinerion partners with Eugen to expand Patient Network Explorer coverage to patients and hospitals in Uruguay.
Eugen will support the expansion of Clinerion’s Patient Network Explorer to hospitals and clinical trial sites in Uruguay. Eugen will also offer Patient Network Explorer services on behalf of Clinerion to clinical researchers and trial sponsors in Uruguay.
Press release: Clinerion partners with Eugen to expand Patient Network Explorer coverage to patients

Eugen, a clinical development service provider based in Uruguay, will support Clinerion’s expansion by promoting hospitals in the country to join Patient Network Explorer (PNEx), adding to the platform true global representativeness. They will use PNEx to provide clients with solid real patient health data insights when choosing their clinical trial’s geographic distribution, better trial design tools and effective patient enrollment. Hospitals in Uruguay will increase their visibility and be in a better position to attract global multicentric trials while providing patients with innovative treatments.



Press release: Arabkir Joint Medical Center & Institute of Child and Adolescent Health joins the Patient Network Explorer platform, expanding Clinerion’s global hospital network to Armenia.

Publication date: November 21, 2019

Arabkir Joint Medical Center & Institute of Child and Adolescent Health gains visibility for participation in international clinical studies, thus bringing innovative treatment and medicines to the Center’s patients. Arabkir Medical Center is the first hospital in Armenia to join the Patient Network Explorer platform.

“With this collaboration, we aim to have our own impact in the field of medicine and drug development, as well as contribute to the evolvement of the healthcare infrastructure in the country,” says Arman Babloyan, Director of the Arabkir Joint Medical Center & Institute of Child and Adolescent Health.

PDF File: Click here to read the full release >

Press release: Arabkir Joint Medical Center & Institute of Child and Adolescent Health joins the Patient Network Explorer platform, expanding Clinerion’s global hospital network to Armenia.

Press release: Arabkir Joint Medical Center & Institute of Child and Adolescent Health joins the Patient Network Explorer platform, expanding Clinerion’s global hospital network to Armenia.
Arabkir Joint Medical Center & Institute of Child and Adolescent Health gains visibility for participation in international clinical studies, thus bringing innovative treatment and medicines to the Center’s patients. Arabkir Medical Center is the first hospital in Armenia to join the Patient Network Explorer platform.
Press release: Arabkir Joint Medical Center & Institute of Child and Adolescent Health joins the

“With this collaboration, we aim to have our own impact in the field of medicine and drug development, as well as contribute to the evolvement of the healthcare infrastructure in the country,” says Arman Babloyan, Director of the Arabkir Joint Medical Center & Institute of Child and Adolescent Health.



Press release: Clinerion partners with Semedy to incorporate Semedy’s Clinical Knowledge Management System technology into Clinerion’s Patient Network Explorer.

Publication date: November 15, 2019

Clinerion will implement Semedy’s Clinical Knowledge Management System (CKMS) to manage and maintain the terminologies in Patient Network Explorer provided by the partners in Clinerion’s hospital network around the world.

Semedy’s Clinical Knowledge Management System (CKMS) will empower Clinerion’s advanced Patient Network Explorer to integrate, manage and maintain multilingual terminologies, ontologies, and data dictionaries provided by Clinerion’s different hospital partners around the world.

PDF File: Click here to read the full release >

Press release: Clinerion partners with Semedy to incorporate Semedy’s Clinical Knowledge Management System technology into Clinerion’s Patient Network Explorer.

Press release: Clinerion partners with Semedy to incorporate Semedy’s Clinical Knowledge Management System technology into Clinerion’s Patient Network Explorer.
Clinerion will implement Semedy’s Clinical Knowledge Management System (CKMS) to manage and maintain the terminologies in Patient Network Explorer provided by the partners in Clinerion’s hospital network around the world.
Press release: Clinerion partners with Semedy to incorporate Semedy’s Clinical Knowledge Management S

Semedy’s Clinical Knowledge Management System (CKMS) will empower Clinerion’s advanced Patient Network Explorer to integrate, manage and maintain multilingual terminologies, ontologies, and data dictionaries provided by Clinerion’s different hospital partners around the world.



Press release: Clinerion partners with PPC to bring Patient Network Explorer coverage and services to patients and hospitals in Korea, China and Taiwan.

Publication date: October 31, 2019

PPC will offer Patient Network Explorer services for accelerating clinical trial site selection and recruitment in Korea, China and Taiwan. PPC will support Clinerion in the expansion of their hospital network in Korea, China and Taiwan.

As part of the partnership, PPC will use the Patient Network Explorer platform to advance clinical trials, trial enrollment, and accelerate global studies conducted in the People’s Republic of China, the Republic of China (Taiwan) and the Republic of Korea (South Korea). PPC will encourage hospitals to participate in Clinerion’s Patient Network Explorer platform for generation of RWD/RWE and bringing more global studies to hospitals.

PDF File: Click here to read the full release >

Press release: Clinerion partners with PPC to bring Patient Network Explorer coverage and services to patients and hospitals in Korea, China and Taiwan.

Press release: Clinerion partners with PPC to bring Patient Network Explorer coverage and services to patients and hospitals in Korea, China and Taiwan.
PPC will offer Patient Network Explorer services for accelerating clinical trial site selection and recruitment in Korea, China and Taiwan. PPC will support Clinerion in the expansion of their hospital network in Korea, China and Taiwan.
Press release: Clinerion partners with PPC to bring Patient Network Explorer coverage and services to

As part of the partnership, PPC will use the Patient Network Explorer platform to advance clinical trials, trial enrollment, and accelerate global studies conducted in the People’s Republic of China, the Republic of China (Taiwan) and the Republic of Korea (South Korea). PPC will encourage hospitals to participate in Clinerion’s Patient Network Explorer platform for generation of RWD/RWE and bringing more global studies to hospitals.



Press release: Hospital Angelina Caron extends the hospital coverage of Clinerion’s Patient Network Explorer platform in Brazil.

Publication date: September 30, 2019

Hospital Angelina Caron, of Campina Grande do Sul, Paraná, is the latest Brazilian hospital to join Clinerion’s network of partner hospitals on its Patient Network Explorer platform.

“With the Clinerion database system, there will be a great progress in research at our center, facilitating patient selection and increasing our effectiveness. Today, a database and facilitating access to information are fundamental to the evolution of research”, says Dalton B. Precoma (M.D; Ph.D), cardiologist of Hospital Angelina Caron.

PDF File: Click here to read the full release >

Press release: Hospital Angelina Caron extends the hospital coverage of Clinerion’s Patient Network Explorer platform in Brazil.

Press release: Hospital Angelina Caron extends the hospital coverage of Clinerion’s Patient Network Explorer platform in Brazil.
Hospital Angelina Caron, of Campina Grande do Sul, Paraná, is the latest Brazilian hospital to join Clinerion’s network of partner hospitals on its Patient Network Explorer platform.
Press release: Hospital Angelina Caron extends the hospital coverage of Clinerion’s Patient Network E

“With the Clinerion database system, there will be a great progress in research at our center, facilitating patient selection and increasing our effectiveness. Today, a database and facilitating access to information are fundamental to the evolution of research”, says Dalton B. Precoma (M.D; Ph.D), cardiologist of Hospital Angelina Caron.



Clinerion selected among the Top 100 Swiss companies supporting longevity

Publication date: September 24, 2019

We've been recognised by Aging Analytics Agency as one of the Swiss companies which support the most precision medicine, and therefore longevity. Driven by a government initiative to harmonize healthcare data across Switzerland, Clinerion Ltd is building a Federated Query Ecosystem which will allow researchers to run medical queries against EMR data in all 5 university hospitals, Basel, Bern, Geneva, Lausanne and Zurich.

According to the Aging Analytics Agency's recent report, a lean political system and a strong research environment for GeroScience and for digital health are some of the main reasons explaing why Switzerland has one of the best life expectancy in the world (#2 overall with 83.4 years). Getting more homogeneous national health data still remains a challenge.

> View full report (more than 500 pages, free access) 

To access the full report, sign up on Aging Analytics Agency's website - it only takes a few seconds.

Clinerion selected among the Top 100 Swiss companies supporting longevity

Clinerion selected among the Top 100 Swiss companies supporting longevity
We've been recognised by Aging Analytics Agency as one of the Swiss companies which support the most precision medicine, and therefore longevity. Driven by a government initiative to harmonize healthcare data across Switzerland, Clinerion Ltd is building a Federated Query Ecosystem which will allow researchers to run medical queries against EMR data in all 5 university hospitals, Basel, Bern, Geneva, Lausanne and Zurich.
Clinerion selected among the Top 100 Swiss companies supporting longevity

According to the Aging Analytics Agency's recent report, a lean political system and a strong research environment for GeroScience and for digital health are some of the main reasons explaing why Switzerland has one of the best life expectancy in the world (#2 overall with 83.4 years). Getting more homogeneous national health data still remains a challenge.

> View full report (more than 500 pages, free access) 

To access the full report, sign up on Aging Analytics Agency's website - it only takes a few seconds.



O.I.s) partners with Andaman7 to advance cancer research

Publication date: September 19, 2019

Our partner O.I.s) - OncologyInformationService - is now collaborating with Andaman7 to achieve a major advance in developing a patient-centered, real-world dataset for cancer research.

This new partnership will allow to build a holistic view of cancer treatment. 

We are proud to be a piece of this puzzle, as we already partner with O.I.s) to build a larger database which not only consists of e-health records data, but also of clinical trial related data. 

3 technologies, 1 purpose:

  • We will leverage our Patient Network Explorer (PNEx): 19 countries, 100+ hospitals, 80 million patients
  • O.I.s) will leverage its RWD database, TherapyMonitor, which consists of more than 5,000 treatment courses from 200+ institutions
  • Andaman7 will use its App to gather patient-reported treatment experience in daily life.

...Connecting these tools will allow to generate unique real world evidence (RWE) to see what really works for patients, and create better patients' outcomes and experience. 

> View infographics

PDF File: Read Full Press Release

O.I.s) partners with Andaman7 to advance cancer research

O.I.s) partners with Andaman7 to advance cancer research
Our partner O.I.s) - OncologyInformationService - is now collaborating with Andaman7 to achieve a major advance in developing a patient-centered, real-world dataset for cancer research.
O.I.s) partners with Andaman7 to advance cancer research

This new partnership will allow to build a holistic view of cancer treatment. 

We are proud to be a piece of this puzzle, as we already partner with O.I.s) to build a larger database which not only consists of e-health records data, but also of clinical trial related data. 

3 technologies, 1 purpose:

  • We will leverage our Patient Network Explorer (PNEx): 19 countries, 100+ hospitals, 80 million patients
  • O.I.s) will leverage its RWD database, TherapyMonitor, which consists of more than 5,000 treatment courses from 200+ institutions
  • Andaman7 will use its App to gather patient-reported treatment experience in daily life.

...Connecting these tools will allow to generate unique real world evidence (RWE) to see what really works for patients, and create better patients' outcomes and experience. 

> View infographics



Press release: Clinerion partners with Volv Global to bring treatment earlier to patients by enhancing diagnosis search on Patient Network Explorer with inTrigue AI algorithms.

Publication date: September 11, 2019

Volv Global’s inTrigue AI algorithms identify diagnostic signals from patient medical record data and help patients receive treatment earlier by enabling earlier diagnosis, particularly of rare and difficult to diagnose diseases. The partnership brings this capability to the Patient Network Explorer platform, which comprises patient data from across Clinerion’s global network of hospital partners. Use of Volv’s inTrigue AI algorithms on Patient Network Explorer will allow more intelligent and earlier identification of disease onset among patients in Clinerion’s network, and therefore earlier therapeutic and clinical treatment to many more patients.

The partnership between Clinerion and Volv Global brings benefits to patients by combining Volv’s uniquely accurate cohort identification algorithms with Clinerion’s growing data network of hospitals around the world. The Volv and Clinerion partnership will deploy Volv’s inTrigue algorithms across many more hospitals and this will create tangible outcomes for patients who suffer from late diagnosis of between seven and 15 years, as well as from misdiagnosis and subsequent increased disease burden.

PDF File: Click here to read the full release >

Press release: Clinerion partners with Volv Global to bring treatment earlier to patients by enhancing diagnosis search on Patient Network Explorer with inTrigue AI algorithms.

Press release: Clinerion partners with Volv Global to bring treatment earlier to patients by enhancing diagnosis search on Patient Network Explorer with inTrigue AI algorithms.
Volv Global’s inTrigue AI algorithms identify diagnostic signals from patient medical record data and help patients receive treatment earlier by enabling earlier diagnosis, particularly of rare and difficult to diagnose diseases. The partnership brings this capability to the Patient Network Explorer platform, which comprises patient data from across Clinerion’s global network of hospital partners. Use of Volv’s inTrigue AI algorithms on Patient Network Explorer will allow more intelligent and earlier identification of disease onset among patients in Clinerion’s network, and therefore earlier therapeutic and clinical treatment to many more patients.
Press release: Clinerion partners with Volv Global to bring treatment earlier to patients by enhancin

The partnership between Clinerion and Volv Global brings benefits to patients by combining Volv’s uniquely accurate cohort identification algorithms with Clinerion’s growing data network of hospitals around the world. The Volv and Clinerion partnership will deploy Volv’s inTrigue algorithms across many more hospitals and this will create tangible outcomes for patients who suffer from late diagnosis of between seven and 15 years, as well as from misdiagnosis and subsequent increased disease burden.



Press release: Clinerion and O.I.s (OncologyInformationService) partner on delivering real-world data services in oncology by using both partners’ technologies to aggregate cancer treatment data from each partner’s networks of institutions.

Publication date: September 05, 2019

The partnership between Clinerion and OncologyInformationService will create a platform of live, aggregated, anonymous, longitudinal cancer patient data from both partner’s networks of treatment institutions. The resulting real-world database will provide services in oncology to researchers, treating institutions, medical associations and the pharmaceutical industry.

The partnership between Clinerion and OncologyInformationService (O.I.s) will create a platform for oncology which integrates O.I.s’ real-world databases with Clinerion’s patient data network, via Clinerion’s patented patient data analytics technologies. The partners aim to establish a real-world evidence (RWE) database from a network of cancer treating institutions which will also allow real-time query of the participating institutions’ electronic medical records (EMRs). 

PDF File: Click here to read the full release >

Press release: Clinerion and O.I.s (OncologyInformationService) partner on delivering real-world data services in oncology by using both partners’ technologies to aggregate cancer treatment data from each partner’s networks of institutions.

Press release: Clinerion and O.I.s (OncologyInformationService) partner on delivering real-world data services in oncology by using both partners’ technologies to aggregate cancer treatment data from each partner’s networks of institutions.
The partnership between Clinerion and OncologyInformationService will create a platform of live, aggregated, anonymous, longitudinal cancer patient data from both partner’s networks of treatment institutions. The resulting real-world database will provide services in oncology to researchers, treating institutions, medical associations and the pharmaceutical industry.
Press release: Clinerion and O.I.s (OncologyInformationService) partner on delivering real-world data

The partnership between Clinerion and OncologyInformationService (O.I.s) will create a platform for oncology which integrates O.I.s’ real-world databases with Clinerion’s patient data network, via Clinerion’s patented patient data analytics technologies. The partners aim to establish a real-world evidence (RWE) database from a network of cancer treating institutions which will also allow real-time query of the participating institutions’ electronic medical records (EMRs). 



Press release: Jehangir Hospital, along with its research arm Jehangir Clinical Development Centre (JCDC), is the first hospital in India to bring its patients access to international clinical trials by joining Clinerion’s Patient Network Explorer platform.

Publication date: August 15, 2019

Patients of Jehangir Clinical Development Centre (JCDC) gain visibility on Patient Network Explorer for matching to international trials run by sponsors around the world. JCDC is the first healthcare institution in India to join Clinerion’s global network of partner hospitals.

“We at JCDC are delighted about partnering with Clinerion as there is an ideal alignment of Clinerion’s innovative technology and our clinical research expertise,” says Pathik Divate, CEO of the JCDC. “We are excited about harnessing the power of this technology to leverage our diverse patient population and bring in further efficiency in patient recruitment.”

PDF File: Click here to read the full release >

Press release: Jehangir Hospital, along with its research arm Jehangir Clinical Development Centre (JCDC), is the first hospital in India to bring its patients access to international clinical trials by joining Clinerion’s Patient Network Explorer platform.

Press release: Jehangir Hospital, along with its research arm Jehangir Clinical Development Centre (JCDC), is the first hospital in India to bring its patients access to international clinical trials by joining Clinerion’s Patient Network Explorer platform.
Patients of Jehangir Clinical Development Centre (JCDC) gain visibility on Patient Network Explorer for matching to international trials run by sponsors around the world. JCDC is the first healthcare institution in India to join Clinerion’s global network of partner hospitals.
Press release: Jehangir Hospital, along with its research arm Jehangir Clinical Development Centre (J

“We at JCDC are delighted about partnering with Clinerion as there is an ideal alignment of Clinerion’s innovative technology and our clinical research expertise,” says Pathik Divate, CEO of the JCDC. “We are excited about harnessing the power of this technology to leverage our diverse patient population and bring in further efficiency in patient recruitment.”



Press release: The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network, consolidating Patient Network Explorer coverage in Greece.

Publication date: August 06, 2019

Geniko Nosokomeio Thessalonikis “Papageorgiou” brings its patients and physicians quicker access to innovative medical treatments by joining Clinerion’s Patient Network Explorer platform.

With the hospital joining Patient Network Explorer, patients at Geniko Nosokomeio Thessalonikis “Papageorgiou” will be matched to clinical trials being run by international pharmaceutical companies on innovative medical interventions, as well as those being run by the hospital’s own academic researchers. This gives patients and physicians at the hospital access to leading-edge treatment options and supports the acceleration of the introduction of these treatments into the market.

PDF File: Click here to read the full release >

Press release: The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network, consolidating Patient Network Explorer coverage in Greece.

Press release: The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network, consolidating Patient Network Explorer coverage in Greece.
Geniko Nosokomeio Thessalonikis “Papageorgiou” brings its patients and physicians quicker access to innovative medical treatments by joining Clinerion’s Patient Network Explorer platform.
Press release: The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network

With the hospital joining Patient Network Explorer, patients at Geniko Nosokomeio Thessalonikis “Papageorgiou” will be matched to clinical trials being run by international pharmaceutical companies on innovative medical interventions, as well as those being run by the hospital’s own academic researchers. This gives patients and physicians at the hospital access to leading-edge treatment options and supports the acceleration of the introduction of these treatments into the market.



DayOne Experts in Basel: key takeaways

Publication date: August 06, 2019

During the recent event hosted by BaselArea Swiss, insightful talks were given, including Randy Ramin-Wright's presentation, which demonstrated how patient recruitment works in the digital age.

Which industry is lagging behind the most in terms of digitization? Right, it is the healthcare industry! But who would have expected the usual lamentation of why this is the case; blaming regulatory constraints, scarce innovation culture, or unachievable technology barriers proved wrong. The appetite for change and finding new ways of doing things was too strong among Basel’s Healthcare innovators at the DayOne Expert Session on “Next Generation Digital Trials”.

Read the event's key takeaways [via BaselArea] >

DayOne Experts in Basel: key takeaways

DayOne Experts in Basel: key takeaways
During the recent event hosted by BaselArea Swiss, insightful talks were given, including Randy Ramin-Wright's presentation, which demonstrated how patient recruitment works in the digital age.
DayOne Experts in Basel: key takeaways

Which industry is lagging behind the most in terms of digitization? Right, it is the healthcare industry! But who would have expected the usual lamentation of why this is the case; blaming regulatory constraints, scarce innovation culture, or unachievable technology barriers proved wrong. The appetite for change and finding new ways of doing things was too strong among Basel’s Healthcare innovators at the DayOne Expert Session on “Next Generation Digital Trials”.

Read the event's key takeaways [via BaselArea] >



EHDEN Finalises SME Open Call Process - Paves way to build federated health data source network

Publication date: July 31, 2019

Clinerion has been selected as one of eleven SMEs (Small & Medium-sized Enterprises) to apply for training and certification by EHDEN, with the objective to speed up the process to map health data from various formats and institutions to the OMOP common data model.

The European Health Data & Evidence Network (EHDEN) recently achieved an important milestone in the effort to tap into the potential of real-world data and realise its mission to develop a federated network, standardised to a common data model. This will ultimately result in a Europe that more smartly manages and shares research methodologies - and expands education in open science and collaboration.

In concluding its first open call to SMEs (Small & Medium-sized Enterprises) to apply for training and certification, EHDEN has paved the way for speeding up the process to map health data from various formats and institutions to the OMOP common data model.

Eleven SMEs have been selected from a pool of twenty-eight eligible applications. The first wave of training will begin this month for five of the SMEs, with the other six following closely thereafter.

Prof. Peter Rijnbeek, Erasmus Medical Center, Rotterdam, The Netherlands and Coordinator of EHDEN, said, “We warmly welcome this initial group of SMEs. EHDEN provides SMEs with free training and certification, an ability to expand their market presence, and to be part of a transformational initiative that will have positive impact on patient outcomes across Europe.”   

“Establishing this first geographically diverse SME network is a critical step in building an eco-system that supports a range of data partners and other stakeholders in mapping and using health data,” said Nigel Hughes, Janssen Scientific Director RWD/WRE, and Co-Lead of EHDEN. “Once certified, these SMEs, together with the data partners that will be joining in the coming months and years, will become a key part of the EHDEN community,” he added.

For more information, please visit the EHDEN website.

The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

More on EHDEN >

Clinerion Partners page >

EHDEN Finalises SME Open Call Process - Paves way to build federated health data source network

EHDEN Finalises SME Open Call Process - Paves way to build federated health data source network
Clinerion has been selected as one of eleven SMEs (Small & Medium-sized Enterprises) to apply for training and certification by EHDEN, with the objective to speed up the process to map health data from various formats and institutions to the OMOP common data model.
EHDEN Finalises SME Open Call Process - Paves way to build federated health data source network

The European Health Data & Evidence Network (EHDEN) recently achieved an important milestone in the effort to tap into the potential of real-world data and realise its mission to develop a federated network, standardised to a common data model. This will ultimately result in a Europe that more smartly manages and shares research methodologies - and expands education in open science and collaboration.

In concluding its first open call to SMEs (Small & Medium-sized Enterprises) to apply for training and certification, EHDEN has paved the way for speeding up the process to map health data from various formats and institutions to the OMOP common data model.

Eleven SMEs have been selected from a pool of twenty-eight eligible applications. The first wave of training will begin this month for five of the SMEs, with the other six following closely thereafter.

Prof. Peter Rijnbeek, Erasmus Medical Center, Rotterdam, The Netherlands and Coordinator of EHDEN, said, “We warmly welcome this initial group of SMEs. EHDEN provides SMEs with free training and certification, an ability to expand their market presence, and to be part of a transformational initiative that will have positive impact on patient outcomes across Europe.”   

“Establishing this first geographically diverse SME network is a critical step in building an eco-system that supports a range of data partners and other stakeholders in mapping and using health data,” said Nigel Hughes, Janssen Scientific Director RWD/WRE, and Co-Lead of EHDEN. “Once certified, these SMEs, together with the data partners that will be joining in the coming months and years, will become a key part of the EHDEN community,” he added.

For more information, please visit the EHDEN website.

The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

More on EHDEN >

Clinerion Partners page >



Press release: Clinerion partners with the Dresden International University to generate Real World Evidence from a Real World Data Network for the first time in an academic setting.

Publication date: July 29, 2019

Clinerion fosters the wellbeing of patients by supporting the education of the next generation of clinicians and scientists around the world. Students of the Master’s Program in Clinical Research at Dresden International University will gain access to de-identified Real World Data from a subset of the hospital network on Clinerion’s Patient Network Explorer platform. This will allow the generation of Real World Evidence for the first time in a teaching program.

The Real World Data for the course will be sourced from a subset of the de-identified electronic health records of patients in Clinerion’s hospital network. DIU Master’s students will gain access to Patient Network Explorer, Clinerion’s platform for secure, cloud-based query of remote, de-identified hospital patient data.

PDF File: Click here to read the full release >

Press release: Clinerion partners with the Dresden International University to generate Real World Evidence from a Real World Data Network for the first time in an academic setting.

Press release: Clinerion partners with the Dresden International University to generate Real World Evidence from a Real World Data Network for the first time in an academic setting.
Clinerion fosters the wellbeing of patients by supporting the education of the next generation of clinicians and scientists around the world. Students of the Master’s Program in Clinical Research at Dresden International University will gain access to de-identified Real World Data from a subset of the hospital network on Clinerion’s Patient Network Explorer platform. This will allow the generation of Real World Evidence for the first time in a teaching program.
Press release: Clinerion partners with the Dresden International University to generate Real World Ev

The Real World Data for the course will be sourced from a subset of the de-identified electronic health records of patients in Clinerion’s hospital network. DIU Master’s students will gain access to Patient Network Explorer, Clinerion’s platform for secure, cloud-based query of remote, de-identified hospital patient data.



Press release: Clinerion continues expansion of Patient Network Explorer coverage in South America by partnering with B-TRIALS in Chile.

Publication date: July 11, 2019

Clinerion’s Partnership with the company B-TRIALS will drive the expansion of Patient Network Explorer’s coverage in Chile, one of the fastest growing economies in Latin America, thereby bringing greater access to innovative treatments to patients in the country.

The Chilean company B-TRIALS, a specialist in providing tools and solutions in the health area, will be responsible for the expansion of Clinerion in Chile. This will give patients in Chile quicker and better access to innovative medical treatments via increased participation in clinical trials, and via accelerated product launch due to more efficient patient recruitment for clinical trials.

PDF File: Click here to read the full release >

Press release: Clinerion continues expansion of Patient Network Explorer coverage in South America by partnering with B-TRIALS in Chile.

Press release: Clinerion continues expansion of Patient Network Explorer coverage in South America by partnering with B-TRIALS in Chile.
Clinerion’s Partnership with the company B-TRIALS will drive the expansion of Patient Network Explorer’s coverage in Chile, one of the fastest growing economies in Latin America, thereby bringing greater access to innovative treatments to patients in the country.
Press release: Clinerion continues expansion of Patient Network Explorer coverage in South America by

The Chilean company B-TRIALS, a specialist in providing tools and solutions in the health area, will be responsible for the expansion of Clinerion in Chile. This will give patients in Chile quicker and better access to innovative medical treatments via increased participation in clinical trials, and via accelerated product launch due to more efficient patient recruitment for clinical trials.



Press release: Clinerion partners with 2 GL Outsourcing to bring patients and hospitals in Serbia, and Bosnia and Herzegovina quicker access to next-generation medical treatments.

Publication date: July 04, 2019

2 GL Outsourcing will support Clinerion in expanding the coverage of the Patient Network Explorer platform to patients and hospitals in Serbia, and Bosnia and Herzegovina, who will be matched to leading-edge, sponsored, international clinical trials, accelerating their access to medical innovations.

Separately and in combination, Clinerion and 2 GL’s services will accelerate access for patients and hospitals to next-generation medical treatments. Patients in the region will become more visible to sponsors for trial recruitment, and hospitals in the region will become better placed to run clinical trials. This ultimately accelerates drug launch

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion partners with 2 GL Outsourcing to bring patients and hospitals in Serbia, and Bosnia and Herzegovina quicker access to next-generation medical treatments.

Press release: Clinerion partners with 2 GL Outsourcing to bring patients and hospitals in Serbia, and Bosnia and Herzegovina quicker access to next-generation medical treatments.
2 GL Outsourcing will support Clinerion in expanding the coverage of the Patient Network Explorer platform to patients and hospitals in Serbia, and Bosnia and Herzegovina, who will be matched to leading-edge, sponsored, international clinical trials, accelerating their access to medical innovations.
Press release: Clinerion partners with 2 GL Outsourcing to bring patients and hospitals in Serbia, an

Separately and in combination, Clinerion and 2 GL’s services will accelerate access for patients and hospitals to next-generation medical treatments. Patients in the region will become more visible to sponsors for trial recruitment, and hospitals in the region will become better placed to run clinical trials. This ultimately accelerates drug launch

Download the PDF for the full release.



Press Release: The Medison network of clinics, Tbilisi, Georgia, joins Clinerion’s Patient Network Explorer platform, bringing their patients accelerated access to next generation treatments and therapies.

Publication date: June 27, 2019

Patients at Medison’s network of clinics will gain access to next generation treatments and therapies by being matched to leading-edge, international clinical trials. This will also accelerate the launch of new treatments and medications in Georgia.

The Medison network of clinics specializes in outpatient and dental services for all social strata, focusing on patient health care, disease prevention, and timely and correct diagnosis. The four clinics in Tbilisi, Georgia, provide medical care to over 6,000 patients each month.

The network has highly qualified, specialist clinical staff and is fully equipped for state-of-the-art clinical trials. Medison currently has several trials running. “We are determined to provide our patients with the best possible care and we are deeply convinced that this partnership with Clinerion will help us achieve this,” says Tsotne Sherozia, Director of Medison. “Patient Network Explorer will give our patients access to the most innovative drugs in development, worldwide.”

PDF File: Download Full Press Release

Press Release: The Medison network of clinics, Tbilisi, Georgia, joins Clinerion’s Patient Network Explorer platform, bringing their patients accelerated access to next generation treatments and therapies.

Press Release: The Medison network of clinics, Tbilisi, Georgia, joins Clinerion’s Patient Network Explorer platform, bringing their patients accelerated access to next generation treatments and therapies.
Patients at Medison’s network of clinics will gain access to next generation treatments and therapies by being matched to leading-edge, international clinical trials. This will also accelerate the launch of new treatments and medications in Georgia.
Press Release: The Medison network of clinics, Tbilisi, Georgia, joins Clinerion’s Patient Network Ex

The Medison network of clinics specializes in outpatient and dental services for all social strata, focusing on patient health care, disease prevention, and timely and correct diagnosis. The four clinics in Tbilisi, Georgia, provide medical care to over 6,000 patients each month.

The network has highly qualified, specialist clinical staff and is fully equipped for state-of-the-art clinical trials. Medison currently has several trials running. “We are determined to provide our patients with the best possible care and we are deeply convinced that this partnership with Clinerion will help us achieve this,” says Tsotne Sherozia, Director of Medison. “Patient Network Explorer will give our patients access to the most innovative drugs in development, worldwide.”



Press Release: EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform.

Publication date: May 20, 2019

EMC Szpitale augments Clinerion’s patient coverage in Poland by joining the Patient Network Explorer platform. Patients at the hospital group will gain greater access to clinical trials, and actively support in accelerating the successful launch of innovative medical treatments.

EMC Szpitale operates 11 hospitals and 19 outpatient clinics, providing primary and specialized medical care to over one million patients across Poland. EMC Szpitale specializations include advanced diagnostics to comprehensive hospital treatment in gastroenterology, rehabilitation, urology, orthopedics, general surgery, gynecology, obstetrics and geriatric care. Currently, the hospital group is running 37 different clinical trials. 

 “We care for our patients. Everyday. In a better way. That’s why we work to increase interest and enrollment in clinical trials to ultimately ensure greater availability of innovative therapies for our patients,” says Anna Szewczuk-Lebska, spokesperson for EMC Szpitale.

PDF File: Download Full Press Release

Press Release: EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform.

Press Release: EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform.
EMC Szpitale augments Clinerion’s patient coverage in Poland by joining the Patient Network Explorer platform. Patients at the hospital group will gain greater access to clinical trials, and actively support in accelerating the successful launch of innovative medical treatments.
Press Release: EMC Szpitale, Poland, brings access to innovative treatments to its patients by joinin

EMC Szpitale operates 11 hospitals and 19 outpatient clinics, providing primary and specialized medical care to over one million patients across Poland. EMC Szpitale specializations include advanced diagnostics to comprehensive hospital treatment in gastroenterology, rehabilitation, urology, orthopedics, general surgery, gynecology, obstetrics and geriatric care. Currently, the hospital group is running 37 different clinical trials. 

 “We care for our patients. Everyday. In a better way. That’s why we work to increase interest and enrollment in clinical trials to ultimately ensure greater availability of innovative therapies for our patients,” says Anna Szewczuk-Lebska, spokesperson for EMC Szpitale.



Clinerion Article: How EHR-based Recruitment & Retention supports Patient Centricity (Journal for Clinical Studies)

Publication date: May 16, 2019

Clinerion, together with the Founder of Bioserv SMO Keyla Deucher, explain how patient data, in the form of hospital electronic health records, offer a data-driven entry point into patient centricity, making trial participation more easy, democratizing patient engagement, accelerating trial recruitment and enhancing retention.

"When it comes to understanding the patient experience, the main tools are surveys, interviews (and focus groups) and patient shadowing. In this article, we would like to focus on how querying of de-identified patient electronic health records (EHRs) can provide its own trove of data on the patient experience, particularly the patient journey and outcomes. EHRs are de facto patient-centric, and analysis of EHRs can offer key directions for recruitment, engagement and retention". 

©www.jforcs.com

 

Download to read full article >

Clinerion Article: How EHR-based Recruitment & Retention supports Patient Centricity (Journal for Clinical Studies)

Clinerion Article: How EHR-based Recruitment & Retention supports Patient Centricity (Journal for Clinical Studies)
Clinerion, together with the Founder of Bioserv SMO Keyla Deucher, explain how patient data, in the form of hospital electronic health records, offer a data-driven entry point into patient centricity, making trial participation more easy, democratizing patient engagement, accelerating trial recruitment and enhancing retention.
Clinerion Article: How EHR-based Recruitment & Retention supports Patient Centricity (Journal for

"When it comes to understanding the patient experience, the main tools are surveys, interviews (and focus groups) and patient shadowing. In this article, we would like to focus on how querying of de-identified patient electronic health records (EHRs) can provide its own trove of data on the patient experience, particularly the patient journey and outcomes. EHRs are de facto patient-centric, and analysis of EHRs can offer key directions for recruitment, engagement and retention". 

©www.jforcs.com

 

Download to read full article >



Press Release: Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research market.

Publication date: May 13, 2019

Inpharamo, a subsidiary of the Spanish multinational Semicrol, has signed a collaboration agreement to support our entry in Mexico.

The partnership between Inpharamo and Clinerion is grounded on the success to-date of the alliance established by Semicrol and Clinerion in September, 2018, which has enabled the integration of the functionality of Clinerion’s Patient Network Explorer with that of Semicrol’s Fundanet CTMS (clinical trial management system). This has provided a new tool for Fundanet users that improves the process of identifying candidate patients for clinical trials. 

Ian Rentsch, CEO of Clinerion, and Ricardo Márquez, Medical Director of Inpharamo, will officially launch the partnership during the second edition of the International Congress of Clinical Research, Mexico, to be held from May 16th to 18th, in Guadalajara (Jalisco). 

PDF File: Download Full Press Release (English Version) >

PDF File: Download Full Press Release (Spanish Version) >

Press Release: Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research market.

Press Release: Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research market.
Inpharamo, a subsidiary of the Spanish multinational Semicrol, has signed a collaboration agreement to support our entry in Mexico.
Press Release: Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research ma

The partnership between Inpharamo and Clinerion is grounded on the success to-date of the alliance established by Semicrol and Clinerion in September, 2018, which has enabled the integration of the functionality of Clinerion’s Patient Network Explorer with that of Semicrol’s Fundanet CTMS (clinical trial management system). This has provided a new tool for Fundanet users that improves the process of identifying candidate patients for clinical trials. 

Ian Rentsch, CEO of Clinerion, and Ricardo Márquez, Medical Director of Inpharamo, will officially launch the partnership during the second edition of the International Congress of Clinical Research, Mexico, to be held from May 16th to 18th, in Guadalajara (Jalisco). 

PDF File: Download Full Press Release (English Version) >



Press Release: Clinerion partners with the Czech Clinical Research Institute (CCRI) to bring its services to patients in the Czech Republic and Slovakia.

Publication date: May 06, 2019

The Czech Clinical Research Institute (CCRI) will support patients and physicians in the Czech Republic and Slovakia in accessing innovative treatments by expanding Clinerion’s hospital and patient coverage into those countries. CCRI will also accelerate the development of innovative medications by offering the services and real-world data solutions of Clinerion’s Patient Network Explorer platform.

Czech Clinical Research Institute (CCRI) is a full-service contract research organization providing tailor-made solutions for clinical trials monitoring, project management and Good Clinical Practice auditing services, operating mainly in the Czech Republic and Slovakia.

“CCRI is a great match for Clinerion in the Czech Republic and Slovakia, traditionally countries with high medical expertise and infrastructure but low trial participation,” says Ian Rentsch, CEO of Clinerion. [...]

PDF File: Download Now

Press Release: Clinerion partners with the Czech Clinical Research Institute (CCRI) to bring its services to patients in the Czech Republic and Slovakia.

Press Release: Clinerion partners with the Czech Clinical Research Institute (CCRI) to bring its services to patients in the Czech Republic and Slovakia.
The Czech Clinical Research Institute (CCRI) will support patients and physicians in the Czech Republic and Slovakia in accessing innovative treatments by expanding Clinerion’s hospital and patient coverage into those countries. CCRI will also accelerate the development of innovative medications by offering the services and real-world data solutions of Clinerion’s Patient Network Explorer platform.
Press Release: Clinerion partners with the Czech Clinical Research Institute (CCRI) to bring its serv

Czech Clinical Research Institute (CCRI) is a full-service contract research organization providing tailor-made solutions for clinical trials monitoring, project management and Good Clinical Practice auditing services, operating mainly in the Czech Republic and Slovakia.

“CCRI is a great match for Clinerion in the Czech Republic and Slovakia, traditionally countries with high medical expertise and infrastructure but low trial participation,” says Ian Rentsch, CEO of Clinerion. [...]



Press Article: Clinerion partners with Dubai-headquartered CRO Clinart (Outsourcing Pharma)

Publication date: April 30, 2019

Clinerion partners with Clinart to expand its footprint in the Middle East and North African region while advancing research in the area.

Following our recent partnership with Clinart, expanding our reach to the Middle East countries, Outsourcing Pharma has released an article which sums up Clinerion's recent progresses, as our international network has tapped into new countries where patients are still often underserved by clinical research at the moment. 

Read the Full Article on Outsourcing Pharma's website >

Press Article: Clinerion partners with Dubai-headquartered CRO Clinart (Outsourcing Pharma)

Press Article: Clinerion partners with Dubai-headquartered CRO Clinart (Outsourcing Pharma)
Clinerion partners with Clinart to expand its footprint in the Middle East and North African region while advancing research in the area.
Press Article: Clinerion partners with Dubai-headquartered CRO Clinart (Outsourcing Pharma)

Following our recent partnership with Clinart, expanding our reach to the Middle East countries, Outsourcing Pharma has released an article which sums up Clinerion's recent progresses, as our international network has tapped into new countries where patients are still often underserved by clinical research at the moment. 

Read the Full Article on Outsourcing Pharma's website >



Press release: Clinerion partners with Bioforum to expand its coverage and offer its services into Israel and Australia.

Publication date: April 29, 2019

Bioforum the Data Masters will bring the real-world data solutions of Clinerion’s Patient Network Explorer platform to patients and physicians in Israel and Australia, accelerating the development of innovative medications and improving access to new treatments.

Bioforum is a data-focused Contract Research Organization (CRO), offering a wide range of consulting services, including medical writing, data management and bio-statistical support.

“We are extremely excited to launch this collaboration and are confident that together we can promote clinical research in our target markets. We are keen to introduce more medical centers to Clinerion’s advanced technology,” says Bioforum’s President & Co-Founder, Mr. Amir Malka. [...]

Download the PDF for the full release

 

 

 

PDF File: Download here

Press release: Clinerion partners with Bioforum to expand its coverage and offer its services into Israel and Australia.

Press release: Clinerion partners with Bioforum to expand its coverage and offer its services into Israel and Australia.
Bioforum the Data Masters will bring the real-world data solutions of Clinerion’s Patient Network Explorer platform to patients and physicians in Israel and Australia, accelerating the development of innovative medications and improving access to new treatments.
Press release: Clinerion partners with Bioforum to expand its coverage and offer its services into Is

Bioforum is a data-focused Contract Research Organization (CRO), offering a wide range of consulting services, including medical writing, data management and bio-statistical support.

“We are extremely excited to launch this collaboration and are confident that together we can promote clinical research in our target markets. We are keen to introduce more medical centers to Clinerion’s advanced technology,” says Bioforum’s President & Co-Founder, Mr. Amir Malka. [...]

Download the PDF for the full release

 

 

 



Press release: Partnership with Clinart brings Clinerion into the MENA region.

Publication date: April 17, 2019

In support of bringing medical innovation faster to patients in the Middle East and North Africa (MENA) region, Clinart will collaborate with Clinerion to expand its international network of healthcare institution partners in the region. Clinart will also offer Clinerion’s services to advance academic and sponsored research in MENA.

Clinart has a strong position as an innovative, leading regional contract research organization offering a full-service end-to-end solution and access in the MENA region. Clinart will support Clinerion by linking sites and hospitals to the global network on Clinerion’s Patient Network Explorer (PNEx) platform. This will help hospitals in the region be more visible and accessible for global trial sponsors and attract more studies to the region. Clinart will also offer services derived from PNEx for the running of local real-world evidence studies and academic research.

The collaboration will initially focus on the Gulf countries of the United Arab Emirates and Saudi Arabia. This will expand later to other countries in the region [...] 

Download the PDF for the full release

 

PDF File: Download here

Press release: Partnership with Clinart brings Clinerion into the MENA region.

Press release: Partnership with Clinart brings Clinerion into the MENA region.
In support of bringing medical innovation faster to patients in the Middle East and North Africa (MENA) region, Clinart will collaborate with Clinerion to expand its international network of healthcare institution partners in the region. Clinart will also offer Clinerion’s services to advance academic and sponsored research in MENA.
Press release: Partnership with Clinart brings Clinerion into the MENA region.

Clinart has a strong position as an innovative, leading regional contract research organization offering a full-service end-to-end solution and access in the MENA region. Clinart will support Clinerion by linking sites and hospitals to the global network on Clinerion’s Patient Network Explorer (PNEx) platform. This will help hospitals in the region be more visible and accessible for global trial sponsors and attract more studies to the region. Clinart will also offer services derived from PNEx for the running of local real-world evidence studies and academic research.

The collaboration will initially focus on the Gulf countries of the United Arab Emirates and Saudi Arabia. This will expand later to other countries in the region [...] 

Download the PDF for the full release

 



Press Articles: Clinerion at Digital Health Conclave 2019

Publication date: April 09, 2019

View hot off the press articles following the Digital Health Conclave 2019, where Clinerion has taken part in the discussions.

[UPDATED 15.04.2019 - New article by Express Healthcare]

Randy Ramin-Wright, our International Business Director, spoke on “Improving Healthcare Outcomes with Real-World Data ecosystem throughout India” and how patient outcomes could be improved, new treatments could be brought to patients faster and the use of world evidence to support healthcare decision making. 

Read full article from Express Healthcare >

[09.04.2019 - Article by BioSpectrum]

BioSpectrum India published a paper wrap-up of the event explaining how Switzerland and India can collaborate to support healthcare education, research and innovation. 

“Traditional trial countries in Europe and North America are in high demand and may be somewhat saturated, with clinical trials competing for the same patient population. However, regions like Asia offer attractive untapped potential.[...]" - our International Business Director Randy Ramin-Wright has joined other experts to discuss how a Real World Data ecosystem can be introduced in India. 

Read full article from BioSpectrum > 

View Digital Health Conclave event >

Press Articles: Clinerion at Digital Health Conclave 2019

Press Articles: Clinerion at Digital Health Conclave 2019
View hot off the press articles following the Digital Health Conclave 2019, where Clinerion has taken part in the discussions.
Press Articles: Clinerion at Digital Health Conclave 2019

[UPDATED 15.04.2019 - New article by Express Healthcare]

Randy Ramin-Wright, our International Business Director, spoke on “Improving Healthcare Outcomes with Real-World Data ecosystem throughout India” and how patient outcomes could be improved, new treatments could be brought to patients faster and the use of world evidence to support healthcare decision making. 

Read full article from Express Healthcare >

[09.04.2019 - Article by BioSpectrum]

BioSpectrum India published a paper wrap-up of the event explaining how Switzerland and India can collaborate to support healthcare education, research and innovation. 

“Traditional trial countries in Europe and North America are in high demand and may be somewhat saturated, with clinical trials competing for the same patient population. However, regions like Asia offer attractive untapped potential.[...]" - our International Business Director Randy Ramin-Wright has joined other experts to discuss how a Real World Data ecosystem can be introduced in India. 

Read full article from BioSpectrum > 

View Digital Health Conclave event >



Press release: Clinerion partners with Alpha MD to accelerate the development of innovative treatments and improve patient outcomes in India.

Publication date: April 08, 2019

Clinerion is partnering with Alpha MD to expand patient treatment options in India. Indian patients may be matched with international research studies by bringing Indian healthcare organizations onto the Patient Network Explorer platform.

Alpha MD is a global clinical research and technology consultancy that provides end-to-end solutions to healthcare partners.

With this partnership, patients in India will gain better access to clinical care as the Patient Network Explorer draws international clinical studies to the country, directly to the patients who will benefit most from participation in trials. Patients will also benefit from the efficiencies created in the clinical research process by Patient Network Explorer which contribute to getting drugs faster to market. Patient Network Explorer’s efficiencies include accelerating study protocol development, identifying suitable trial sites, and speeding up patient search and identification for trial enrollment.

Clinerion and Alpha MD's partnership was launched via our participation to the Digital Health Conclave in Bangalore.

View Digital Health Conclave event >

View Event Press Article >

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion partners with Alpha MD to accelerate the development of innovative treatments and improve patient outcomes in India.

Press release: Clinerion partners with Alpha MD to accelerate the development of innovative treatments and improve patient outcomes in India.
Clinerion is partnering with Alpha MD to expand patient treatment options in India. Indian patients may be matched with international research studies by bringing Indian healthcare organizations onto the Patient Network Explorer platform.
Press release: Clinerion partners with Alpha MD to accelerate the development of innovative treatment

Alpha MD is a global clinical research and technology consultancy that provides end-to-end solutions to healthcare partners.

With this partnership, patients in India will gain better access to clinical care as the Patient Network Explorer draws international clinical studies to the country, directly to the patients who will benefit most from participation in trials. Patients will also benefit from the efficiencies created in the clinical research process by Patient Network Explorer which contribute to getting drugs faster to market. Patient Network Explorer’s efficiencies include accelerating study protocol development, identifying suitable trial sites, and speeding up patient search and identification for trial enrollment.

Clinerion and Alpha MD's partnership was launched via our participation to the Digital Health Conclave in Bangalore.

View Digital Health Conclave event >

View Event Press Article >

Download the PDF for the full release.



Press release: Clinerion partners with Sigmasoft to expand patient treatment options in Greece and Cyprus.

Publication date: April 02, 2019

Clinerion and Sigmasoft aim to bring access to international clinical studies for patients, physicians and healthcare institutions in Greece and Cyprus and to bring new treatments quicker to patients by accelerating trial recruitment.

Sigmasoft is a medical software company based in Greece and Cyprus with six years’ experience in eHealth. The company provides innovative software systems and consulting services for healthcare providers, institutions and pharmaceutical companies.

As part of the partnership, Sigmasoft will support Clinerion in integrating healthcare institutions and physicians in Clinerion’s international Patient Network Explorer platform, expanding clinical research opportunities for patients in Greece and Cyprus.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion partners with Sigmasoft to expand patient treatment options in Greece and Cyprus.

Press release: Clinerion partners with Sigmasoft to expand patient treatment options in Greece and Cyprus.
Clinerion and Sigmasoft aim to bring access to international clinical studies for patients, physicians and healthcare institutions in Greece and Cyprus and to bring new treatments quicker to patients by accelerating trial recruitment.
Press release: Clinerion partners with Sigmasoft to expand patient treatment options in Greece and Cy

Sigmasoft is a medical software company based in Greece and Cyprus with six years’ experience in eHealth. The company provides innovative software systems and consulting services for healthcare providers, institutions and pharmaceutical companies.

As part of the partnership, Sigmasoft will support Clinerion in integrating healthcare institutions and physicians in Clinerion’s international Patient Network Explorer platform, expanding clinical research opportunities for patients in Greece and Cyprus.

Download the PDF for the full release.



Press release: Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion’s Patient Network Explorer platform.

Publication date: March 12, 2019

Szpital Specjalistyczny w Brzozowie is the first site in Poland to join Clinerion’s global hospital network.

Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzozów), Poland, specializes in oncology, hematology and cardiology. The hospital has 485 beds and electronic hospital records for more than 250,000 patients. Each specialization has its own Primary Investigator and research team and the hospital runs roughly 30 trials per year.

Download the PDF for the full release.

PDF File: Download here

Press release: Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion’s Patient Network Explorer platform.

Press release: Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion’s Patient Network Explorer platform.
Szpital Specjalistyczny w Brzozowie is the first site in Poland to join Clinerion’s global hospital network.
Press release: Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clin

Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzozów), Poland, specializes in oncology, hematology and cardiology. The hospital has 485 beds and electronic hospital records for more than 250,000 patients. Each specialization has its own Primary Investigator and research team and the hospital runs roughly 30 trials per year.

Download the PDF for the full release.



Press release: The University of Debrecen brings Hungarian patients in to Clinerion’s Patient Network Explorer.

Publication date: March 05, 2019

Clinerion expands into Hungary by adding the University of Debrecen to its international patient network. The university offers clinical trial study sites with expertise in a variety of therapeutic areas.

The University of Debrecen, Clinical Center, has a strong reputation for clinical research, currently running over 360 trials, with 113 starting in 2018, alone. The University is a “Global Prime Site” for IQVIA, a “Premier Site” for Sanofi, and has partnership with several CROs, pharma companies (incl. Pfizer, Novartis, ICON, Parexel).​

The University of Debrecen will have a higher profile with sponsors and gain participation in international trials of leading-edge medications by being visible on Clinerion’s Patient Network Explorer platform. Patients at the university will gain access to leading-edge medical treatments as a result.

Download the PDF for the full release.

PDF File: Download here

Press release: The University of Debrecen brings Hungarian patients in to Clinerion’s Patient Network Explorer.

Press release: The University of Debrecen brings Hungarian patients in to Clinerion’s Patient Network Explorer.
Clinerion expands into Hungary by adding the University of Debrecen to its international patient network. The university offers clinical trial study sites with expertise in a variety of therapeutic areas.
Press release: The University of Debrecen brings Hungarian patients in to Clinerion’s Patient Network

The University of Debrecen, Clinical Center, has a strong reputation for clinical research, currently running over 360 trials, with 113 starting in 2018, alone. The University is a “Global Prime Site” for IQVIA, a “Premier Site” for Sanofi, and has partnership with several CROs, pharma companies (incl. Pfizer, Novartis, ICON, Parexel).​

The University of Debrecen will have a higher profile with sponsors and gain participation in international trials of leading-edge medications by being visible on Clinerion’s Patient Network Explorer platform. Patients at the university will gain access to leading-edge medical treatments as a result.

Download the PDF for the full release.



Press article: Clinerion inks EHR partnership to expand global footprint (Outsourcing Pharma)

Publication date: March 01, 2019

Outsourcing Pharma interviewed us about our new partnership with MEDSOFT in Georgia.

Original publication date: February 28, 2019.

"Clinerion is expanding access to international clinical studies with the help of the Georgian medical software company, Medsoft. ”

Click here to read the article > 

Press article: Clinerion inks EHR partnership to expand global footprint (Outsourcing Pharma)

Press article: Clinerion inks EHR partnership to expand global footprint (Outsourcing Pharma)
Outsourcing Pharma interviewed us about our new partnership with MEDSOFT in Georgia.
Press article: Clinerion inks EHR partnership to expand global footprint (Outsourcing Pharma)

Original publication date: February 28, 2019.

"Clinerion is expanding access to international clinical studies with the help of the Georgian medical software company, Medsoft. ”

Click here to read the article > 



Press release: Clinerion partners with MEDSOFT on expanding clinical research in Georgia.

Publication date: February 26, 2019

Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic research. Georgian Medical Software – MEDSOFT, an EHR supplier, will support Clinerion in expanding its footprint in Georgia.

Georgian Medical Software – MEDSOFT, an EHR systems supplier with 10 years’ experience in eHealth in Tbilisi, Georgia, supports hospitals and the medical community with innovative technology and dedicated services. More than 40 hospitals and medical centers in Georgia use MEDSOFT’s software. Their MEDWORK hospital information system (HIS) is integrated with the Georgian Ministry of Health, financial systems, and laboratory information systems, allowing costless and effective information management for the healthcare community.

As part of their partnership, MEDSOFT will support Clinerion in integrating hospitals in Georgia in Clinerion’s international network of partner hospitals on its Patient Network Explorer platform.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion partners with MEDSOFT on expanding clinical research in Georgia.

Press release: Clinerion partners with MEDSOFT on expanding clinical research in Georgia.
Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic research. Georgian Medical Software – MEDSOFT, an EHR supplier, will support Clinerion in expanding its footprint in Georgia.
Press release: Clinerion partners with MEDSOFT on expanding clinical research in Georgia.

Georgian Medical Software – MEDSOFT, an EHR systems supplier with 10 years’ experience in eHealth in Tbilisi, Georgia, supports hospitals and the medical community with innovative technology and dedicated services. More than 40 hospitals and medical centers in Georgia use MEDSOFT’s software. Their MEDWORK hospital information system (HIS) is integrated with the Georgian Ministry of Health, financial systems, and laboratory information systems, allowing costless and effective information management for the healthcare community.

As part of their partnership, MEDSOFT will support Clinerion in integrating hospitals in Georgia in Clinerion’s international network of partner hospitals on its Patient Network Explorer platform.

Download the PDF for the full release.



Press release: New Clinerion And Citeline Partnership Simplifies and Strengthens Matchmaking Between Clinical Researchers and Qualified Patients

Publication date: February 19, 2019

Collaboration between two companies leads to more informed decisions for clinical researchers, grounded in real-world evidence.

 


Citeline, part of the Informa Pharma Intelligence family, and Clinerion, today announced a partnership between the two companies providing clinical researchers with a more holistic method for making more evidence-based decisions during their clinical trial processes.

Meet Clinerion and Citeline at SCOPE 2019 >

Download the PDF for the full release.

PDF File: Download here

Press release: New Clinerion And Citeline Partnership Simplifies and Strengthens Matchmaking Between Clinical Researchers and Qualified Patients

Press release: New Clinerion And Citeline Partnership Simplifies and Strengthens Matchmaking Between Clinical Researchers and Qualified Patients
Collaboration between two companies leads to more informed decisions for clinical researchers, grounded in real-world evidence.
Press release: New Clinerion And Citeline Partnership Simplifies and Strengthens Matchmaking Between

 


Citeline, part of the Informa Pharma Intelligence family, and Clinerion, today announced a partnership between the two companies providing clinical researchers with a more holistic method for making more evidence-based decisions during their clinical trial processes.

Meet Clinerion and Citeline at SCOPE 2019 >

Download the PDF for the full release.



Clinerion article: Realising International Data Access Through Data Collaborations (European Pharmaceutical Contractor)

Publication date: February 12, 2019

European Pharmaceutical Contractor asked for our thoughts on how integration / consolidation of patient data from many sources and repositories can be achieved to support real-world evidence, market access, or clinical trial patient search. Our article is now published!

"Enabling access to real-world data on a global scale is daunting, but surmountable by applying a new collaboration model with innovative technologies for consolidation of data."

This article is taken from European Pharmaceutical Contractor February 2019, pages 39-42. © Samedan Ltd.

Link to the article in European Pharmaceutical Contractor >

PDF File: Download here

Clinerion article: Realising International Data Access Through Data Collaborations (European Pharmaceutical Contractor)

Clinerion article: Realising International Data Access Through Data Collaborations (European Pharmaceutical Contractor)
European Pharmaceutical Contractor asked for our thoughts on how integration / consolidation of patient data from many sources and repositories can be achieved to support real-world evidence, market access, or clinical trial patient search. Our article is now published!
Clinerion article: Realising International Data Access Through Data Collaborations (European Pharmace

"Enabling access to real-world data on a global scale is daunting, but surmountable by applying a new collaboration model with innovative technologies for consolidation of data."

This article is taken from European Pharmaceutical Contractor February 2019, pages 39-42. © Samedan Ltd.

Link to the article in European Pharmaceutical Contractor >



Press release: North Estonia Medical Centre expands Clinerion’s Patient Network Explorer hospital network in Estonia.

Publication date: January 03, 2019

North Estonia Medical Centre has joined the network of hospitals on Clinerion’s Patient Network Explorer platform.

 

 

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as well as in the northern part of the country. As a tertiary care center, it covers two thirds of the population of Estonia. NEMC’s team has over 4000 doctors, nurses, caregivers and other specialists. Over 500 of them are doctors and more than 150 are medical residents.

NEMC has a leading expertise in clinical trials in Estonia, where continuous education programs about GCP and clinical trials methodology have been provided for many years for different target groups – investigators, pharmacists, nurses and study coordinators. 

NEMC currently runs about 85 clinical trials per year, 25 of them begun in 2018, with the capacity and expertise to run many more.

Download the PDF for the full release.

PDF File: Download here

Press release: North Estonia Medical Centre expands Clinerion’s Patient Network Explorer hospital network in Estonia.

Press release: North Estonia Medical Centre expands Clinerion’s Patient Network Explorer hospital network in Estonia.
North Estonia Medical Centre has joined the network of hospitals on Clinerion’s Patient Network Explorer platform.
Press release: North Estonia Medical Centre expands Clinerion’s Patient Network Explorer hospital net

 

 

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as well as in the northern part of the country. As a tertiary care center, it covers two thirds of the population of Estonia. NEMC’s team has over 4000 doctors, nurses, caregivers and other specialists. Over 500 of them are doctors and more than 150 are medical residents.

NEMC has a leading expertise in clinical trials in Estonia, where continuous education programs about GCP and clinical trials methodology have been provided for many years for different target groups – investigators, pharmacists, nurses and study coordinators. 

NEMC currently runs about 85 clinical trials per year, 25 of them begun in 2018, with the capacity and expertise to run many more.

Download the PDF for the full release.



Press release: Clinerion welcomes the Santa Casa da Misericordia hospital to the Patient Network Explorer hospital network.

Publication date: December 05, 2018

The Santa Casa da Misericordia hospital of Porto Alegre, Brazil, will expand Clinerion’s network of partner hospitals in Brazil. Patients from the hospital’s seven clinics will gain access to leading-edge, innovative medical treatment via Clinerion’s Patient Network Explorer platform.

“Together with our partner, iHealth, Clinerion is in the process of a significant push to encompass coverage of the majority of patients in Brazil,” says Clinerion CEO Ian Rentsch. “Santa Casa da Misericordia represents an important addition to Clinerion’s network of partner hospitals in the country, the region, and the world.”

"Santa Casa has a long tradition in Clinical Research and the Clinerion / iHealth Patient Network Explore will help us maintain leadership in this area,” says Dr. Jorge Hetzel, Medical Director for Teaching and Research.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion welcomes the Santa Casa da Misericordia hospital to the Patient Network Explorer hospital network.

Press release: Clinerion welcomes the Santa Casa da Misericordia hospital to the Patient Network Explorer hospital network.
The Santa Casa da Misericordia hospital of Porto Alegre, Brazil, will expand Clinerion’s network of partner hospitals in Brazil. Patients from the hospital’s seven clinics will gain access to leading-edge, innovative medical treatment via Clinerion’s Patient Network Explorer platform.
Press release: Clinerion welcomes the Santa Casa da Misericordia hospital to the Patient Network Expl

“Together with our partner, iHealth, Clinerion is in the process of a significant push to encompass coverage of the majority of patients in Brazil,” says Clinerion CEO Ian Rentsch. “Santa Casa da Misericordia represents an important addition to Clinerion’s network of partner hospitals in the country, the region, and the world.”

"Santa Casa has a long tradition in Clinical Research and the Clinerion / iHealth Patient Network Explore will help us maintain leadership in this area,” says Dr. Jorge Hetzel, Medical Director for Teaching and Research.

Download the PDF for the full release.



Press release: Clinerion upgrades its website with realtime statistics from Patient Network Explorer and a dynamic map searchable for disease indications across its global patient network.

Publication date: November 28, 2018

Clinerion has added a live heatmap to its homepage indicating prevalence of searchable disease indications by ICD10 code according to the global patient network in its Patient Network Explorer. Real-time statistics including the number of countries, sites and patients from Clinerion’s international network of partner hospitals are also now displayed.

Visitors to Clinerion’s website may now see a dynamic visual representation of its patient network on a map. The map shows locations, by country, and numbers of patients. When searched for a disease indication, the map shows a heatmap representation of the prevalence of the searched term, including partial matches. The user can then select a particular term to see its prevalence displayed on the map. This heatmap is linked directly to Clinerion’s Patient Network Explorer platform and shows live data from Clinerion’s international network of partner hospitals.

Alongside the map, visitors can also see the current global coverage of Patient Network Explorer, in terms of numbers of patients, sites and countries. These metrics reflect the current state of data on Clinerion’s network of partner hospitals and other data partners.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion upgrades its website with realtime statistics from Patient Network Explorer and a dynamic map searchable for disease indications across its global patient network.

Press release: Clinerion upgrades its website with realtime statistics from Patient Network Explorer and a dynamic map searchable for disease indications across its global patient network.
Clinerion has added a live heatmap to its homepage indicating prevalence of searchable disease indications by ICD10 code according to the global patient network in its Patient Network Explorer. Real-time statistics including the number of countries, sites and patients from Clinerion’s international network of partner hospitals are also now displayed.
Press release: Clinerion upgrades its website with realtime statistics from Patient Network Explorer

Visitors to Clinerion’s website may now see a dynamic visual representation of its patient network on a map. The map shows locations, by country, and numbers of patients. When searched for a disease indication, the map shows a heatmap representation of the prevalence of the searched term, including partial matches. The user can then select a particular term to see its prevalence displayed on the map. This heatmap is linked directly to Clinerion’s Patient Network Explorer platform and shows live data from Clinerion’s international network of partner hospitals.

Alongside the map, visitors can also see the current global coverage of Patient Network Explorer, in terms of numbers of patients, sites and countries. These metrics reflect the current state of data on Clinerion’s network of partner hospitals and other data partners.

Download the PDF for the full release.



Clinerion article: Digital Technologies in Clinical Research Networks - Clinical Connectivity (International Clinical Trials)

Publication date: November 21, 2018

International Clinical Trials asked for our thoughts on how digital and cloud technologies are impacting clinical trials. Our article is now published!

"Using modern digital technologies, today’s research networks are embracing new ways of more intimate collaboration and constructive improvisation to increase the speed and quality of clinical research"

This article is taken from International Clinical Trials November 2018, pages 22-25. © Samedan Ltd.

Link to the article in International Clinical Trials November 2018 >

PDF File: Download here

Clinerion article: Digital Technologies in Clinical Research Networks - Clinical Connectivity (International Clinical Trials)

Clinerion article: Digital Technologies in Clinical Research Networks - Clinical Connectivity (International Clinical Trials)
International Clinical Trials asked for our thoughts on how digital and cloud technologies are impacting clinical trials. Our article is now published!
Clinerion article: Digital Technologies in Clinical Research Networks - Clinical Connectivity (Intern

"Using modern digital technologies, today’s research networks are embracing new ways of more intimate collaboration and constructive improvisation to increase the speed and quality of clinical research"

This article is taken from International Clinical Trials November 2018, pages 22-25. © Samedan Ltd.

Link to the article in International Clinical Trials November 2018 >



Press release: Clinerion expands team and moves to new headquarters in Basel.

Publication date: November 05, 2018

Clinerion’s move to new headquarters is driven by growth in its business and its team, and matches the expansion in its international network of partner hospitals.


Clinerion is moving to new offices in Basel, Switzerland. Following strong expansion in its business, the company is in the process of growing its global team. In the six months leading up to the start of 2019, the company expects to have added several additional new positions. Staffing is increasing in all areas of the company, from Customer Solutions to Site & Patient Network Development, from Software Development to Data Analytics and Marketing.

Clinerion’s new offices have nearly double the floorspace of its old premises, matching the increased requirements of its expanding business. The company’s headquarters remain in Basel, Switzerland, the major worldwide hub for the pharmaceutical industry, and global headquarters of two of the world’s top ten pharma companies. From here, Clinerion’s analysts will tap into and derive valuable insights from anonymized patient data throughout its network of hospital and data partners.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion expands team and moves to new headquarters in Basel.

Press release: Clinerion expands team and moves to new headquarters in Basel.
Clinerion’s move to new headquarters is driven by growth in its business and its team, and matches the expansion in its international network of partner hospitals.
Press release: Clinerion expands team and moves to new headquarters in Basel.


Clinerion is moving to new offices in Basel, Switzerland. Following strong expansion in its business, the company is in the process of growing its global team. In the six months leading up to the start of 2019, the company expects to have added several additional new positions. Staffing is increasing in all areas of the company, from Customer Solutions to Site & Patient Network Development, from Software Development to Data Analytics and Marketing.

Clinerion’s new offices have nearly double the floorspace of its old premises, matching the increased requirements of its expanding business. The company’s headquarters remain in Basel, Switzerland, the major worldwide hub for the pharmaceutical industry, and global headquarters of two of the world’s top ten pharma companies. From here, Clinerion’s analysts will tap into and derive valuable insights from anonymized patient data throughout its network of hospital and data partners.

Download the PDF for the full release.



Press release: Clinerion and S4 Research partner to accelerate the introduction of innovative medical treatments to India.

Publication date: October 17, 2018

Clinerion and S4 Research announce a partnership to expand the global network of hospitals on the Clinerion’s Patient Network Explorer platform into India. International pharmaceutical companies will be able to match their leading-edge clinical trials to patients in India.

S4 Research, with its wide network in India and its deep experience in the clinical trials space, will support Clinerion in the expansion of its global network of partner hospitals in India.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion and S4 Research partner to accelerate the introduction of innovative medical treatments to India.

Press release: Clinerion and S4 Research partner to accelerate the introduction of innovative medical treatments to India.
Clinerion and S4 Research announce a partnership to expand the global network of hospitals on the Clinerion’s Patient Network Explorer platform into India. International pharmaceutical companies will be able to match their leading-edge clinical trials to patients in India.
Press release: Clinerion and S4 Research partner to accelerate the introduction of innovative medical

S4 Research, with its wide network in India and its deep experience in the clinical trials space, will support Clinerion in the expansion of its global network of partner hospitals in India.

Download the PDF for the full release.



Press release: Athens Medical Group joins the Clinerion network of hospitals, expanding its global footprint in Greece and Romania.

Publication date: September 13, 2018

Athens Medical Group (AMG), including Athens Medical Center, joins Clinerion’s hospitals network, and expands Clinerion’s footprint in Western Europe. Their Medsana Bucharest Medical Center in Romania will also join Clinerion’s Patient Network Explorer platform.

Athens Medical Group (AMG) runs eight ultramodern hospitals in Greece, seven in the Athens Metropolitan Area and one in Thessaloniki, Northern Greece. AMG cooperates with an extensive nationwide network of 390 diagnostic centers, eight haemodialysis units and a growing network of official associate centers throughout Greece. A multinational company, it operates Medsana clinics, four modern and specialized diagnostic centers in Romania, which also have presence, through affiliate companies, in North Africa, the Balkan area, Russia and the Former Soviet Union countries.

Joining Clinerion’s Patient Network Explorer platform will bring more innovative treatments to the patients of Athens Medical Center’s hospitals and clinics, and give their physicians more options in treating their patients. The group will also gain more exposure to global clinical trials run by international pharmaceutical companies and contract research organizations.

Drug developers working on innovative treatments will now benefit from access to new geographies and clinics with strong therapeutic focus.

Download the PDF for the full release.

PDF File: Download here

Press release: Athens Medical Group joins the Clinerion network of hospitals, expanding its global footprint in Greece and Romania.

Press release: Athens Medical Group joins the Clinerion network of hospitals, expanding its global footprint in Greece and Romania.
Athens Medical Group (AMG), including Athens Medical Center, joins Clinerion’s hospitals network, and expands Clinerion’s footprint in Western Europe. Their Medsana Bucharest Medical Center in Romania will also join Clinerion’s Patient Network Explorer platform.
Press release: Athens Medical Group joins the Clinerion network of hospitals, expanding its global fo

Athens Medical Group (AMG) runs eight ultramodern hospitals in Greece, seven in the Athens Metropolitan Area and one in Thessaloniki, Northern Greece. AMG cooperates with an extensive nationwide network of 390 diagnostic centers, eight haemodialysis units and a growing network of official associate centers throughout Greece. A multinational company, it operates Medsana clinics, four modern and specialized diagnostic centers in Romania, which also have presence, through affiliate companies, in North Africa, the Balkan area, Russia and the Former Soviet Union countries.

Joining Clinerion’s Patient Network Explorer platform will bring more innovative treatments to the patients of Athens Medical Center’s hospitals and clinics, and give their physicians more options in treating their patients. The group will also gain more exposure to global clinical trials run by international pharmaceutical companies and contract research organizations.

Drug developers working on innovative treatments will now benefit from access to new geographies and clinics with strong therapeutic focus.

Download the PDF for the full release.



Press article: Clinerion and Semicrol collaborate to provide end-to-end clinical trial management (Outsourcing Pharma)

Publication date: September 11, 2018

Outsourcing Pharma dug deep into our collaboration with Semicrol.

Original publication date: September 11, 2018.

"The collaboration will integrate the functionality of Clinerion's Patient Networlk Explorer with Semicrol's Fundanet clincial trials management system (CTMS).”

Click here to read the article > 

Press article: Clinerion and Semicrol collaborate to provide end-to-end clinical trial management (Outsourcing Pharma)

Press article: Clinerion and Semicrol collaborate to provide end-to-end clinical trial management (Outsourcing Pharma)
Outsourcing Pharma dug deep into our collaboration with Semicrol.
Press article: Clinerion and Semicrol collaborate to provide end-to-end clinical trial management (Ou

Original publication date: September 11, 2018.

"The collaboration will integrate the functionality of Clinerion's Patient Networlk Explorer with Semicrol's Fundanet clincial trials management system (CTMS).”

Click here to read the article > 



Press release: Clinerion and Semicrol integrate Patient Network Explorer and Fundanet CTMS to enable end-to-end clinical trial management.

Publication date: September 10, 2018

Clinerion and Semicrol announce a collaboration which will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet CTMS. The partnership will integrate patient data throughout the clinical trial process, from planning to reporting of results.

The technical and commercial collaboration between the two companies will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet Clinical Trials Management System (CTMS), enabling the automated, efficient sharing of patient data from a hospital’s electronic health records system to the CTMS running a clinical trial at that hospital.

The collaboration will give clinical trial sponsors and managers unified tools to manage trial data and workflows throughout the clinical trial process, from planning to reporting of results. This will enable a broader approach in clinical trials, drug development support and better outcomes for patients. Patient data privacy is preserved, and patient data remains within the hospital IT infrastructure throughout.

Clinerion and Semicrol will attend BIOSPAIN together >

Semicrol Press Release (Spanish) >
Semicrol release on the Semicrol site >
Semicrol release on the Fundanet site >

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion and Semicrol integrate Patient Network Explorer and Fundanet CTMS to enable end-to-end clinical trial management.

Press release: Clinerion and Semicrol integrate Patient Network Explorer and Fundanet CTMS to enable end-to-end clinical trial management.
Clinerion and Semicrol announce a collaboration which will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet CTMS. The partnership will integrate patient data throughout the clinical trial process, from planning to reporting of results.
Press release: Clinerion and Semicrol integrate Patient Network Explorer and Fundanet CTMS to enable

The technical and commercial collaboration between the two companies will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet Clinical Trials Management System (CTMS), enabling the automated, efficient sharing of patient data from a hospital’s electronic health records system to the CTMS running a clinical trial at that hospital.

The collaboration will give clinical trial sponsors and managers unified tools to manage trial data and workflows throughout the clinical trial process, from planning to reporting of results. This will enable a broader approach in clinical trials, drug development support and better outcomes for patients. Patient data privacy is preserved, and patient data remains within the hospital IT infrastructure throughout.

Clinerion and Semicrol will attend BIOSPAIN together >

Semicrol Press Release (Spanish) >
Semicrol release on the Semicrol site >
Semicrol release on the Fundanet site >

Download the PDF for the full release.



Press article: Clinerion, Patient iP partnership aims to globalize access to real world data (Outsourcing Pharma)

Publication date: September 06, 2018

Outsourcing Pharma interviewed Patient iP founder and CEO Michael Margiotta on our recently announced collaboration.

Original publication date: September 4, 2018.

"To improve clinical trial design, site selection, and patient enrollment, the real-world data solutions firm Clinerion is partnering with Patient iP, a health data and analytics company.”

Click here to read the article > 

Press article: Clinerion, Patient iP partnership aims to globalize access to real world data (Outsourcing Pharma)

Press article: Clinerion, Patient iP partnership aims to globalize access to real world data (Outsourcing Pharma)
Outsourcing Pharma interviewed Patient iP founder and CEO Michael Margiotta on our recently announced collaboration.
Press article: Clinerion, Patient iP partnership aims to globalize access to real world data (Outsour

Original publication date: September 4, 2018.

"To improve clinical trial design, site selection, and patient enrollment, the real-world data solutions firm Clinerion is partnering with Patient iP, a health data and analytics company.”

Click here to read the article > 



Press release: Clinerion and Patient iP Team Up to Globalize Access to Real World Data for Clinical Trial Applications.

Publication date: September 04, 2018

Clinerion, a real-world data solutions firm focusing on improving efficiency in clinical trials across geographies, and Patient iP, a health data and analytics company providing patient data insights to accelerate and transform clinical research within the United States, are partnering to improve clinical trial design, site selection and patient enrollment.

The companies will collaborate using Clinerion’s intelligent, patented Patient Network Explorer platform and Patient iP’s proprietary daTAscape asset to better target clinical trial sites and accelerate trial enrollment on a global scale. Clinerion aggregates healthcare information across institutions and geographies from their global network of partner hospitals, creating one single comprehensive real-time view. Clinerion’s network currently includes more than 16 million real time patient lives, with an additional 55 million lives contracted and in implementation, across more than 100 hospitals in the Americas, Europe and Asia. Used in combination with Patient iP’s platform which contains more than 16 million ambulatory electronic medical records (EMR) across 5,000 practice sites, the partnership will bring remarkable improvements to clinical trials.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion and Patient iP Team Up to Globalize Access to Real World Data for Clinical Trial Applications.

Press release: Clinerion and Patient iP Team Up to Globalize Access to Real World Data for Clinical Trial Applications.
Clinerion, a real-world data solutions firm focusing on improving efficiency in clinical trials across geographies, and Patient iP, a health data and analytics company providing patient data insights to accelerate and transform clinical research within the United States, are partnering to improve clinical trial design, site selection and patient enrollment.
Press release: Clinerion and Patient iP Team Up to Globalize Access to Real World Data for Clinical T

The companies will collaborate using Clinerion’s intelligent, patented Patient Network Explorer platform and Patient iP’s proprietary daTAscape asset to better target clinical trial sites and accelerate trial enrollment on a global scale. Clinerion aggregates healthcare information across institutions and geographies from their global network of partner hospitals, creating one single comprehensive real-time view. Clinerion’s network currently includes more than 16 million real time patient lives, with an additional 55 million lives contracted and in implementation, across more than 100 hospitals in the Americas, Europe and Asia. Used in combination with Patient iP’s platform which contains more than 16 million ambulatory electronic medical records (EMR) across 5,000 practice sites, the partnership will bring remarkable improvements to clinical trials.

Download the PDF for the full release.



Clinerion article: Research Networks in the Digital Healthcare Environment: A Review (Journal for Clinical Studies)

Publication date: August 28, 2018

We were thrilled to be invited to contribute to the Journal for Clinical Studies on how data-driven EHR-based analytics can support the work of research networks.

"Teaching hospitals and academic institutions which band together to conduct research reap the benefits of the increasing digitalisation of healthcare. In this article, we examine the attendant benefits and challenges, with particular focus on electronic health records and the privacy issues relating to patient data. We review the permissions-based sharing model for patient data as an optimal solution which allows flexibility in adapting the individual hospital’s digital infrastructure to the challenges and needs of different types of research networks and projects."

Link to the article in Journal for Clinical Studies, Volume 10, Issue 4 >

PDF File: Download here

Clinerion article: Research Networks in the Digital Healthcare Environment: A Review (Journal for Clinical Studies)

Clinerion article: Research Networks in the Digital Healthcare Environment: A Review (Journal for Clinical Studies)
We were thrilled to be invited to contribute to the Journal for Clinical Studies on how data-driven EHR-based analytics can support the work of research networks.
Clinerion article: Research Networks in the Digital Healthcare Environment: A Review (Journal for Cli

"Teaching hospitals and academic institutions which band together to conduct research reap the benefits of the increasing digitalisation of healthcare. In this article, we examine the attendant benefits and challenges, with particular focus on electronic health records and the privacy issues relating to patient data. We review the permissions-based sharing model for patient data as an optimal solution which allows flexibility in adapting the individual hospital’s digital infrastructure to the challenges and needs of different types of research networks and projects."

Link to the article in Journal for Clinical Studies, Volume 10, Issue 4 >



Press release: The Hygeia Group of hospitals expands Clinerion’s global network of hospitals into Greece.

Publication date: August 08, 2018

The Hygeia Group, comprising three hospitals in Athens, Greece, joins Clinerion’s hospital network, and expands Clinerion’s Patient Network Explorer footprint in Europe.

The Hygeia Group comprises three hospitals:

  • the Hygeia hospital, a diagnostic and therapeutic center and general hospital in Athens, Greece with 315 beds;
  • the Mitera Hospital, a general hospital specializing in maternity, gynecology and children’s health in Athens, Greece with 459 beds;
  • the Leto Hospital, a maternity and gynecology hospital, and surgical center in Athens, Greece with 100 beds.
     

The Hygeia Hospital is the only hospital in Greece with a Joint Commission International (JCI) Gold Seal accreditation for quality and safety in healthcare. The group currently conducts above 80 clinical trials per year.

Download the PDF for the full release.

PDF File: Download here

Press release: The Hygeia Group of hospitals expands Clinerion’s global network of hospitals into Greece.

Press release: The Hygeia Group of hospitals expands Clinerion’s global network of hospitals into Greece.
The Hygeia Group, comprising three hospitals in Athens, Greece, joins Clinerion’s hospital network, and expands Clinerion’s Patient Network Explorer footprint in Europe.
Press release: The Hygeia Group of hospitals expands Clinerion’s global network of hospitals into Gre

The Hygeia Group comprises three hospitals:

  • the Hygeia hospital, a diagnostic and therapeutic center and general hospital in Athens, Greece with 315 beds;
  • the Mitera Hospital, a general hospital specializing in maternity, gynecology and children’s health in Athens, Greece with 459 beds;
  • the Leto Hospital, a maternity and gynecology hospital, and surgical center in Athens, Greece with 100 beds.
     

The Hygeia Hospital is the only hospital in Greece with a Joint Commission International (JCI) Gold Seal accreditation for quality and safety in healthcare. The group currently conducts above 80 clinical trials per year.

Download the PDF for the full release.



Press release: Clinerion and the Precision Medicine-Hospital Information System Development Group of Korea University Medical Center collaborate on patient-data-driven solutions for precision medicine.

Publication date: July 12, 2018

Clinerion and the Precision Medicine-Hospital Information System Development Group of Korea University Medical Center (P-HIS Development Group) sign a Memorandum of Understanding to support the development of the Korean national Precision Medicine Enterprise project with real-patient data solutions.

“Clinerion’s established approach fits very well with the direction we have been pursuing,” says Professor Sang-Heon Lee, Head of Korea Precision Medicine Development Group and Professor at Korea University Medical Center. “We are very pleased with the reliability and scalability of their solution. As South Korea has very strict patient privacy regulations, we are also happy to see their in-built protections for privacy.”

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion and the Precision Medicine-Hospital Information System Development Group of Korea University Medical Center collaborate on patient-data-driven solutions for precision medicine.

Press release: Clinerion and the Precision Medicine-Hospital Information System Development Group of Korea University Medical Center collaborate on patient-data-driven solutions for precision medicine.
Clinerion and the Precision Medicine-Hospital Information System Development Group of Korea University Medical Center (P-HIS Development Group) sign a Memorandum of Understanding to support the development of the Korean national Precision Medicine Enterprise project with real-patient data solutions.
Press release: Clinerion and the Precision Medicine-Hospital Information System Development Group of

“Clinerion’s established approach fits very well with the direction we have been pursuing,” says Professor Sang-Heon Lee, Head of Korea Precision Medicine Development Group and Professor at Korea University Medical Center. “We are very pleased with the reliability and scalability of their solution. As South Korea has very strict patient privacy regulations, we are also happy to see their in-built protections for privacy.”

Download the PDF for the full release.



Press release: First Hospital, Tbilisi, expands Clinerion’s global network of hospitals into Georgia.

Publication date: July 03, 2018

First Hospital, Tbilisi, becomes the first hospital in Georgia to join Clinerion’s global network of hospitals.

First Hospital, Tbilisi, is considered one of the best sites in Georgia by contract research organizations (CROs) running clinical trials due to the quantity of screened patients. The hospital serves the Tbilisi area (population: 1.2 M) and has 100 beds. It works in emergency medicine, critical care, general surgery, gynecology, traumatology, orthopedics, cardiology, anesthesiology, neurology, colon and rectal surgery, angiology, internal medicine, neurosurgery, transfusiology, and neonatology, with a specialization in intensive care, incl. for clinical trials.

Download the PDF for the full release.

PDF File: Download here

Press release: First Hospital, Tbilisi, expands Clinerion’s global network of hospitals into Georgia.

Press release: First Hospital, Tbilisi, expands Clinerion’s global network of hospitals into Georgia.
First Hospital, Tbilisi, becomes the first hospital in Georgia to join Clinerion’s global network of hospitals.
Press release: First Hospital, Tbilisi, expands Clinerion’s global network of hospitals into Georgia.

First Hospital, Tbilisi, is considered one of the best sites in Georgia by contract research organizations (CROs) running clinical trials due to the quantity of screened patients. The hospital serves the Tbilisi area (population: 1.2 M) and has 100 beds. It works in emergency medicine, critical care, general surgery, gynecology, traumatology, orthopedics, cardiology, anesthesiology, neurology, colon and rectal surgery, angiology, internal medicine, neurosurgery, transfusiology, and neonatology, with a specialization in intensive care, incl. for clinical trials.

Download the PDF for the full release.



Press release: The University Hospital Center Zagreb, Croatia, joins Clinerion’s global network of hospitals.

Publication date: May 31, 2018

The University Hospital Center (UHC) Zagreb brings 1.3 million patients to Clinerion’s network of hospitals, expanding its global footprint into Croatia.

"UHC Zagreb (in Croatian: Klinički bolnički centar (KBC) Zagreb) has 1,800 beds. The hospital conducted 51 clinical trials in 2016 and 61 in 2017. It has 39 Principal Investigators and an additional 120 doctors working on trials.

"By joining Clinerion’s network of partner hospitals, UHC Zagreb brings its patients and clinicians access to the latest innovative medical treatments being developed by the pharmaceutical industry. Clinerion’s clients, international pharmaceutical companies and contract research organizations, use Clinerion’s technology solution to establish the availability and location of populations of eligible patient cohorts for enrollment in clinical trials. Clinerion’s technology makes it easy and reliable to assess whether patients of a partner hospital match the inclusion / exclusion criteria in a trial protocol."

Download the PDF for the full release.

PDF File: Download here

Press release: The University Hospital Center Zagreb, Croatia, joins Clinerion’s global network of hospitals.

Press release: The University Hospital Center Zagreb, Croatia, joins Clinerion’s global network of hospitals.
The University Hospital Center (UHC) Zagreb brings 1.3 million patients to Clinerion’s network of hospitals, expanding its global footprint into Croatia.
Press release: The University Hospital Center Zagreb, Croatia, joins Clinerion’s global network of ho

"UHC Zagreb (in Croatian: Klinički bolnički centar (KBC) Zagreb) has 1,800 beds. The hospital conducted 51 clinical trials in 2016 and 61 in 2017. It has 39 Principal Investigators and an additional 120 doctors working on trials.

"By joining Clinerion’s network of partner hospitals, UHC Zagreb brings its patients and clinicians access to the latest innovative medical treatments being developed by the pharmaceutical industry. Clinerion’s clients, international pharmaceutical companies and contract research organizations, use Clinerion’s technology solution to establish the availability and location of populations of eligible patient cohorts for enrollment in clinical trials. Clinerion’s technology makes it easy and reliable to assess whether patients of a partner hospital match the inclusion / exclusion criteria in a trial protocol."

Download the PDF for the full release.



Report: Biotechnology Park Opening, Armenia

Publication date: May 22, 2018

A report on our attendance of the opening of the FMD K&L Biotechnology Park, Yerevan, Armenia

The main focus was to explain the technology driven processes of the recently established Clinical Trials Center. Principal investigators and study teams can now make data driven feasibility, patient identification and protocol optimization using Clinerion’s technology solutions. Researchers can also leverage the technology to make faster publications. 

Read our full report on the event, here >

Report: Biotechnology Park Opening, Armenia

Report: Biotechnology Park Opening, Armenia
A report on our attendance of the opening of the FMD K&L Biotechnology Park, Yerevan, Armenia
Report: Biotechnology Park Opening, Armenia

The main focus was to explain the technology driven processes of the recently established Clinical Trials Center. Principal investigators and study teams can now make data driven feasibility, patient identification and protocol optimization using Clinerion’s technology solutions. Researchers can also leverage the technology to make faster publications. 

Read our full report on the event, here >



Report: Introduction to Clinerion's technology solutions at Başkent University, Turkey

Publication date: May 17, 2018

Clinerion Turkey organized 3 different sessions at Başkent University, Ankara, to introduce Clinerion’s technology solutions.

The main focus was to explain the technology driven processes of the recently established Clinical Trials Center. Principal investigators and study teams can now make data driven feasibility, patient identification and protocol optimization using Clinerion’s technology solutions. Researchers can also leverage the technology to make faster publications. 

Read our full report on the event, here >

Report: Introduction to Clinerion's technology solutions at Başkent University, Turkey

Report: Introduction to Clinerion's technology solutions at Başkent University, Turkey
Clinerion Turkey organized 3 different sessions at Başkent University, Ankara, to introduce Clinerion’s technology solutions.
Report: Introduction to Clinerion's technology solutions at Başkent University, Turkey

The main focus was to explain the technology driven processes of the recently established Clinical Trials Center. Principal investigators and study teams can now make data driven feasibility, patient identification and protocol optimization using Clinerion’s technology solutions. Researchers can also leverage the technology to make faster publications. 

Read our full report on the event, here >



Report: "Good Clinical Practice and Clinical Research" Training Seminar

Publication date: March 28, 2018

A report on our "Good Clinical Practice and Clinical Research" training seminar, run in collaboration with Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Training Hospital (IMAEH), Istanbul University Medical Faculty Pharmacology Department and IQVIA Turkey, in Istanbul.

Clinerion organized this training seminar on March 17th in collaboration with Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Training Hospital (IMAEH), Istanbul University Medical Faculty Pharmacology Department and IQVIA Turkey.

The seminar had the aim of improving the clinical research infrastructure in the hospital and had 80 participants, from hospitals, pharmaceutical companies and CROs. The training ended with an exam and certification for the successful participants. The certifications are approved by the Ministry of Health, and can therefore be used in appropriate applications. 68 participants successfully received certifications and one participant received a participation certificate.

Read our full report on the event, here >

Report: "Good Clinical Practice and Clinical Research" Training Seminar

Report: "Good Clinical Practice and Clinical Research" Training Seminar
A report on our "Good Clinical Practice and Clinical Research" training seminar, run in collaboration with Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Training Hospital (IMAEH), Istanbul University Medical Faculty Pharmacology Department and IQVIA Turkey, in Istanbul.
Report: "Good Clinical Practice and Clinical Research" Training Seminar

Clinerion organized this training seminar on March 17th in collaboration with Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Training Hospital (IMAEH), Istanbul University Medical Faculty Pharmacology Department and IQVIA Turkey.

The seminar had the aim of improving the clinical research infrastructure in the hospital and had 80 participants, from hospitals, pharmaceutical companies and CROs. The training ended with an exam and certification for the successful participants. The certifications are approved by the Ministry of Health, and can therefore be used in appropriate applications. 68 participants successfully received certifications and one participant received a participation certificate.

Read our full report on the event, here >



Press article: Ex-IQVIA executive takes the reins at patient recruitment specialist Clinerion (Fierce Biotech)

Publication date: March 21, 2018

Fierce Biotech dug deeper into our management news ...

Original publication date: March 20, 2018.

"Further footprint growth is underway, as the company plans to reach every continent and almost double the number of accessible patients to 310 million by the end of 2018.

“This global footprint, balanced in terms of geography and in terms of medical specialization, will allow our clients a comprehensive, varied and representative view of patients and trial sites around the world for all of their needs”

Click here to read the article > 

Press article: Ex-IQVIA executive takes the reins at patient recruitment specialist Clinerion (Fierce Biotech)

Press article: Ex-IQVIA executive takes the reins at patient recruitment specialist Clinerion (Fierce Biotech)
Fierce Biotech dug deeper into our management news ...
Press article: Ex-IQVIA executive takes the reins at patient recruitment specialist Clinerion (Fierce

Original publication date: March 20, 2018.

"Further footprint growth is underway, as the company plans to reach every continent and almost double the number of accessible patients to 310 million by the end of 2018.

“This global footprint, balanced in terms of geography and in terms of medical specialization, will allow our clients a comprehensive, varied and representative view of patients and trial sites around the world for all of their needs”

Click here to read the article > 



Press release: Ian Rentsch is Clinerion’s new CEO

Publication date: March 19, 2018

Clinerion’s Board of Directors announces the appointment of Ian Rentsch as new CEO of the company, effective April 1, 2018.

We are thrilled to welcome Ian Rentsch as our new CEO!

Rentsch brings more than 21 years of international experience in multinational pharmaceutical companies as well as in small/niche and global CROs.

Taking on leadership of Clinerion, Ian aims to solve the main industry challenge by bridging the divide between patients, sites, and drug developers.

“The company’s focus on electronic health data and innovative technologies allows it to reimagine how clinical research is conducted and how sites and patient communities around the world become engaged.” says Rentsch.

Download the PDF for the full release.

PDF File: Download here

Press release: Ian Rentsch is Clinerion’s new CEO

Press release: Ian Rentsch is Clinerion’s new CEO
Clinerion’s Board of Directors announces the appointment of Ian Rentsch as new CEO of the company, effective April 1, 2018.
Press release: Ian Rentsch is Clinerion’s new CEO

We are thrilled to welcome Ian Rentsch as our new CEO!

Rentsch brings more than 21 years of international experience in multinational pharmaceutical companies as well as in small/niche and global CROs.

Taking on leadership of Clinerion, Ian aims to solve the main industry challenge by bridging the divide between patients, sites, and drug developers.

“The company’s focus on electronic health data and innovative technologies allows it to reimagine how clinical research is conducted and how sites and patient communities around the world become engaged.” says Rentsch.

Download the PDF for the full release.



Press article: Clinerion joins BlueCloud: “Data is becoming the new oil” (Outsourcing Pharma)

Publication date: February 14, 2018

Outsourcing Pharma reported on the launch event for our collaboration with BlueCloud at SCOPE 2018, as well as our new hospital partner in Romania

Original publication date: Febriary 14, 2018.

"HealthCarePoint has announced a mutual collaboration with Clinerion through which members of the company’s BlueCloud Sponsor Network will gain access to Clinerion’s patient database via a dynamic map."

Click here to read the article > 

Press article: Clinerion joins BlueCloud: “Data is becoming the new oil” (Outsourcing Pharma)

Press article: Clinerion joins BlueCloud: “Data is becoming the new oil” (Outsourcing Pharma)
Outsourcing Pharma reported on the launch event for our collaboration with BlueCloud at SCOPE 2018, as well as our new hospital partner in Romania
Press article: Clinerion joins BlueCloud: “Data is becoming the new oil” (Outsourcing Pharma)

Original publication date: Febriary 14, 2018.

"HealthCarePoint has announced a mutual collaboration with Clinerion through which members of the company’s BlueCloud Sponsor Network will gain access to Clinerion’s patient database via a dynamic map."

Click here to read the article > 



Press release: The Children’s Emergency Hospital "Louis Turcanu" expands Clinerion’s PRS hospitals network into Romania.

Publication date: February 12, 2018

Clinerion is expanding our network of hospital partners – both geographically, into Romania, and also into the specialized field of pediatric medicine.

"The Children’s Emergency Hospital "Louis Turcanu" brings over 90,000 patients in the Timișoara area to the PRS network of hospitals, expanding Clinerion’s global footprint into Romania."

Download the PDF for the full release.

PDF File: Download here

Press release: The Children’s Emergency Hospital "Louis Turcanu" expands Clinerion’s PRS hospitals network into Romania.

Press release: The Children’s Emergency Hospital "Louis Turcanu" expands Clinerion’s PRS hospitals network into Romania.
Clinerion is expanding our network of hospital partners – both geographically, into Romania, and also into the specialized field of pediatric medicine.
Press release: The Children’s Emergency Hospital "Louis Turcanu" expands Clinerion’s PRS ho

"The Children’s Emergency Hospital "Louis Turcanu" brings over 90,000 patients in the Timișoara area to the PRS network of hospitals, expanding Clinerion’s global footprint into Romania."

Download the PDF for the full release.



Clinerion article: The Challenges and Benefits of Integrating Electronic Medical Record Data into Observational Studies (Journal for Clinical Studies)

Publication date: February 05, 2018

We wrote an article with our partner, Cisiv, for the Journal for Clinical Studies, on the new technologies underpinning EHR-EDC functionality ...

"The integration of solutions for querying patient electronic health records with electronic data capture (EDC) technologies generates more comprehensive data for real-world evidence, creating new efciencies and improving data quality."

Link to Journal for Clinical Studies, Volume 10, Issue 1 >

PDF File: Download here

Clinerion article: The Challenges and Benefits of Integrating Electronic Medical Record Data into Observational Studies (Journal for Clinical Studies)

Clinerion article: The Challenges and Benefits of Integrating Electronic Medical Record Data into Observational Studies (Journal for Clinical Studies)
We wrote an article with our partner, Cisiv, for the Journal for Clinical Studies, on the new technologies underpinning EHR-EDC functionality ...
Clinerion article: The Challenges and Benefits of Integrating Electronic Medical Record Data into Obs

"The integration of solutions for querying patient electronic health records with electronic data capture (EDC) technologies generates more comprehensive data for real-world evidence, creating new efciencies and improving data quality."

Link to Journal for Clinical Studies, Volume 10, Issue 1 >



Press release: Clinerion Joins the BlueCloud Network

Publication date: December 19, 2017

Clinerion brings EHR-based patient search and identification for clinical trials to HealthCarePoint’s BlueCloud Patient Network.

"HealthCarePoint, a Texas-based health care and clinical research networking-technology company founded by patient-survivors, today announced its mutual collaboration with Clinerion. The collaboration will further both companies’ shared mission of transforming clinical trials by expanding access to patient data analytics services.

"Members of the BlueCloud Sponsor Network will be able to view the locations and numbers of Clinerion’s patients on a dynamic map. Drill-downs allow the user to narrow the selection by therapeutic area and indication. Clinerion is expanding its global coverage rapidly and will keep the patient map up-to-date. With 76 Sponsors currently in their network, managerial healthcare professionals will now be able to search tens of millions of patients around the world on Clinerion’s PRS platform by therapeutic area and indication."

Read the full press release on PRWeb/Cision >

Press release: Clinerion Joins the BlueCloud Network

Press release: Clinerion Joins the BlueCloud Network
Clinerion brings EHR-based patient search and identification for clinical trials to HealthCarePoint’s BlueCloud Patient Network.
Press release: Clinerion Joins the BlueCloud Network

"HealthCarePoint, a Texas-based health care and clinical research networking-technology company founded by patient-survivors, today announced its mutual collaboration with Clinerion. The collaboration will further both companies’ shared mission of transforming clinical trials by expanding access to patient data analytics services.

"Members of the BlueCloud Sponsor Network will be able to view the locations and numbers of Clinerion’s patients on a dynamic map. Drill-downs allow the user to narrow the selection by therapeutic area and indication. Clinerion is expanding its global coverage rapidly and will keep the patient map up-to-date. With 76 Sponsors currently in their network, managerial healthcare professionals will now be able to search tens of millions of patients around the world on Clinerion’s PRS platform by therapeutic area and indication."

Read the full press release on PRWeb/Cision >



Press event: Clinerion and ASUS Life announce that the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals, at the Taiwan Healthcare Expo.

Publication date: December 10, 2017

Clinerion was pleased to join our partner, ASUS Life, at the Taiwan Healthcare Expo, both at their booth and their press event. We jointly officially announced that the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals.

Here is the statement by Clinerion's International Business Director, Randy Ramin-Wright:

"Today, I have the pleasure to announce that our partnership with ASUS Life has reached a new milestone, as the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals. This represents a major step forward as Show Chwan is the first hospital in Taiwan to join Clinerion’s hospital network.

"With this step, Show Chwan demonstrates once again its commitment to innovative technologies for the advancement of clinical research and the care of its patients. We are thrilled about the prospect of a long-term relationship with the Show Chwan Hospital Group and helping them extend their international sponsored clinical trial program.

"Our objective is to bring innovations in medicine to ever more patients around the world. To do this, we need support and coverage from leading, high-technology hospitals with an excellent clinical reputation across the globe. In this sense, Show Chwan is a key, invaluable partner.

"ASUS Life, as Clinerion’s partner in Taiwan, is uniquely positioned to help realize this goal. With its existing global ASUS Cloud infrastructure, ASUS Life is ideally able to provide comprehensive and cutting edge data solutions for the healthcare domain. We are delighted to have ASUS Life as our partner and are confident our partnership will translate into major advances in Taiwanese healthcare!"

Press event: Clinerion and ASUS Life announce that the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals, at the Taiwan Healthcare Expo.

Press event: Clinerion and ASUS Life announce that the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals, at the Taiwan Healthcare Expo.
Clinerion was pleased to join our partner, ASUS Life, at the Taiwan Healthcare Expo, both at their booth and their press event. We jointly officially announced that the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals.
Press event: Clinerion and ASUS Life announce that the Show Chwan Hospital Group is joining Clinerion

Here is the statement by Clinerion's International Business Director, Randy Ramin-Wright:

"Today, I have the pleasure to announce that our partnership with ASUS Life has reached a new milestone, as the Show Chwan Hospital Group is joining Clinerion’s global network of hospitals. This represents a major step forward as Show Chwan is the first hospital in Taiwan to join Clinerion’s hospital network.

"With this step, Show Chwan demonstrates once again its commitment to innovative technologies for the advancement of clinical research and the care of its patients. We are thrilled about the prospect of a long-term relationship with the Show Chwan Hospital Group and helping them extend their international sponsored clinical trial program.

"Our objective is to bring innovations in medicine to ever more patients around the world. To do this, we need support and coverage from leading, high-technology hospitals with an excellent clinical reputation across the globe. In this sense, Show Chwan is a key, invaluable partner.

"ASUS Life, as Clinerion’s partner in Taiwan, is uniquely positioned to help realize this goal. With its existing global ASUS Cloud infrastructure, ASUS Life is ideally able to provide comprehensive and cutting edge data solutions for the healthcare domain. We are delighted to have ASUS Life as our partner and are confident our partnership will translate into major advances in Taiwanese healthcare!"



Press release: Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research in Brazil by introducing Clinerion’s PRS to the Hospital São Vicente de Paulo.

Publication date: December 06, 2017

In concert with its Brazilian partner, the iHealth Group, Clinerion has agreed with Bioserv SMO to add Bioserv’s trial sites to the PRS platform. The Hospital São Vicente de Paulo is the first implementation, bringing another 540 thousand patient lives to Clinerion’s coverage in Brazil.

"Bioserv SMO manages trial sites in the Rio Grande do Sul region of Brazil. The first implementation of PRS will take place at the Hospital São Vicente de Paulo, in the city of Passo Fundo. São Vicente de Paulo has 600 beds, and its hospital information system holds 540K patient lives.

"The hospital’s 26 Principal Investigators specialize in multiple therapeutic areas, running studies in Phase Ib, II, III and IV on drugs and medical devices. Currently, they have 60 ongoing studies."

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research in Brazil by introducing Clinerion’s PRS to the Hospital São Vicente de Paulo.

Press release: Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research in Brazil by introducing Clinerion’s PRS to the Hospital São Vicente de Paulo.
In concert with its Brazilian partner, the iHealth Group, Clinerion has agreed with Bioserv SMO to add Bioserv’s trial sites to the PRS platform. The Hospital São Vicente de Paulo is the first implementation, bringing another 540 thousand patient lives to Clinerion’s coverage in Brazil.
Press release: Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research i

"Bioserv SMO manages trial sites in the Rio Grande do Sul region of Brazil. The first implementation of PRS will take place at the Hospital São Vicente de Paulo, in the city of Passo Fundo. São Vicente de Paulo has 600 beds, and its hospital information system holds 540K patient lives.

"The hospital’s 26 Principal Investigators specialize in multiple therapeutic areas, running studies in Phase Ib, II, III and IV on drugs and medical devices. Currently, they have 60 ongoing studies."

Download the PDF for the full release.



Press article: Clinerion adds Estonia- and Turkey-based hospitals to patient recruitment network (Outsourcing Pharma)

Publication date: November 28, 2017

Outsourcing Pharma covered our news about expanding in Turkey and Estonia ...

Original publication date: November 27, 2017.

"Clinerion has expanded its patient recruitment system (PRS) platform [in Estonia and Turkey] to provide its clients, pharma companies, and contract research organizations (CROs) greater access to potential clinical trial participants."

Click here to read the article > 

Press article: Clinerion adds Estonia- and Turkey-based hospitals to patient recruitment network (Outsourcing Pharma)

Press article: Clinerion adds Estonia- and Turkey-based hospitals to patient recruitment network (Outsourcing Pharma)
Outsourcing Pharma covered our news about expanding in Turkey and Estonia ...
Press article: Clinerion adds Estonia- and Turkey-based hospitals to patient recruitment network (Out

Original publication date: November 27, 2017.

"Clinerion has expanded its patient recruitment system (PRS) platform [in Estonia and Turkey] to provide its clients, pharma companies, and contract research organizations (CROs) greater access to potential clinical trial participants."

Click here to read the article > 



Press release: Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.

Publication date: November 27, 2017

Tartu University Hospital, the only university hospital in Estonia and an e-Health pioneer, has joined the network of hospitals on Clinerion’s PRS platform.

"The hospital has a catchment area which covers ~50% of the Estonian population. It performs 40,000 inpatient treatments and receives 400,000 outpatient visits annually.

"Tartu University Hospital is the pioneer of e-Health in Estonia. 80% of its medical data communication is digital.

"Tartu University Hospital currently runs 30-40 clinical trials per year, with capacity to do many more, and the expertise to back it up. By joining, the PRS platform, the university hospital’s clinical trials facilities will be exposed to a wide range of global clinical trials run by Clinerion’s clients, international pharmaceutical companies and contract research organizations."

Download the PDF for the full release.

PDF File: Download here

Press release: Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.

Press release: Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.
Tartu University Hospital, the only university hospital in Estonia and an e-Health pioneer, has joined the network of hospitals on Clinerion’s PRS platform.
Press release: Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.

"The hospital has a catchment area which covers ~50% of the Estonian population. It performs 40,000 inpatient treatments and receives 400,000 outpatient visits annually.

"Tartu University Hospital is the pioneer of e-Health in Estonia. 80% of its medical data communication is digital.

"Tartu University Hospital currently runs 30-40 clinical trials per year, with capacity to do many more, and the expertise to back it up. By joining, the PRS platform, the university hospital’s clinical trials facilities will be exposed to a wide range of global clinical trials run by Clinerion’s clients, international pharmaceutical companies and contract research organizations."

Download the PDF for the full release.



Press release: IMAEH Hospital joins Clinerion’s PRS network of hospitals.

Publication date: November 16, 2017

IMAEH will become more visible to international sponsors seeking sites for clinical trials. Patients at IMAEH will now have access to a wider range of treatment options and physicians at IMAEH will be able to offer a better standard of care.

IMAEH will have more than 600 beds in 2018, including an intensive care unit with 174 beds. With PRS IMAEH will be able to identify and recruit patients also in an emergency setting. IMAEH adds more than 2 million medical records and 260,000 patient lives to PRS.

Download the PDF for the full release.

PDF File: Download here

Press release: IMAEH Hospital joins Clinerion’s PRS network of hospitals.

Press release: IMAEH Hospital joins Clinerion’s PRS network of hospitals.
IMAEH will become more visible to international sponsors seeking sites for clinical trials. Patients at IMAEH will now have access to a wider range of treatment options and physicians at IMAEH will be able to offer a better standard of care.
Press release: IMAEH Hospital joins Clinerion’s PRS network of hospitals.

IMAEH will have more than 600 beds in 2018, including an intensive care unit with 174 beds. With PRS IMAEH will be able to identify and recruit patients also in an emergency setting. IMAEH adds more than 2 million medical records and 260,000 patient lives to PRS.

Download the PDF for the full release.



Press article: Clinerion expands coverage by 60m patients via strategic partnership (Outsourcing Pharma)

Publication date: November 02, 2017

Outsourcing Pharma interviewed us about our expansion in the US. We explained more about why we joined forces with Provisio.

Original publication date: October 30, 2017.

"Clinerion has partnered with Provisio Inc. to expand its service coverage in the Americas by approximately 60m patients."

Click here to read the article > 

Press article: Clinerion expands coverage by 60m patients via strategic partnership (Outsourcing Pharma)

Press article: Clinerion expands coverage by 60m patients via strategic partnership (Outsourcing Pharma)
Outsourcing Pharma interviewed us about our expansion in the US. We explained more about why we joined forces with Provisio.
Press article: Clinerion expands coverage by 60m patients via strategic partnership (Outsourcing Phar

Original publication date: October 30, 2017.

"Clinerion has partnered with Provisio Inc. to expand its service coverage in the Americas by approximately 60m patients."

Click here to read the article > 



Press article: Clinerion adds 60M U.S. patients to clinical trial recruitment system (Fierce Biotech)

Publication date: November 02, 2017

Thrilled that Fierce Biotech has picked up the story on our expansion into the US, as well!

Original publication date: November 2, 2017.

"Through a new collaboration with Provisio, Clinerion can now reach over 60 million patients in the U.S. for potential clinical trial recruitment and real-world evidence data generation. This marks a major step forward for the company’s effort in the past 12 months to expand the reach of its patient recruitment system (PRS) around the world."

Click here to read the article > 

Press article: Clinerion adds 60M U.S. patients to clinical trial recruitment system (Fierce Biotech)

Press article: Clinerion adds 60M U.S. patients to clinical trial recruitment system (Fierce Biotech)
Thrilled that Fierce Biotech has picked up the story on our expansion into the US, as well!
Press article: Clinerion adds 60M U.S. patients to clinical trial recruitment system (Fierce Biotech)

Original publication date: November 2, 2017.

"Through a new collaboration with Provisio, Clinerion can now reach over 60 million patients in the U.S. for potential clinical trial recruitment and real-world evidence data generation. This marks a major step forward for the company’s effort in the past 12 months to expand the reach of its patient recruitment system (PRS) around the world."

Click here to read the article > 



Press release: Clinerion expands the global coverage of its services in the Americas, adding 60 million patients in North America via partnership with Provisio Inc.

Publication date: October 30, 2017

Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc.

Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion expands the global coverage of its services in the Americas, adding 60 million patients in North America via partnership with Provisio Inc.

Press release: Clinerion expands the global coverage of its services in the Americas, adding 60 million patients in North America via partnership with Provisio Inc.
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc.
Press release: Clinerion expands the global coverage of its services in the Americas, adding 60 milli

Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities.

Download the PDF for the full release.



Press release: Clinerion adds FHIR data model to its set of standard electronic medical record formats.

Publication date: October 17, 2017

Clinerion announces that data integration to its Patient Recruitment System platform can now also process electronic medical records made available by hospitals using the Fast Healthcare Interoperability Resources (FHIR) standard.

Hospitals using FHIR may now directly exchange data with Patient Recruitment System without the need for additional implementation effort.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion adds FHIR data model to its set of standard electronic medical record formats.

Press release: Clinerion adds FHIR data model to its set of standard electronic medical record formats.
Clinerion announces that data integration to its Patient Recruitment System platform can now also process electronic medical records made available by hospitals using the Fast Healthcare Interoperability Resources (FHIR) standard.
Press release: Clinerion adds FHIR data model to its set of standard electronic medical record format

Hospitals using FHIR may now directly exchange data with Patient Recruitment System without the need for additional implementation effort.

Download the PDF for the full release.



Interview: "In Switzerland, we often sell promising technologies too early" (BaselArea.swiss)

Publication date: September 05, 2017

BaselArea.swiss interviewed Clinerion CEO Ulf Claesson on the challenges and opportunities inherent in running startups in healthtech.

Original publication date: September 5, 2017.

"Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on to become firmly established in the market. In 2012, he joined Clinerion as CEO and shareholder. Since then, the company has positioned itself in the medical data field and recently entered into a partnership with British company Cisiv. Clinerion's software helps recruit patients for clinical trials run by major pharmaceutical companies – in real time. But the competition never sleeps. A growing number of competitors is now appearing, especially in the USA where there is no shortage of risk capital. In this interview for the Innovation Report, Claesson explains how the Basel-based healthtech company plans to maintain its leadership position ..."

Link: www.baselarea.swiss/baselarea-swiss/channels/innovation-report/2017/09/In-Switzerland-we-often-sell-promising-technologies-too-early.html

Interview: "In Switzerland, we often sell promising technologies too early" (BaselArea.swiss)

Interview: "In Switzerland, we often sell promising technologies too early" (BaselArea.swiss)
BaselArea.swiss interviewed Clinerion CEO Ulf Claesson on the challenges and opportunities inherent in running startups in healthtech.
Interview: "In Switzerland, we often sell promising technologies too early" (BaselArea.swis

Original publication date: September 5, 2017.

"Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on to become firmly established in the market. In 2012, he joined Clinerion as CEO and shareholder. Since then, the company has positioned itself in the medical data field and recently entered into a partnership with British company Cisiv. Clinerion's software helps recruit patients for clinical trials run by major pharmaceutical companies – in real time. But the competition never sleeps. A growing number of competitors is now appearing, especially in the USA where there is no shortage of risk capital. In this interview for the Innovation Report, Claesson explains how the Basel-based healthtech company plans to maintain its leadership position ..."

Link: www.baselarea.swiss/baselarea-swiss/channels/innovation-report/2017/09/In-Switzerland-we-often-sell-promising-technologies-too-early.html



Press release: Clinerion releases revamped design with improved functionality for Patient Recruitment System.

Publication date: August 24, 2017

Clinerion has redesigned the web application for Patient Recruitment System, creating a sleek, professional and intuitive new user interface with analytical capabilities. The system’s functionality and speed have been improved, further supporting decision-making for clinical trial site selection and recruitment strategies.

"The Patient Recruitment System (PRS) web application has been completely redesigned, using state of the art web design principles based on Material Design. It now incorporates new functionalities and improvements in ease-of-use, resulting in a modern, visually attractive, intuitive and user-friendly appearance. The entire application can now be used on touch displays ..."

A new look for the Protocol Designer.

​Results in graphical format by age and gender.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion releases revamped design with improved functionality for Patient Recruitment System.

Press release: Clinerion releases revamped design with improved functionality for Patient Recruitment System.
Clinerion has redesigned the web application for Patient Recruitment System, creating a sleek, professional and intuitive new user interface with analytical capabilities. The system’s functionality and speed have been improved, further supporting decision-making for clinical trial site selection and recruitment strategies.
Press release: Clinerion releases revamped design with improved functionality for Patient Recruitment

"The Patient Recruitment System (PRS) web application has been completely redesigned, using state of the art web design principles based on Material Design. It now incorporates new functionalities and improvements in ease-of-use, resulting in a modern, visually attractive, intuitive and user-friendly appearance. The entire application can now be used on touch displays ..."

A new look for the Protocol Designer.

​Results in graphical format by age and gender.

Download the PDF for the full release.



Press article: Clinerion talks 'technically groundbreaking' patient recruitment system. (Outsourcing Pharma)

Publication date: August 23, 2017

Outsourcing Pharma interviews Clinerion CEO Ulf Claesson on our new technology for patient search and identification using anonymized patient data, ANID.

Original publication date: August 23, 2017.

"Permission to use electronic patient data differs from country to country, and can also depend on the interpretation thereof by hospital authorities.  This limits the pool of hospitals which can be called upon for online patient recruitment for clinical trials.

"With Clinerion’s ANID technology, all these concerns are automatically allayed, because the technology only uses anonymized data ...

"To our knowledge, there are no other patient recruitment solutions which work using fully anonymized data."

​Link: www.outsourcing-pharma.com/Clinical-Development/Clinerion-patents-anonymized-identification-technology

Press article: Clinerion talks 'technically groundbreaking' patient recruitment system. (Outsourcing Pharma)

Press article: Clinerion talks 'technically groundbreaking' patient recruitment system. (Outsourcing Pharma)
Outsourcing Pharma interviews Clinerion CEO Ulf Claesson on our new technology for patient search and identification using anonymized patient data, ANID.
Press article: Clinerion talks 'technically groundbreaking' patient recruitment system. (Ou

Original publication date: August 23, 2017.

"Permission to use electronic patient data differs from country to country, and can also depend on the interpretation thereof by hospital authorities.  This limits the pool of hospitals which can be called upon for online patient recruitment for clinical trials.

"With Clinerion’s ANID technology, all these concerns are automatically allayed, because the technology only uses anonymized data ...

"To our knowledge, there are no other patient recruitment solutions which work using fully anonymized data."

​Link: www.outsourcing-pharma.com/Clinical-Development/Clinerion-patents-anonymized-identification-technology



Press release: Clinerion announces a new technology for patient identification using fully anonymized electronic patient data.

Publication date: August 16, 2017

Clinerion has filed an international patent application following the PCT route for a new technology for patient search and identification based on the electronic medical records of patients held by hospitals. The “anonymized identification” (ANID) technology involves exclusively the use of anonymized data, ensuring the privacy and security of patient information.

  • “Anonymized identification” is based on fully anonymized patient records, with no use of pseudo IDs.
  • PCT patent filed for a new technology which uses a combination of techniques to match anonymized records with corresponding hospital medical records.
  • New system set-up increases data security and privacy protection.
  • Technology can be applied in the identification of clinical trial candidate patients within trial sites.

Visit the new patent page >

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion announces a new technology for patient identification using fully anonymized electronic patient data.

Press release: Clinerion announces a new technology for patient identification using fully anonymized electronic patient data.
Clinerion has filed an international patent application following the PCT route for a new technology for patient search and identification based on the electronic medical records of patients held by hospitals. The “anonymized identification” (ANID) technology involves exclusively the use of anonymized data, ensuring the privacy and security of patient information.
Press release: Clinerion announces a new technology for patient identification using fully anonymized
  • “Anonymized identification” is based on fully anonymized patient records, with no use of pseudo IDs.
  • PCT patent filed for a new technology which uses a combination of techniques to match anonymized records with corresponding hospital medical records.
  • New system set-up increases data security and privacy protection.
  • Technology can be applied in the identification of clinical trial candidate patients within trial sites.

Visit the new patent page >

Download the PDF for the full release.



Clinerion article: Accelerating Clinical Research in Brazil (Journal for Clinical Studies)

Publication date: August 08, 2017

Brazil punches under its weight class for clinical research. In our article for the Journal for Clinical Studies, we outline developments promising the acceleration of clinical research in Brazil ...

"Clinical research is underdeveloped in Brazil, although the country has the requisite expertise and infrastructure. We examine the situation and trends in South America and Brazil. In particular, we look at two developments which promise the acceleration of clinical research in Brazil. First, the approval in the Senate of the PLS 200 law, which gives a framework for making clinical trials approvals more efcient. Second, the initiatives for digitisation of health data, which permit the use of new patient data analytics technologies."

Link to Journal for Clinical Studies, Volume 9, Issue 4: www.jforcs.com/accelerating-clinical-research-brazil

PDF File: Download here

Clinerion article: Accelerating Clinical Research in Brazil (Journal for Clinical Studies)

Clinerion article: Accelerating Clinical Research in Brazil (Journal for Clinical Studies)
Brazil punches under its weight class for clinical research. In our article for the Journal for Clinical Studies, we outline developments promising the acceleration of clinical research in Brazil ...
Clinerion article: Accelerating Clinical Research in Brazil (Journal for Clinical Studies)

"Clinical research is underdeveloped in Brazil, although the country has the requisite expertise and infrastructure. We examine the situation and trends in South America and Brazil. In particular, we look at two developments which promise the acceleration of clinical research in Brazil. First, the approval in the Senate of the PLS 200 law, which gives a framework for making clinical trials approvals more efcient. Second, the initiatives for digitisation of health data, which permit the use of new patient data analytics technologies."

Link to Journal for Clinical Studies, Volume 9, Issue 4: www.jforcs.com/accelerating-clinical-research-brazil



Press article: Clinerion adds 4.5m patients to recruitment platform (Outsourcing Pharma)

Publication date: August 07, 2017

Outsourcing Pharma dug a bit deeper into our recent news about Başkent University joining Clinerion's Patient Recruitment System and interviewed our Head of EEMEA Region, Bariş Erdoğan, PhD ...

Original publication date: August 3, 2017.

"Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants."

​Link: www.outsourcing-pharma.com/Clinical-Development/Clinerion-adds-4.5m-patients-to-recruitment-platform

 

Press article: Clinerion adds 4.5m patients to recruitment platform (Outsourcing Pharma)

Press article: Clinerion adds 4.5m patients to recruitment platform (Outsourcing Pharma)
Outsourcing Pharma dug a bit deeper into our recent news about Başkent University joining Clinerion's Patient Recruitment System and interviewed our Head of EEMEA Region, Bariş Erdoğan, PhD ...
Press article: Clinerion adds 4.5m patients to recruitment platform (Outsourcing Pharma)

Original publication date: August 3, 2017.

"Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants."

​Link: www.outsourcing-pharma.com/Clinical-Development/Clinerion-adds-4.5m-patients-to-recruitment-platform

 



Clinerion article: On the Record (International Clinical Trials)

Publication date: August 04, 2017

The rise and the benefits of precision medicine - and how data analytics of electronic health records helps to unlock its potential. Read our article in "International Clinical Trials," August 2017. © Samedan Ltd.

"Precision medicine is fast becoming recognised as the way forward for the treatment of diseases. Having the right patient medical information is key, and IT technologies are crucial in being able to analyse it. Of all the data sources, electronic medical records seem to hold the most potential."

Link to August 2017 edition of International Clinical Trials: www.samedanltd.com/magazine/current/13

PDF File: Download here

Clinerion article: On the Record (International Clinical Trials)

Clinerion article: On the Record (International Clinical Trials)
The rise and the benefits of precision medicine - and how data analytics of electronic health records helps to unlock its potential. Read our article in "International Clinical Trials," August 2017. © Samedan Ltd.
Clinerion article: On the Record (International Clinical Trials)

"Precision medicine is fast becoming recognised as the way forward for the treatment of diseases. Having the right patient medical information is key, and IT technologies are crucial in being able to analyse it. Of all the data sources, electronic medical records seem to hold the most potential."

Link to August 2017 edition of International Clinical Trials: www.samedanltd.com/magazine/current/13



Press release: Başkent University joins Clinerion’s Patient Recruitment System Platform.

Publication date: August 02, 2017

Başkent University’s hospital cluster is joining the Patient Recruitment System platform, giving their 4.5 M patients access to innovative treatments and therapies offered by cutting edge clinical research.

"With this move, Başkent University will gain the advantages of partnership with the Patient Recruitment System (PRS) platform: visibility to sponsors making trial siting decisions, increased speed and effectiveness in recruitment, increased efficiency in matching studies to the hospital’s own patient population. Sites can also make use of PRS, internally, for academic trials with the assurance of compliance to hospital-level data access permissions.

"Patients at Başkent University will be able to access the latest treatments and therapies offered by the running of clinical research trials for innovative medicines in development."

Download the PDF for the full release.

PDF File: Download here

Press release: Başkent University joins Clinerion’s Patient Recruitment System Platform.

Press release: Başkent University joins Clinerion’s Patient Recruitment System Platform.
Başkent University’s hospital cluster is joining the Patient Recruitment System platform, giving their 4.5 M patients access to innovative treatments and therapies offered by cutting edge clinical research.
Press release: Başkent University joins Clinerion’s Patient Recruitment System Platform.

"With this move, Başkent University will gain the advantages of partnership with the Patient Recruitment System (PRS) platform: visibility to sponsors making trial siting decisions, increased speed and effectiveness in recruitment, increased efficiency in matching studies to the hospital’s own patient population. Sites can also make use of PRS, internally, for academic trials with the assurance of compliance to hospital-level data access permissions.

"Patients at Başkent University will be able to access the latest treatments and therapies offered by the running of clinical research trials for innovative medicines in development."

Download the PDF for the full release.



Press article: Partnership unveils EHR-EDC integration (CenterWatch Weekly)

Publication date: July 24, 2017

Front page on CenterWatch Weekly this week is the news of Clinerion's partnership with Cisiv.

Original publication date: July 24, 2017.

"Two industry innovators have joined forces to take the lead in real-world studies. Clinerion and Cisiv have formed a groundbreaking partnership to offer a revolutionary approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC). The partnering of both companies’ patented technologies will reduce the data entry burden to physicians participating in observational studies, improve data quality and enable smooth and rapid data collection in real-world settings. Clinerion and Cisiv share a vision of using technology to make real-world research leaner, easier to implement and, ultimately, more cost-efficient."

CWWeekly is only available to subscribers.

​Link: www.centerwatch.com/news-online/2017/07/24/centerwatch-weekly-july-24-2017/

Press article: Partnership unveils EHR-EDC integration (CenterWatch Weekly)

Press article: Partnership unveils EHR-EDC integration (CenterWatch Weekly)
Front page on CenterWatch Weekly this week is the news of Clinerion's partnership with Cisiv.
Press article: Partnership unveils EHR-EDC integration (CenterWatch Weekly)

Original publication date: July 24, 2017.

"Two industry innovators have joined forces to take the lead in real-world studies. Clinerion and Cisiv have formed a groundbreaking partnership to offer a revolutionary approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC). The partnering of both companies’ patented technologies will reduce the data entry burden to physicians participating in observational studies, improve data quality and enable smooth and rapid data collection in real-world settings. Clinerion and Cisiv share a vision of using technology to make real-world research leaner, easier to implement and, ultimately, more cost-efficient."

CWWeekly is only available to subscribers.

​Link: www.centerwatch.com/news-online/2017/07/24/centerwatch-weekly-july-24-2017/



Press release: Clinerion partners with Cisiv to lead innovation in real-world research.

Publication date: July 17, 2017

Clinerion and Cisiv have formed a groundbreaking partnership to offer a revolutionary approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC).

Two industry innovators are joining forces to take the lead in real-world studies.

Visit Clinerion's Partners page >

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion partners with Cisiv to lead innovation in real-world research.

Press release: Clinerion partners with Cisiv to lead innovation in real-world research.
Clinerion and Cisiv have formed a groundbreaking partnership to offer a revolutionary approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC).
Press release: Clinerion partners with Cisiv to lead innovation in real-world research.

Two industry innovators are joining forces to take the lead in real-world studies.

Visit Clinerion's Partners page >

Download the PDF for the full release.



Clinerion article: Accelerating clinical research in Brazil (pharmaphorum)

Publication date: July 04, 2017

The challenges and opportunities for clinical research in Brazil. Following Clinerion's recent partnership with the iHealth Group in Brazil and our subsequent industry event on accelerating clinical research in the country, pharmaphorum commissioned us to outline how we saw the development of clinical research in the country.

Original Publication Date: July 3, 2017.

"Though Brazil has the expertise and infrastructure, clinical research is not at the level that might be expected of the world’s fifth-most-populous country. Luis Magalhaes and Le Vin Chin examine the challenges and two developments that promise to improve the situation: the approval of the PLS 200 law, to smooth clinical trials approvals, and the digitalisation of health data, enabling patient data analytics."

Link: www.pharmaphorum.com/views-and-analysis/accelerating-clinical-research-brazil

Press release: Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform >

Report: “Accelerating Clinical Research in Brazil” Seminar​ >

Clinerion article: Accelerating clinical research in Brazil (pharmaphorum)

Clinerion article: Accelerating clinical research in Brazil (pharmaphorum)
The challenges and opportunities for clinical research in Brazil. Following Clinerion's recent partnership with the iHealth Group in Brazil and our subsequent industry event on accelerating clinical research in the country, pharmaphorum commissioned us to outline how we saw the development of clinical research in the country.
Clinerion article: Accelerating clinical research in Brazil (pharmaphorum)

Original Publication Date: July 3, 2017.

"Though Brazil has the expertise and infrastructure, clinical research is not at the level that might be expected of the world’s fifth-most-populous country. Luis Magalhaes and Le Vin Chin examine the challenges and two developments that promise to improve the situation: the approval of the PLS 200 law, to smooth clinical trials approvals, and the digitalisation of health data, enabling patient data analytics."

Link: www.pharmaphorum.com/views-and-analysis/accelerating-clinical-research-brazil

Press release: Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform >

Report: “Accelerating Clinical Research in Brazil” Seminar​ >



Clinerion article: Regulations and Recruitment: Experiences in the Middle East (Journal for Clinical Studies)

Publication date: June 26, 2017

How best to approach clinical research in the Middle East? Clinerion outlines our experience and recommendations in the region, in our article in the "Journal for Clinical Studies."

"The potential for the pharmaceuticals industry in the Middle East is vast, and growing. Clinical research is also growing, alongside pharma, in the region, despite variations in situation from country to country, and despite certain barriers that still need to be solved. The challenges of regulations and patient recruitment, in particular, are analysed. We take a specifc look at one of the most established countries in the region for clinical trials, Turkey, to see how it might act as a model for the rest of the region."

Link to Journal for Clinical Studies, Volume 9, Issue 3: www.jforcs.com/regulations-recruitment-experiences-middle-east

©www.jforcs.com.

PDF File: Download here

Clinerion article: Regulations and Recruitment: Experiences in the Middle East (Journal for Clinical Studies)

Clinerion article: Regulations and Recruitment: Experiences in the Middle East (Journal for Clinical Studies)
How best to approach clinical research in the Middle East? Clinerion outlines our experience and recommendations in the region, in our article in the "Journal for Clinical Studies."
Clinerion article: Regulations and Recruitment: Experiences in the Middle East (Journal for Clinical

"The potential for the pharmaceuticals industry in the Middle East is vast, and growing. Clinical research is also growing, alongside pharma, in the region, despite variations in situation from country to country, and despite certain barriers that still need to be solved. The challenges of regulations and patient recruitment, in particular, are analysed. We take a specifc look at one of the most established countries in the region for clinical trials, Turkey, to see how it might act as a model for the rest of the region."

Link to Journal for Clinical Studies, Volume 9, Issue 3: www.jforcs.com/regulations-recruitment-experiences-middle-east

©www.jforcs.com.



Clinerion is Switzerland Global Enterprise's Member of the Month!

Publication date: June 01, 2017

Check out their feature on us!

Clinerion is Switzerland Global Enterprise's Member of the Month!

Clinerion is Switzerland Global Enterprise's Member of the Month!
Check out their feature on us!
Clinerion is Switzerland Global Enterprise's Member of the Month!


Interview: “In Switzerland, we are not aggressive enough” (Startupticker.ch)

Publication date: May 29, 2017

Clinerion CEO Ulf Claesson was interviewed by Startupticker.ch when he participated in a panel on "Digitization in the healthcare sector" during the recent "Biotech and Digitization Day" in Basel, Switzerland.

Original publication date: May 24, 2017.

"Digitalisation in the health sector is in full swing. Switzerland is well positioned, but must be careful not to be overtaken by old and new competitors, according to serial entrepreneur Ulf Claesson. Active himself in this field with Clinerion, Claesson knows the situation first hand ..."

Link: www.startupticker.ch/en/news/may-2017/in-switzerland-we-are-not-aggressive-enough

Interview: “In Switzerland, we are not aggressive enough” (Startupticker.ch)

Interview: “In Switzerland, we are not aggressive enough” (Startupticker.ch)
Clinerion CEO Ulf Claesson was interviewed by Startupticker.ch when he participated in a panel on "Digitization in the healthcare sector" during the recent "Biotech and Digitization Day" in Basel, Switzerland.
Interview: “In Switzerland, we are not aggressive enough” (Startupticker.ch)

Original publication date: May 24, 2017.

"Digitalisation in the health sector is in full swing. Switzerland is well positioned, but must be careful not to be overtaken by old and new competitors, according to serial entrepreneur Ulf Claesson. Active himself in this field with Clinerion, Claesson knows the situation first hand ..."

Link: www.startupticker.ch/en/news/may-2017/in-switzerland-we-are-not-aggressive-enough



News: International Clinical Trials Day 2017

Publication date: May 19, 2017

Celebrating the practice of clinical trials, recognizing the practitioners, and raising awareness.

Taking the supposed date of the very first clinical trial, for scurvy, by ship surgeon James Lind, aboard the HMS Salisbury, International Clinical Trials Day celebrates the practice of clinical trials itself, as well as recognizing the practitioners whose efforts contribute to the advancement of medicine and public health. The Day also acts to raise awareness among the general public on the benefits of the practice.

Link (ACRP): www.clinicaltrialsday.org
Link (ECRIN): www.ecrin.org/event/international-clinical-trials-day-2017

News: International Clinical Trials Day 2017

News: International Clinical Trials Day 2017
Celebrating the practice of clinical trials, recognizing the practitioners, and raising awareness.
News: International Clinical Trials Day 2017

Taking the supposed date of the very first clinical trial, for scurvy, by ship surgeon James Lind, aboard the HMS Salisbury, International Clinical Trials Day celebrates the practice of clinical trials itself, as well as recognizing the practitioners whose efforts contribute to the advancement of medicine and public health. The Day also acts to raise awareness among the general public on the benefits of the practice.

Link (ACRP): www.clinicaltrialsday.org
Link (ECRIN): www.ecrin.org/event/international-clinical-trials-day-2017



Report: “Accelerating Clinical Research in Brazil” Seminar

Publication date: May 19, 2017

A report on our “Accelerating Clinical Research in Brazil” Seminar, run with the support of the Consulate General of Switzerland, in São Paulo.

On Monday, May 15, 2017, Clinerion ran a seminar on “Accelerating Clinical Research in Brazil” with the support of the Consulate General of Switzerland, in São Paulo.

The event was very well attended and featured speakers across the field of clinical research, which included the Brazilian association for Clinical Research, Aliança; the Patient Society of Multiple Sclerosis, ABEM; the iHealth Group; and the International Clinical Trial Center Network, ICN.

Attendees included representatives from several public and private hospitals, the president of the Brazilian Federal University Hospitals Network (EBSERH), CROs and pharmaceutical companies. 

The event allowed the attendees to exchange and discuss the great, new opportunity for the Brazilian clinical research community to expand its role as a major world player in the field of clinical research with the passing of the "PL200" law in the Brazilian Senate; and the exciting tools, techniques and technologies which are the way forward.

Read our full report on the event, here >

Report: “Accelerating Clinical Research in Brazil” Seminar

Report: “Accelerating Clinical Research in Brazil” Seminar
A report on our “Accelerating Clinical Research in Brazil” Seminar, run with the support of the Consulate General of Switzerland, in São Paulo.
Report: “Accelerating Clinical Research in Brazil” Seminar

On Monday, May 15, 2017, Clinerion ran a seminar on “Accelerating Clinical Research in Brazil” with the support of the Consulate General of Switzerland, in São Paulo.

The event was very well attended and featured speakers across the field of clinical research, which included the Brazilian association for Clinical Research, Aliança; the Patient Society of Multiple Sclerosis, ABEM; the iHealth Group; and the International Clinical Trial Center Network, ICN.

Attendees included representatives from several public and private hospitals, the president of the Brazilian Federal University Hospitals Network (EBSERH), CROs and pharmaceutical companies. 

The event allowed the attendees to exchange and discuss the great, new opportunity for the Brazilian clinical research community to expand its role as a major world player in the field of clinical research with the passing of the "PL200" law in the Brazilian Senate; and the exciting tools, techniques and technologies which are the way forward.

Read our full report on the event, here >



Press release: Clinerion presents tools to accelerate clinical research at São Paulo event.

Publication date: May 09, 2017

Clinerion launches a seminar event in São Paulo to introduce cutting-edge tools and technologies for the acceleration of clinical research.

"Clinerion will be running an open seminar event in São Paulo on May 15th, 2017, presenting cutting-edge techniques and technologies which can increase the speed, efficiency and competitiveness of Brazilian clinical trials. The event is supported by the Consulate General of Switzerland in São Paulo, and will take place at the official residence of the Consul General."

See the event on our Events page >

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion presents tools to accelerate clinical research at São Paulo event.

Press release: Clinerion presents tools to accelerate clinical research at São Paulo event.
Clinerion launches a seminar event in São Paulo to introduce cutting-edge tools and technologies for the acceleration of clinical research.
Press release: Clinerion presents tools to accelerate clinical research at São Paulo event.

"Clinerion will be running an open seminar event in São Paulo on May 15th, 2017, presenting cutting-edge techniques and technologies which can increase the speed, efficiency and competitiveness of Brazilian clinical trials. The event is supported by the Consulate General of Switzerland in São Paulo, and will take place at the official residence of the Consul General."

See the event on our Events page >

Download the PDF for the full release.



Clinerion article: Overcoming the challenges of clinical trial recruitment using big data technologies (World Pharma Today)

Publication date: April 25, 2017

How do Clinerion's partner hospitals benefit from being on our Patient Recruitment System platform? We summarized Creative Intellect Consulting's findings in World Pharma Today.

"The problem defined: Any prospective new drug must successfully pass a succession of three clinical trials phases, before it can apply for market approval.

"These trials represent a significant investment for a pharma company and, as they are prone to delays and can even fail altogether, they put immense financial pressure on them.

"One of the root causes for the failure of trials is the inability to recruit the specified number of eligible patients in the foreseen time span. Delays in the market launch can amount to as much as US$8 million per day for a blockbuster drug in opportunity costs for a pharmaceutical company."

Link: www.worldpharmatoday.com/Articles/overcoming-the-challenges-of-clinical-trial-recruitment-using-big-data-technologies

Clinerion article: Overcoming the challenges of clinical trial recruitment using big data technologies (World Pharma Today)

Clinerion article: Overcoming the challenges of clinical trial recruitment using big data technologies (World Pharma Today)
How do Clinerion's partner hospitals benefit from being on our Patient Recruitment System platform? We summarized Creative Intellect Consulting's findings in World Pharma Today.
Clinerion article: Overcoming the challenges of clinical trial recruitment using big data technologie

"The problem defined: Any prospective new drug must successfully pass a succession of three clinical trials phases, before it can apply for market approval.

"These trials represent a significant investment for a pharma company and, as they are prone to delays and can even fail altogether, they put immense financial pressure on them.

"One of the root causes for the failure of trials is the inability to recruit the specified number of eligible patients in the foreseen time span. Delays in the market launch can amount to as much as US$8 million per day for a blockbuster drug in opportunity costs for a pharmaceutical company."

Link: www.worldpharmatoday.com/Articles/overcoming-the-challenges-of-clinical-trial-recruitment-using-big-data-technologies



Press release: Clinerion Announces a New Push in Eastern Europe, the Middle East and Africa.

Publication date: March 07, 2017

Clinerion announces the expansion of its activities into countries in Eastern Europe, the Middle East and Africa (EEMEA), spearheaded by a newly appointed regional head.

“Clinical trials bring many benefits to a country’s economy, to hospitals, physicians and patients,” says Clinerion’s newly appointed Head of EEMEA Region, Bariş Erdoğan, PhD. “Now, hospitals in the EEMEA region have the opportunity to take a share of the global market for clinical trials. Clinerion offers them an effective way to come to the attention of trial sponsors and bring new studies to their countries.”

Clinerion solutions for the EEMEA Region will next be presented in attendance at the "Emerging Markets Forum: Pharma and OTC go-to-market strategies, partnerships and market access" meeting in Berlin, Germany (March 13-14, 2017), and the Clinical Trials in Central and Eastern Europe conference in Budapest, Hungary (April 25-26, 2017).

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion Announces a New Push in Eastern Europe, the Middle East and Africa.

Press release: Clinerion Announces a New Push in Eastern Europe, the Middle East and Africa.
Clinerion announces the expansion of its activities into countries in Eastern Europe, the Middle East and Africa (EEMEA), spearheaded by a newly appointed regional head.
Press release: Clinerion Announces a New Push in Eastern Europe, the Middle East and Africa.

“Clinical trials bring many benefits to a country’s economy, to hospitals, physicians and patients,” says Clinerion’s newly appointed Head of EEMEA Region, Bariş Erdoğan, PhD. “Now, hospitals in the EEMEA region have the opportunity to take a share of the global market for clinical trials. Clinerion offers them an effective way to come to the attention of trial sponsors and bring new studies to their countries.”

Clinerion solutions for the EEMEA Region will next be presented in attendance at the "Emerging Markets Forum: Pharma and OTC go-to-market strategies, partnerships and market access" meeting in Berlin, Germany (March 13-14, 2017), and the Clinical Trials in Central and Eastern Europe conference in Budapest, Hungary (April 25-26, 2017).

Download the PDF for the full release.



Press article: Clinerion enters Asia through strategic alliance with ASUS Life (Outsourcing Pharma)

Publication date: February 24, 2017

Outsourcing Pharma interviewed our CEO, Ulf Claesson, for more insights on our recent agreement with ASUS Life in Taiwan.

Press article: Clinerion enters Asia through strategic alliance with ASUS Life (Outsourcing Pharma)

Press article: Clinerion enters Asia through strategic alliance with ASUS Life (Outsourcing Pharma)
Outsourcing Pharma interviewed our CEO, Ulf Claesson, for more insights on our recent agreement with ASUS Life in Taiwan.
Press article: Clinerion enters Asia through strategic alliance with ASUS Life (Outsourcing Pharma)


Press release: Clinerion comes to Asia, forging a strategic alliance with Taiwan’s ASUS Life.

Publication date: February 20, 2017

Clinerion and ASUS Life signed a strategic alliance today at the HIMSS 17 conference in Orlando, Florida. Clinerion and ASUS Life, together with the Show Chwan Healthcare System, will deliver innovative services for the efficient running of clinical trials, clinical patient recruitment, market access and real-world evidence in Taiwan.

The new alliance between Clinerion and ASUS Life helps shorten the time it takes to bring a new drug to market, benefitting patients who get earlier access to new medicines.

With this collaboration, researchers at hospitals, pharmaceutical companies and contract research organizations gain real-time, EHR-based insight on the Taiwanese patient population. Eligible patients can subsequently be recruited by trial staff at Show Chwan’s 8 hospital sites. The collaboration will also enable the matching of patients with medications for rare and orphan diseases and the generation of data for real-world evidence analyses.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion comes to Asia, forging a strategic alliance with Taiwan’s ASUS Life.

Press release: Clinerion comes to Asia, forging a strategic alliance with Taiwan’s ASUS Life.
Clinerion and ASUS Life signed a strategic alliance today at the HIMSS 17 conference in Orlando, Florida. Clinerion and ASUS Life, together with the Show Chwan Healthcare System, will deliver innovative services for the efficient running of clinical trials, clinical patient recruitment, market access and real-world evidence in Taiwan.
Press release: Clinerion comes to Asia, forging a strategic alliance with Taiwan’s ASUS Life.

The new alliance between Clinerion and ASUS Life helps shorten the time it takes to bring a new drug to market, benefitting patients who get earlier access to new medicines.

With this collaboration, researchers at hospitals, pharmaceutical companies and contract research organizations gain real-time, EHR-based insight on the Taiwanese patient population. Eligible patients can subsequently be recruited by trial staff at Show Chwan’s 8 hospital sites. The collaboration will also enable the matching of patients with medications for rare and orphan diseases and the generation of data for real-world evidence analyses.

Download the PDF for the full release.



Press article: Clinerion enters an improved clinical trials market in Brazil (CenterWatch Weekly)

Publication date: February 06, 2017

Clinerion announced entry into South America with a partnership with the iHealth Group of Brazil in early January. CenterWatch Weekly followed up with a report on developments in the clinical trials market Brazil and why the time is right for Clinerion's approach.

Original publication date: January 16, 2017.

"To strengthen its presence in this new market, Clinerion has forged a partnership with the iHealth Group of Brazil, which operates 40 hospitals, with a total patient population of 25 million. The iHealth Group’s role is to make consistent quality electronic health records (EHRs) data available, signifcantly broadening the number of patients who could potentially participate in trials.

Download the PDF for the full article.

PDF File: Download here

Press article: Clinerion enters an improved clinical trials market in Brazil (CenterWatch Weekly)

Press article: Clinerion enters an improved clinical trials market in Brazil (CenterWatch Weekly)
Clinerion announced entry into South America with a partnership with the iHealth Group of Brazil in early January. CenterWatch Weekly followed up with a report on developments in the clinical trials market Brazil and why the time is right for Clinerion's approach.
Press article: Clinerion enters an improved clinical trials market in Brazil (CenterWatch Weekly)

Original publication date: January 16, 2017.

"To strengthen its presence in this new market, Clinerion has forged a partnership with the iHealth Group of Brazil, which operates 40 hospitals, with a total patient population of 25 million. The iHealth Group’s role is to make consistent quality electronic health records (EHRs) data available, signifcantly broadening the number of patients who could potentially participate in trials.

Download the PDF for the full article.



Clinerion article: Solutions Driving Efficiency in Clinical Trials (Applied Clinical Trials)

Publication date: February 02, 2017

How has Patient Recruitment System helped Clinerion's partner hospitals? Applied Clinical Trials commissioned us to detail the benefits experienced by hospitals in our network.

Original Publication Date: December 12, 2016.

“Before PRS, our study team recruited 15 patients in six months,” the Cardiology Institute respondent continued. “With PRS they enrolled 36 additional patients, which took less than two months and solely from screening only 15% of PRS’s patient list.”

Link: www.appliedclinicaltrialsonline.com/solutions-driving-efficiency-clinical-trials

This article was based on Clinerion's recent white paper and case study, investigating feedback gathered from current users of Patient Recruitment System.

 

Clinerion article: Solutions Driving Efficiency in Clinical Trials (Applied Clinical Trials)

Clinerion article: Solutions Driving Efficiency in Clinical Trials (Applied Clinical Trials)
How has Patient Recruitment System helped Clinerion's partner hospitals? Applied Clinical Trials commissioned us to detail the benefits experienced by hospitals in our network.
Clinerion article: Solutions Driving Efficiency in Clinical Trials (Applied Clinical Trials)

Original Publication Date: December 12, 2016.

“Before PRS, our study team recruited 15 patients in six months,” the Cardiology Institute respondent continued. “With PRS they enrolled 36 additional patients, which took less than two months and solely from screening only 15% of PRS’s patient list.”

Link: www.appliedclinicaltrialsonline.com/solutions-driving-efficiency-clinical-trials

This article was based on Clinerion's recent white paper and case study, investigating feedback gathered from current users of Patient Recruitment System.

 



Press release: Clinerion Introduces New Services for Market Access.

Publication date: January 25, 2017

Clinerion announces new services for market access which give pharmaceutical companies insight into patient populations based on its health data analytics tools.

Clinerion’s Patient Recruitment System (PRS) Patient Finder tool has a wealth of health data which can now be harnessed to guide pharmaceutical companies in their R&D and commercial decision making by providing information on the prevalence of target diseases and the distribution of patient populations.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion Introduces New Services for Market Access.

Press release: Clinerion Introduces New Services for Market Access.
Clinerion announces new services for market access which give pharmaceutical companies insight into patient populations based on its health data analytics tools.
Press release: Clinerion Introduces New Services for Market Access.

Clinerion’s Patient Recruitment System (PRS) Patient Finder tool has a wealth of health data which can now be harnessed to guide pharmaceutical companies in their R&D and commercial decision making by providing information on the prevalence of target diseases and the distribution of patient populations.

Download the PDF for the full release.



Interview: Ulf Claesson - CEO, Clinerion, Switzerland (Pharma Boardroom)

Publication date: January 16, 2017

Learn all about Clinerion's origins and ambitious plans in Pharma Boardroom's interview with our CEO, Ulf Claesson!

"Ulf Claesson provides a fascinating and passionate account of how his firm is aiming to remove ‘guesswork’ and estimations for medical practices whilst highlighting interesting developments in the global clinical research industry."

Note: this article is free to read, but behind a registration wall.

Link: www.pharmaboardroom.com/interviews/interview-ulf-claesson-ceo-clinerion-switzerland

Interview: Ulf Claesson - CEO, Clinerion, Switzerland (Pharma Boardroom)

Interview: Ulf Claesson - CEO, Clinerion, Switzerland (Pharma Boardroom)
Learn all about Clinerion's origins and ambitious plans in Pharma Boardroom's interview with our CEO, Ulf Claesson!
Interview: Ulf Claesson - CEO, Clinerion, Switzerland (Pharma Boardroom)

"Ulf Claesson provides a fascinating and passionate account of how his firm is aiming to remove ‘guesswork’ and estimations for medical practices whilst highlighting interesting developments in the global clinical research industry."

Note: this article is free to read, but behind a registration wall.

Link: www.pharmaboardroom.com/interviews/interview-ulf-claesson-ceo-clinerion-switzerland



Press article: Clinerion aims for 50m patients by Q2 2017 as it enters South America (Outsourcing Pharma)

Publication date: January 11, 2017

Outsourcing Pharma reports on the recent news that Brazil's iHealth Group has joined Clinerion's Patient Recruitment System platform.



Press release: Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform.

Publication date: January 10, 2017

The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings PRS a potential access to 40 sites and a 25 M patient population, opening up Brazil for Clinerion’s services for clinical patient recruitment, market access and real-world evidence.

With iHealth joining PRS, pharmaceutical companies and contract research organizations sponsoring clinical trials will gain real-time, EHR-based insight on the Brazilian patient population. Sponsors using PRS will be able to evaluate the distribution of eligible patients at iHealth’s sites during the development of a trial protocol and site selection for their clinical trials. These candidates can then be identified and recruited by the sites, themselves. Access to patient data in real-time enables more effective and efficient recruitment, especially for time-dependent criteria. Patient data also becomes available for matching patients with medications for rare and orphan diseases and the generation of data for real-world evidence.

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform.

Press release: Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform.
The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings PRS a potential access to 40 sites and a 25 M patient population, opening up Brazil for Clinerion’s services for clinical patient recruitment, market access and real-world evidence.
Press release: Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitmen

With iHealth joining PRS, pharmaceutical companies and contract research organizations sponsoring clinical trials will gain real-time, EHR-based insight on the Brazilian patient population. Sponsors using PRS will be able to evaluate the distribution of eligible patients at iHealth’s sites during the development of a trial protocol and site selection for their clinical trials. These candidates can then be identified and recruited by the sites, themselves. Access to patient data in real-time enables more effective and efficient recruitment, especially for time-dependent criteria. Patient data also becomes available for matching patients with medications for rare and orphan diseases and the generation of data for real-world evidence.

Download the PDF for the full release.



Clinerion article: Scalability and patient data security in the age of clinical trial recruitment using electronic medical records: an infrastructure solution (World Pharma Today)

Publication date: December 14, 2016

Finding suitable patients to participate in clinical trials is a long, complicated process taking months, today. The emergence of electronic hospital records (EHRs) in a hospital information system (HIS) allows this process to be automated and accelerated. What system infrastructure best suits the needs of doing this over multiple locations? And, given the digital nature of electronic patient information, what about the security of personal medical information? We examine the needs and challenges relating to patient recruitment using EHRs and propose a solution involving a hybrid cloud-based infrastructure.

Clinerion article: Scalability and patient data security in the age of clinical trial recruitment using electronic medical records: an infrastructure solution (World Pharma Today)

Clinerion article: Scalability and patient data security in the age of clinical trial recruitment using electronic medical records: an infrastructure solution (World Pharma Today)
Finding suitable patients to participate in clinical trials is a long, complicated process taking months, today. The emergence of electronic hospital records (EHRs) in a hospital information system (HIS) allows this process to be automated and accelerated. What system infrastructure best suits the needs of doing this over multiple locations? And, given the digital nature of electronic patient information, what about the security of personal medical information? We examine the needs and challenges relating to patient recruitment using EHRs and propose a solution involving a hybrid cloud-based infrastructure.
Clinerion article: Scalability and patient data security in the age of clinical trial recruitment usi


Press release: The University of Istanbul Dentistry School joins Clinerion’s Patient Recruitment System platform

Publication date: December 06, 2016

The Dentistry School of the University of Istanbul (IU), Istanbul, Turkey, joins Clinerion’s Patient Recruitment System platform, opening up new patient populations for patient recruitment and new clinical expertise areas for the running of clinical trials.

The IU Dentistry School specializes in all fields of dentistry, from Oral and Maxillofacial Surgery to Prosthodontics, from Periodontology to Pediatric Dentistry, Endodontics to Orthodontics. The hospital treated over 97,500 patients in the past year.

“We see a great benefit for our patients as well as for our hospital,” says Prof. Dr. Gülsüm Ak, the Dean of the Dentistry School. “PRS will bring our patients access to innovative new treatments, while the Dentistry School will gain higher exposure and visibility for leading edge clinical research.”

Download the PDF for the full release.

PDF File: Download here

Press release: The University of Istanbul Dentistry School joins Clinerion’s Patient Recruitment System platform

Press release: The University of Istanbul Dentistry School joins Clinerion’s Patient Recruitment System platform
The Dentistry School of the University of Istanbul (IU), Istanbul, Turkey, joins Clinerion’s Patient Recruitment System platform, opening up new patient populations for patient recruitment and new clinical expertise areas for the running of clinical trials.
Press release: The University of Istanbul Dentistry School joins Clinerion’s Patient Recruitment Syst

The IU Dentistry School specializes in all fields of dentistry, from Oral and Maxillofacial Surgery to Prosthodontics, from Periodontology to Pediatric Dentistry, Endodontics to Orthodontics. The hospital treated over 97,500 patients in the past year.

“We see a great benefit for our patients as well as for our hospital,” says Prof. Dr. Gülsüm Ak, the Dean of the Dentistry School. “PRS will bring our patients access to innovative new treatments, while the Dentistry School will gain higher exposure and visibility for leading edge clinical research.”

Download the PDF for the full release.



Press release: Clinerion's Patient Recruitment System Matches Patients with Precision Medicine Treatments.

Publication date: November 17, 2016

Clinerion announces a new service which gives patient populations access to precision medicine treatments based on its Patient Recruitment System’s Patient Finder tool.

Clinerion announces a new service and use case for its Patient Recruitment System (PRS). The PRS Patient Finder tool can now be used to give patients requiring personalized, precision, or orphan treatments access to new medicines earlier, and give physicians additional options in treating them.

With the new service, patients in “hard-to-reach” populations, such as patients with rare diseases and patients requiring personalized treatments, can be matched with new, targeted treatments. As patients with rare diseases are de facto very rare, connecting the patient to an innovative treatment is often very inefficient without a technological solution in place ...

Download the PDF for the full release.

PDF File: Download here

Press release: Clinerion's Patient Recruitment System Matches Patients with Precision Medicine Treatments.

Press release: Clinerion's Patient Recruitment System Matches Patients with Precision Medicine Treatments.
Clinerion announces a new service which gives patient populations access to precision medicine treatments based on its Patient Recruitment System’s Patient Finder tool.
Press release: Clinerion's Patient Recruitment System Matches Patients with Precision Medicine T

Clinerion announces a new service and use case for its Patient Recruitment System (PRS). The PRS Patient Finder tool can now be used to give patients requiring personalized, precision, or orphan treatments access to new medicines earlier, and give physicians additional options in treating them.

With the new service, patients in “hard-to-reach” populations, such as patients with rare diseases and patients requiring personalized treatments, can be matched with new, targeted treatments. As patients with rare diseases are de facto very rare, connecting the patient to an innovative treatment is often very inefficient without a technological solution in place ...

Download the PDF for the full release.



Partner press release: eClinicalHealth and Clinerion Launch Clinpal Readiness Certification at Several Hospitals in Turkey

Publication date: November 03, 2016

eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, has announced a technology-enabled collaboration with Clinerion that will offer unprecedented access to 27.5 million potential study candidates at several hospitals in Turkey.

The Clinerion-supported hospitals in Turkey will complete an online training program and earn Clinpal Readiness Certification. The training ensures each hospital has key stakeholders with the skills necessary to solicit, enroll and engage study patients through its use of the Clinpal technology.

Link to press release: www.businesswire.com/news/home/20161103006251/en/eClinicalHealth-Clinerion-Launch-Clinpal-Readiness-Certification-Hospitals

PDF File: Download here

Partner press release: eClinicalHealth and Clinerion Launch Clinpal Readiness Certification at Several Hospitals in Turkey

Partner press release: eClinicalHealth and Clinerion Launch Clinpal Readiness Certification at Several Hospitals in Turkey
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, has announced a technology-enabled collaboration with Clinerion that will offer unprecedented access to 27.5 million potential study candidates at several hospitals in Turkey.
Partner press release: eClinicalHealth and Clinerion Launch Clinpal Readiness Certification at Severa

The Clinerion-supported hospitals in Turkey will complete an online training program and earn Clinpal Readiness Certification. The training ensures each hospital has key stakeholders with the skills necessary to solicit, enroll and engage study patients through its use of the Clinpal technology.

Link to press release: www.businesswire.com/news/home/20161103006251/en/eClinicalHealth-Clinerion-Launch-Clinpal-Readiness-Certification-Hospitals



Press article: Clinerion patient recruitment system found compliant with privacy directives (Outsourcing Pharma)

Publication date: November 02, 2016

Outsourcing Pharma reports on the recent expert finding that Clinerion's Patient Recruitment System is compliant with regulations that oversee the reuse of personal information, in particular, the Health Insurance Portability and Accountability Act (HIPAA) and the EU Data Protection Directive (95/46/EC).

Press article: Clinerion patient recruitment system found compliant with privacy directives (Outsourcing Pharma)

Press article: Clinerion patient recruitment system found compliant with privacy directives (Outsourcing Pharma)
Outsourcing Pharma reports on the recent expert finding that Clinerion's Patient Recruitment System is compliant with regulations that oversee the reuse of personal information, in particular, the Health Insurance Portability and Accountability Act (HIPAA) and the EU Data Protection Directive (95/46/EC).
Press article: Clinerion patient recruitment system found compliant with privacy directives (Outsourc


Press release: Independent audit confirms Clinerion’s compliance to HIPAA and the EU Data Protection Directive.

Publication date: November 01, 2016

A third party expert has provided an independent assessment which confirms the complete compliance of Clinerion’s Patient Recruitment System (PRS) to regulations that oversee the reuse of personal information, in particular, the Health Insurance Portability and Accountability Act (HIPAA) and the EU Data Protection Directive (95/46/EC).

The expert concluded that Clinerion’s procedures for de-identification and pseudonymization meet the anonymization requirements set forth in international privacy directives, such as the Health Insurance Portability and Accountability Act (HIPAA) and the EU Data Protection Directive (95/46/EC) and judged them consistent with best practices to ensure that the risk of re-identification was sufficiently small, statistically.

PDF File: Download here

Press release: Independent audit confirms Clinerion’s compliance to HIPAA and the EU Data Protection Directive.

Press release: Independent audit confirms Clinerion’s compliance to HIPAA and the EU Data Protection Directive.
A third party expert has provided an independent assessment which confirms the complete compliance of Clinerion’s Patient Recruitment System (PRS) to regulations that oversee the reuse of personal information, in particular, the Health Insurance Portability and Accountability Act (HIPAA) and the EU Data Protection Directive (95/46/EC).
Press release: Independent audit confirms Clinerion’s compliance to HIPAA and the EU Data Protection

The expert concluded that Clinerion’s procedures for de-identification and pseudonymization meet the anonymization requirements set forth in international privacy directives, such as the Health Insurance Portability and Accountability Act (HIPAA) and the EU Data Protection Directive (95/46/EC) and judged them consistent with best practices to ensure that the risk of re-identification was sufficiently small, statistically.



Clinerion article: Maintaining Privacy when Searching for Patients Using Electronic Medical Records. (Journal for Clinical Studies)

Publication date: October 11, 2016

The launch of new drugs is contingent on running safe and thorough clinical trials, but the clinical trials process takes an inordinate amount of time, particularly in patient recruitment. The use of big data analytics methodologies which leverage real databases of electronic medical records is accelerating the clinical trials process and making patient recruitment more efficient. However, use of EHR-databases brings with it the risk of loss of patient privacy. We examine the issues and outline best practice guidelines, in our article in the "Journal for Clinical Studies," September 2016. ©www.jforcs.com.

Recent developments have shown the real benefits arising from the use of big data analytics techniques to interrogate EHR-databases at hospitals directly. With the right software infrastructure, eligible patients can be discovered based on complex combinations of query criteria, and in real-time. Trial managers can unearth more candidates, quicker.

But this development raises questions for patient privacy: using these electronic methods, are an individual’s personal details at risk of arriving in unauthorized hands?

In this paper, we examine the technological and legislative environments, analyse the ensuing risks, and propose some best practice methods for mitigating these risks.

Link to September 2016 edition of the Journal for Clinical Studies: https://issuu.com/mark123/docs/50_jcs_september2016_web

©www.jforcs.com.

PDF File: Download here

Clinerion article: Maintaining Privacy when Searching for Patients Using Electronic Medical Records. (Journal for Clinical Studies)

Clinerion article: Maintaining Privacy when Searching for Patients Using Electronic Medical Records. (Journal for Clinical Studies)
The launch of new drugs is contingent on running safe and thorough clinical trials, but the clinical trials process takes an inordinate amount of time, particularly in patient recruitment. The use of big data analytics methodologies which leverage real databases of electronic medical records is accelerating the clinical trials process and making patient recruitment more efficient. However, use of EHR-databases brings with it the risk of loss of patient privacy. We examine the issues and outline best practice guidelines, in our article in the "Journal for Clinical Studies," September 2016. ©www.jforcs.com.
Clinerion article: Maintaining Privacy when Searching for Patients Using Electronic Medical Records.

Recent developments have shown the real benefits arising from the use of big data analytics techniques to interrogate EHR-databases at hospitals directly. With the right software infrastructure, eligible patients can be discovered based on complex combinations of query criteria, and in real-time. Trial managers can unearth more candidates, quicker.

But this development raises questions for patient privacy: using these electronic methods, are an individual’s personal details at risk of arriving in unauthorized hands?

In this paper, we examine the technological and legislative environments, analyse the ensuing risks, and propose some best practice methods for mitigating these risks.

Link to September 2016 edition of the Journal for Clinical Studies: https://issuu.com/mark123/docs/50_jcs_september2016_web

©www.jforcs.com.



Press release: Clinerion updates Patient Recruitment System with new features and an improved appearance.

Publication date: September 29, 2016

Clinerion is releasing a new version of its Patient Recruitment System (PRS), adding speed, a library of protocol statements, collaboration tools and an updated look-and-feel.

We are working hard to bring even more new technology solutions to PRS, and to improve the user experience. Version 4 makes it even more useful and supportive of the needs of our users.

PDF File: Download here

Press release: Clinerion updates Patient Recruitment System with new features and an improved appearance.

Press release: Clinerion updates Patient Recruitment System with new features and an improved appearance.
Clinerion is releasing a new version of its Patient Recruitment System (PRS), adding speed, a library of protocol statements, collaboration tools and an updated look-and-feel.
Press release: Clinerion updates Patient Recruitment System with new features and an improved appeara

We are working hard to bring even more new technology solutions to PRS, and to improve the user experience. Version 4 makes it even more useful and supportive of the needs of our users.



News: Clinerion.com re-launches!

Publication date: September 05, 2016

Our website has a brand-new look! Our shiny new interface offers quicker access to everything to do with how we help patient recruitment for clinical trials, deeper information about our technologies and competencies, a comprehensive guide to our events attendance and other news, and direct access to the know-how of our experts - whichever language you speak!

Clinerion.com has evolved to be better than ever! If you're reading this, you're already here - please have fun exploring the new site. We hope you enjoy the experience!

News: Clinerion.com re-launches!

News: Clinerion.com re-launches!
Our website has a brand-new look! Our shiny new interface offers quicker access to everything to do with how we help patient recruitment for clinical trials, deeper information about our technologies and competencies, a comprehensive guide to our events attendance and other news, and direct access to the know-how of our experts - whichever language you speak!
News: Clinerion.com re-launches!

Clinerion.com has evolved to be better than ever! If you're reading this, you're already here - please have fun exploring the new site. We hope you enjoy the experience!



Press release: Clinerion launches a series of webinars to introduce the Patient Recruitment System to different regions of the world.

Publication date: August 17, 2016

Clinerion is launching a series of webinars to introduce the features and benefits of its Patient Recruitment System (PRS) to hospitals and clinical research sites around the world.

Clinerion will present their Patient Recruitment System, which makes patient recruitment for clinical trials quicker and more efficient, in a rolling series of webinars targeted at each region.

Go to the Clinerion webinars page >

PDF File: Download here

Press release: Clinerion launches a series of webinars to introduce the Patient Recruitment System to different regions of the world.

Press release: Clinerion launches a series of webinars to introduce the Patient Recruitment System to different regions of the world.
Clinerion is launching a series of webinars to introduce the features and benefits of its Patient Recruitment System (PRS) to hospitals and clinical research sites around the world.
Press release: Clinerion launches a series of webinars to introduce the Patient Recruitment System to

Clinerion will present their Patient Recruitment System, which makes patient recruitment for clinical trials quicker and more efficient, in a rolling series of webinars targeted at each region.

Go to the Clinerion webinars page >



Clinerion article: Pick and Choose (International Clinical Trials)

Publication date: July 27, 2016

What are the new big data techniques that allow the clinical trials process to be completed much more quickly and efficiently, today? We explain all, in our article in "International Clinical Trials," August 2016. © Samedan Ltd.

Traditional methods of fnding suitable candidates for clinical trials are time-intensive and cost drug companies millions, putting the development of new medicines at risk and elevating prices. New techniques borrowed from big data analytics allow the process to be completed much more effciently.

Link to August 2016 edition of International Clinical Trials: www.samedanltd.com/magazine/13

PDF File: Download here

Clinerion article: Pick and Choose (International Clinical Trials)

Clinerion article: Pick and Choose (International Clinical Trials)
What are the new big data techniques that allow the clinical trials process to be completed much more quickly and efficiently, today? We explain all, in our article in "International Clinical Trials," August 2016. © Samedan Ltd.
Clinerion article: Pick and Choose (International Clinical Trials)

Traditional methods of fnding suitable candidates for clinical trials are time-intensive and cost drug companies millions, putting the development of new medicines at risk and elevating prices. New techniques borrowed from big data analytics allow the process to be completed much more effciently.

Link to August 2016 edition of International Clinical Trials: www.samedanltd.com/magazine/13



News: A new patent for Clinerion!

Publication date: July 25, 2016

Clinerion's Patient Recruitment System is built around a number of proprietary, cutting-edge, big data analytics technologies. We are happy to announce that Clinerion has been granted a patent for one of these technologies, which optimizes search results when running feasibility queries.

The patent, “Semantic Interoperability System for Medicinal Information” (U.S. Patent US20130030827 A1, Publication date: January 31, 2013), is used in the semantic search and indexing component at the backend of Patient Recruitment System. This technology applies rules on semantic elements, mostly elements of medical terminologies, on how to link them with patient data for an improved and high-performance indexing and optimized search results.

Congratulations to our team!

Read more about our unique, patented technology >

News: A new patent for Clinerion!

News: A new patent for Clinerion!
Clinerion's Patient Recruitment System is built around a number of proprietary, cutting-edge, big data analytics technologies. We are happy to announce that Clinerion has been granted a patent for one of these technologies, which optimizes search results when running feasibility queries.
News: A new patent for Clinerion!

The patent, “Semantic Interoperability System for Medicinal Information” (U.S. Patent US20130030827 A1, Publication date: January 31, 2013), is used in the semantic search and indexing component at the backend of Patient Recruitment System. This technology applies rules on semantic elements, mostly elements of medical terminologies, on how to link them with patient data for an improved and high-performance indexing and optimized search results.

Congratulations to our team!

Read more about our unique, patented technology >



Press release: Clinerion named a Finalist in 2016 Stratus Awards for Cloud Computing

Publication date: July 21, 2016

Clinerion named a Finalist in awards which recognize companies that offer unique solutions that take advantage of cloud technologies.

The Business Intelligence Group has announced that Clinerion has been recognized as a Finalist in their annual Stratus Awards for Cloud Computing. The organization sought to identify the companies, products and people that are offering unique solutions that take advantage of cloud technologies ...

Business Intelligence Group Press Release: 26 Companies That Prove the Cloud is Dominating Globally.

PDF File: Download here

Press release: Clinerion named a Finalist in 2016 Stratus Awards for Cloud Computing

Press release: Clinerion named a Finalist in 2016 Stratus Awards for Cloud Computing
Clinerion named a Finalist in awards which recognize companies that offer unique solutions that take advantage of cloud technologies.
Press release: Clinerion named a Finalist in 2016 Stratus Awards for Cloud Computing

The Business Intelligence Group has announced that Clinerion has been recognized as a Finalist in their annual Stratus Awards for Cloud Computing. The organization sought to identify the companies, products and people that are offering unique solutions that take advantage of cloud technologies ...

Business Intelligence Group Press Release: 26 Companies That Prove the Cloud is Dominating Globally.



Press article: Enrolling patients and keeping them: electronic patient recruitment companies collaborate (Outsourcing Pharma)

Publication date: July 18, 2016

Outsourcing Pharma reports on the announcement by eClinicalHealth and Clinerion on our collaboration, under which the companies will offer their complementary technologies jointly to hospitals and sponsor companies/CROs ...

Press article: Enrolling patients and keeping them: electronic patient recruitment companies collaborate (Outsourcing Pharma)

Press article: Enrolling patients and keeping them: electronic patient recruitment companies collaborate (Outsourcing Pharma)
Outsourcing Pharma reports on the announcement by eClinicalHealth and Clinerion on our collaboration, under which the companies will offer their complementary technologies jointly to hospitals and sponsor companies/CROs ...
Press article: Enrolling patients and keeping them: electronic patient recruitment companies collabor


Press release: eClinicalHealth and Clinerion join forces to provide complementary and innovative support for clinical trials, creating synergies benefiting the entire clinical trials process.

Publication date: July 11, 2016

A collaboration between Clinerion’s data driven Patient Recruitment System and the direct, individualized patient/physician engagement offered by eClinicalHealth’s Clinpal provides complementary support and synergies throughout the clinical trials process.

Clinerion and eClinicalHealth, innovative companies working in the area of electronic patient recruitment, announce a collaboration between the two companies and their respective platforms, Clinerion’s Patient Recruitment System and eClinicalHealth’s Clinpal.

Under the terms of the collaboration, Clinerion and eClinicalHealth will leverage the complementary nature of their respective technologies by offering them in tandem to hospitals and sponsor companies/CROs.

PDF File: Download here

Press release: eClinicalHealth and Clinerion join forces to provide complementary and innovative support for clinical trials, creating synergies benefiting the entire clinical trials process.

Press release: eClinicalHealth and Clinerion join forces to provide complementary and innovative support for clinical trials, creating synergies benefiting the entire clinical trials process.
A collaboration between Clinerion’s data driven Patient Recruitment System and the direct, individualized patient/physician engagement offered by eClinicalHealth’s Clinpal provides complementary support and synergies throughout the clinical trials process.
Press release: eClinicalHealth and Clinerion join forces to provide complementary and innovative supp

Clinerion and eClinicalHealth, innovative companies working in the area of electronic patient recruitment, announce a collaboration between the two companies and their respective platforms, Clinerion’s Patient Recruitment System and eClinicalHealth’s Clinpal.

Under the terms of the collaboration, Clinerion and eClinicalHealth will leverage the complementary nature of their respective technologies by offering them in tandem to hospitals and sponsor companies/CROs.



Press article: Clinerion patient recruitment system selected as official service for ICN members (Outsourcing Pharma)

Publication date: April 20, 2016

Outsourcing Pharma reports on the International Clinical Trial Center Network (ICN) adopting Clinerion's patient recruitment system as an official service to help its members speed trail startup ...

Press article: Clinerion patient recruitment system selected as official service for ICN members (Outsourcing Pharma)

Press article: Clinerion patient recruitment system selected as official service for ICN members (Outsourcing Pharma)
Outsourcing Pharma reports on the International Clinical Trial Center Network (ICN) adopting Clinerion's patient recruitment system as an official service to help its members speed trail startup ...
Press article: Clinerion patient recruitment system selected as official service for ICN members (Out


Press release: The International Clinical Trial Center Network (ICN) adopts Clinerion's Patient Recruitment System as an official service.

Publication date: April 19, 2016

We are thrilled to announce the adoption of Clinerion's Patient Recruitment System (PRS) as an official service by the International Clinical Trial Center Network (ICN), the network of top-tier clinical research institutions, worldwide. PRS brings automated medical informatics solutions for protocol design, site selection and patient recruitment to members of the ICN.

Clinerion and the International Clinical Trial Center Network (ICN) announce the adoption of Clinerion’s Patient Recruitment System (PRS) as an officially recommended service for members of the ICN. PRS’s three modules, Protocol Designer, Site Finder and Patient Finder, bring leading-edge medical informatics innovations to this network, which includes many of the world’s premier clinical research institutions.

PDF File: Download here

Press release: The International Clinical Trial Center Network (ICN) adopts Clinerion's Patient Recruitment System as an official service.

Press release: The International Clinical Trial Center Network (ICN) adopts Clinerion's Patient Recruitment System as an official service.
We are thrilled to announce the adoption of Clinerion's Patient Recruitment System (PRS) as an official service by the International Clinical Trial Center Network (ICN), the network of top-tier clinical research institutions, worldwide. PRS brings automated medical informatics solutions for protocol design, site selection and patient recruitment to members of the ICN.
Press release: The International Clinical Trial Center Network (ICN) adopts Clinerion's Patient

Clinerion and the International Clinical Trial Center Network (ICN) announce the adoption of Clinerion’s Patient Recruitment System (PRS) as an officially recommended service for members of the ICN. PRS’s three modules, Protocol Designer, Site Finder and Patient Finder, bring leading-edge medical informatics innovations to this network, which includes many of the world’s premier clinical research institutions.



Press release: Clinerion's Patient Recruitment System promises acceleration of clinical trial patient recruitment in the UK

Publication date: March 14, 2016

Clinerion will present its Patient Recruitment System, which allows real-time patient search for clinical trials via simultaneous query of multiple sets of electronic health records, at the UK eHealth Week.

Clinerion will introduce the disruptive innovation brought to clinical research by its Patient Recruitment System (PRS) at the UK e-Health Week, at the Olympia exhibition centre, London, April 19-20, 2016. Clinerion will give live demonstrations of PRS at Booth #45, as well as a presentation on the “TED Talks” stage on the exhibition floor.

PDF File: Download here

Press release: Clinerion's Patient Recruitment System promises acceleration of clinical trial patient recruitment in the UK

Press release: Clinerion's Patient Recruitment System promises acceleration of clinical trial patient recruitment in the UK
Clinerion will present its Patient Recruitment System, which allows real-time patient search for clinical trials via simultaneous query of multiple sets of electronic health records, at the UK eHealth Week.
Press release: Clinerion's Patient Recruitment System promises acceleration of clinical trial pa

Clinerion will introduce the disruptive innovation brought to clinical research by its Patient Recruitment System (PRS) at the UK e-Health Week, at the Olympia exhibition centre, London, April 19-20, 2016. Clinerion will give live demonstrations of PRS at Booth #45, as well as a presentation on the “TED Talks” stage on the exhibition floor.



Press article: Clinerion Revolutionizes Patient Recruitment (SuperbCrew)

Publication date: February 15, 2016

How do we see our technologies revolutionising clinical research? Clinerion's CEO Ulf Claesson explains, in this interview by SuperbCrew ...

Press article: Clinerion Revolutionizes Patient Recruitment (SuperbCrew)

Press article: Clinerion Revolutionizes Patient Recruitment (SuperbCrew)
How do we see our technologies revolutionising clinical research? Clinerion's CEO Ulf Claesson explains, in this interview by SuperbCrew ...
Press article: Clinerion Revolutionizes Patient Recruitment (SuperbCrew)


Press article: Clinerion debuts Patient Recruitment System in North America (CenterWatch)

Publication date: February 01, 2016

Article on Clinerion's North American launch tour in the February 1, 2016 edition of CWWeekly, the weekly publication from CenterWatch.

CWWeekly is only available to subscribers.

Link: CWWeekly.

Press article: Clinerion debuts Patient Recruitment System in North America (CenterWatch)

Press article: Clinerion debuts Patient Recruitment System in North America (CenterWatch)
Article on Clinerion's North American launch tour in the February 1, 2016 edition of CWWeekly, the weekly publication from CenterWatch.
Press article: Clinerion debuts Patient Recruitment System in North America (CenterWatch)

CWWeekly is only available to subscribers.

Link: CWWeekly.



Press release: Clinerion's Patient Recruitment System debuts in North America

Publication date: January 25, 2016

Clinerion will present its Patient Recruitment System, which allows real-time patient search for clinical trials via direct query of electronic health records, for the first time in North America at the SCOPE Summit and the HX360 Executive Forum, part of the HIMSS Health IT Conference.

Clinerion will introduce its clinical research solutions in North America at SCOPE, the Summit for Clinical Ops Executives, and HX360, the Executive Forum for health and technology innovation (part of the HIMSS Health IT Conference). At both events, Clinerion will give live demonstrations of its Patient Recruitment System (PRS) and Quality Risk Management (QRM) system ...

PDF File: Download here

Press release: Clinerion's Patient Recruitment System debuts in North America

Press release: Clinerion's Patient Recruitment System debuts in North America
Clinerion will present its Patient Recruitment System, which allows real-time patient search for clinical trials via direct query of electronic health records, for the first time in North America at the SCOPE Summit and the HX360 Executive Forum, part of the HIMSS Health IT Conference.
Press release: Clinerion's Patient Recruitment System debuts in North America

Clinerion will introduce its clinical research solutions in North America at SCOPE, the Summit for Clinical Ops Executives, and HX360, the Executive Forum for health and technology innovation (part of the HIMSS Health IT Conference). At both events, Clinerion will give live demonstrations of its Patient Recruitment System (PRS) and Quality Risk Management (QRM) system ...



Clinerion article: Quality Risk Management as a Survival Kit: From Idea to Implementation (DIA Global Forum)

Publication date: September 08, 2015

The article Quality Risk Management as a Survival Kit: From Idea to Implementation was published in the journal DIA Global Forum and written by Ramin-Wright, Randy, Director of Quality Risk Management, Clinerion Ltd., Basel Switzerland and Andrianov, Artem, Ph.D., Managing Director, Cyntegrity Germany GmbH, Frankfurt Germany in August 2015 Volume 7, Issue 4.

Efficient risk management becomes a survival kit for a modern pharmaceutical company. How should one select from the available Risk-based Monitoring (RBM) solutions? This article explains the main principles of Risk-based Monitoring, refers to the changing regulatory environment (GCP addendum E6-R2) and categorizes available RBM technologies by IT infrastructure, data sourcing, assessment frequency, risk areas and feature-sets. Moreover, it provides a simple to follow framework for RBM technology selection and a systematic five-step RBM rollout consisting of: proof concept, pilot project, lessons learned, adjustment of RBM and final rollout ...

PDF File: Download here

Clinerion article: Quality Risk Management as a Survival Kit: From Idea to Implementation (DIA Global Forum)

Clinerion article: Quality Risk Management as a Survival Kit: From Idea to Implementation (DIA Global Forum)
The article Quality Risk Management as a Survival Kit: From Idea to Implementation was published in the journal DIA Global Forum and written by Ramin-Wright, Randy, Director of Quality Risk Management, Clinerion Ltd., Basel Switzerland and Andrianov, Artem, Ph.D., Managing Director, Cyntegrity Germany GmbH, Frankfurt Germany in August 2015 Volume 7, Issue 4.
Clinerion article: Quality Risk Management as a Survival Kit: From Idea to Implementation (DIA Global

Efficient risk management becomes a survival kit for a modern pharmaceutical company. How should one select from the available Risk-based Monitoring (RBM) solutions? This article explains the main principles of Risk-based Monitoring, refers to the changing regulatory environment (GCP addendum E6-R2) and categorizes available RBM technologies by IT infrastructure, data sourcing, assessment frequency, risk areas and feature-sets. Moreover, it provides a simple to follow framework for RBM technology selection and a systematic five-step RBM rollout consisting of: proof concept, pilot project, lessons learned, adjustment of RBM and final rollout ...



Press release: Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management

Publication date: May 28, 2015

Clinerion and the Alliance for Clinical Research Excellence and Safety (ACRES) have strategically allied to further the establishment of a shared global technology infrastructure enabling ACRES BlueCloud services so that stakeholders from sites, to CROs and research Sponsors can benefit from established innovative technology services such as those Clinerion provides.

Clinerion, an eClinical technology services provider located in Basel, Switzerland, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge, Massachusetts-based non-profit organization operating in the public interest and dedicated to building a global system to enhance quality, safety, integrity and operational effectiveness in biomedical product development and health research, are pleased to announce their partnership for accelerating patient recruitment and promoting risk-based quality management ...

PDF File: Download here

Press release: Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management

Press release: Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management
Clinerion and the Alliance for Clinical Research Excellence and Safety (ACRES) have strategically allied to further the establishment of a shared global technology infrastructure enabling ACRES BlueCloud services so that stakeholders from sites, to CROs and research Sponsors can benefit from established innovative technology services such as those Clinerion provides.
Press release: Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management

Clinerion, an eClinical technology services provider located in Basel, Switzerland, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge, Massachusetts-based non-profit organization operating in the public interest and dedicated to building a global system to enhance quality, safety, integrity and operational effectiveness in biomedical product development and health research, are pleased to announce their partnership for accelerating patient recruitment and promoting risk-based quality management ...



Clinerion article: SMART Monitoring: Can new Approaches Make a Difference? (Pharmazeutische Medizin)

Publication date: February 25, 2015

The article SMART Monitoring: Can new Approaches Make a Difference? was published in the journal Pharmzeutische Medizin (in English) by Randy Ramin-Wright in the February 2015 edition. It is a practical guide that explains how to successfully improve the effectiveness of one’s current site monitoring practices and ultimately the quality of work done at clinical trial sites. Furthermore, it lays the foundation for a SMART Monitoring approach and provides advice on enabling technology.

Depending on your role in the organization you may have been confronted with the topic of “Risk-based Monitoring”, “Fit for Purpose Monitoring”, “Targeted Monitoring” or some other permutations of the same basic theme in one context or another. You may be wondering what's all the fuss about or you may even have been tasked with the goal of setting up a new monitoring approach at your organization. In either case, this article has something of interest for you as it is a practical guide which explains how one can successfully improve the effectiveness of one’s current site monitoring practices and ultimately the quality of work done at clinical trial sites. The article provides an overview of traditional monitoring practices and a new monitoring initiative in the pharmaceutical industry. Additionally it lays the foundation for a SMART Monitoring approach and provides advice on enabling technology ...

PDF File: Download here

Clinerion article: SMART Monitoring: Can new Approaches Make a Difference? (Pharmazeutische Medizin)

Clinerion article: SMART Monitoring: Can new Approaches Make a Difference? (Pharmazeutische Medizin)
The article SMART Monitoring: Can new Approaches Make a Difference? was published in the journal Pharmzeutische Medizin (in English) by Randy Ramin-Wright in the February 2015 edition. It is a practical guide that explains how to successfully improve the effectiveness of one’s current site monitoring practices and ultimately the quality of work done at clinical trial sites. Furthermore, it lays the foundation for a SMART Monitoring approach and provides advice on enabling technology.
Clinerion article: SMART Monitoring: Can new Approaches Make a Difference? (Pharmazeutische Medizin)

Depending on your role in the organization you may have been confronted with the topic of “Risk-based Monitoring”, “Fit for Purpose Monitoring”, “Targeted Monitoring” or some other permutations of the same basic theme in one context or another. You may be wondering what's all the fuss about or you may even have been tasked with the goal of setting up a new monitoring approach at your organization. In either case, this article has something of interest for you as it is a practical guide which explains how one can successfully improve the effectiveness of one’s current site monitoring practices and ultimately the quality of work done at clinical trial sites. The article provides an overview of traditional monitoring practices and a new monitoring initiative in the pharmaceutical industry. Additionally it lays the foundation for a SMART Monitoring approach and provides advice on enabling technology ...



Press article: Clinerion launches real-time patient recruitment system to boost trial recruitment (CenterWatch)

Publication date: November 12, 2014

Clinerion, a Swiss-based software and services company, has launched its Patient Recruitment System (PRS). Clinerion’s PRS radically boosts recruitment for clinical trials, identifying 10 to 30 times more suitable candidates than those found through a classical manual screening approach, and in a matter of minutes rather than the weeks or months typically needed ...

Press article: Clinerion launches real-time patient recruitment system to boost trial recruitment (CenterWatch)

Press article: Clinerion launches real-time patient recruitment system to boost trial recruitment (CenterWatch)
Clinerion, a Swiss-based software and services company, has launched its Patient Recruitment System (PRS). Clinerion’s PRS radically boosts recruitment for clinical trials, identifying 10 to 30 times more suitable candidates than those found through a classical manual screening approach, and in a matter of minutes rather than the weeks or months typically needed ...
Press article: Clinerion launches real-time patient recruitment system to boost trial recruitment (Ce


News: Clinerion becomes member of ACRES

Publication date: May 20, 2014

Clinerion joins ACRES, the Alliance for Clinical Research Excellence and Safety (ACRES) Technology Consortium.

Clinerion has become a member of the Alliance for Clinical Research Excellence and Safety (ACRES) Technology Consortium, which aims to create an IT platform using existing technologies to fast-track the development of an integrated interface for: sharing of professional credentials, site-capability profiles and demographics for site-qualification assessments; online performance dashboard; risk-based quality management analytics and support; and cloud-based tools for enhanced compliance, safety-reporting and monitoring.

ACRES Press Release: www.prweb.com/releases/GKoskiACRES/TechConsortium/prweb11864883.htm

News: Clinerion becomes member of ACRES

News: Clinerion becomes member of ACRES
Clinerion joins ACRES, the Alliance for Clinical Research Excellence and Safety (ACRES) Technology Consortium.
News: Clinerion becomes member of ACRES

Clinerion has become a member of the Alliance for Clinical Research Excellence and Safety (ACRES) Technology Consortium, which aims to create an IT platform using existing technologies to fast-track the development of an integrated interface for: sharing of professional credentials, site-capability profiles and demographics for site-qualification assessments; online performance dashboard; risk-based quality management analytics and support; and cloud-based tools for enhanced compliance, safety-reporting and monitoring.

ACRES Press Release: www.prweb.com/releases/GKoskiACRES/TechConsortium/prweb11864883.htm



News: Swiss Made Software

Publication date: April 10, 2013

Clinerion is now a member of swiss made software.

Clinerion is dedicated to promoting the Swiss software sector both in Switzerland and abroad.

The label "swiss made software" embraces Swiss values in software development and has now over 200 member companies. For a product to be labeled as "swiss made software", the following conditions must be met:

  • The Swiss share in the production value must be at least 60 percent.
  • The key production process must have taken place in Switzerland

Link: www.swissmadesoftware.org.

News: Swiss Made Software

News: Swiss Made Software
Clinerion is now a member of swiss made software.
News: Swiss Made Software

Clinerion is dedicated to promoting the Swiss software sector both in Switzerland and abroad.

The label "swiss made software" embraces Swiss values in software development and has now over 200 member companies. For a product to be labeled as "swiss made software", the following conditions must be met:

  • The Swiss share in the production value must be at least 60 percent.
  • The key production process must have taken place in Switzerland

Link: www.swissmadesoftware.org.

News